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Abstract  
Engineering artificial cells is currently an emerging area of research that involves constructing 
mimics of biological cells. These biomimetic cellular systems hold tremendous promise for 
the different biomedical applications (diagnostics, therapy, tissue engineering, gene 
transfection, bioactive coatings) as well as aspects of synthetic biology. A key architectural 
principle of the cell is a multicompartmentalized assembly, which is one of the features of 
biological cells that enable the performance of multiple complex biochemical reactions within 
confined environments. For this purpose, this study demonstrates novel artificial cells, not 
only presenting organelle mimics but also incorporating various stimuli for regulating 
enzymatic cascade reactions within the artificial cell and for controlled simultaneous and/or 
subsequent release of the encapsulated (therapeutic) molecules. 
To successfully fabricate the multifunctional polymeric multicompartmentalized systems as 
artificial cells aimed for, in the first step a hollow capsule as biomimetic cellular membrane 
was developed to simulate a key characteristic of functional artificial cells for the selective 
uptake and release of (bio)molecules and particles for intra- and intercellular signaling 
processes. Herein using LbL technique which involved alternate deposition of oppositely 
charged polyelectrolytes on silica template via electrostatic interaction, the pH and 
temperature dual-responsive and photo-crosslinked hollow capsule was fabricated and they 
can be used for the subsequent post-encapsulation process of protein-like macromolecules ( 
≤ 11 nm) and their controllable release triggered by external stimuli for mimicking the 
controllable bio-inspired functions of cell membranes. The reversible temperature and pH 
dual-response ability of the hollow capsules has been analyzed. The uptake and release 
properties of the resulting hollow capsules with different degree of photo-crosslinking for 
cargos have been further investigated at various temperatures (25, 37 or 45°C) and pH (5.5 or 
7.4) of the solution. 
Next, the design of the polymersomal subcompartmens as organelle mimics, which divide the 
interior of the multicompartmentalized systems into subcompartments and can stably 
encapsulate fragile hydrophobic and hydrophilic cargo, e.g., enzymes in order to conduct 
encapsulated catalysis-resembling cell organelles, was also an important subject. The 
fabrication of these subcompartments was starting with the synthesis of suitably end-group 
block copolymers to realize the enzyme-loaded, multifunctional, pH-responsive, photo-
crosslinked and post-labelled polymersomes decorated with adamantane groups. The pH 
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sensitivity and various enzymatic reactions of the established multifunctional Ada-
polymersomes have been investigated. 
Based on the above concepts, a bottom-up approach was developed to assemble a structural 
and functional eukaryotic cell mimics, including “membrane-associated” 
multicompartmentalized system (MS1) and “free-floating” multicompartmentalized system 
(MS2), by loading pH-sensitive Ada-polymersomes inside the multifunctional cell membrane. 
The creation of these multicompartmentalized systems was based on the assembly of enzyme-
loaded Ada-polymersomes as organelle mimics onto sacrificial particle templates by host-
guest interaction, followed by the LbL deposition of temperature-responsive and photo-
crosslinkable PMA(β-CD)/[PAH/PNMD]3 multilayers and outer protective capping 
PAH/PMA(PEG)  bilayer as biomimetic cellular membrane. Upon photo-crosslinking the 
polymer biomimetic membrane and dissolution of the particle templates, 
multicompartmentalized systems were obtained. Spatial position of the subcompartments can 
be controlled using non-covalent host-guest concept, which yielded multicompartmentalized 
systems containing “membrane-associated” and “free-floating” subunits. Moreover, the 
metabolism mimicry of multicompartmentalized systems by performing multiple successive 
two-enzyme cascade reactions in the cells and the multiple parallel reactions by using a third 
enzyme for deactivating the reaction product and interfering the cascade reaction have been 
investigated. 
In conclusion, these multicompartmentalized systems, combining the advantages of both pH-
responsive Ada-polymersomes as organelle mimics and multifunctional hollow capsule as 
biomimetic cellular membrane, present new opportunities for the development of functional 
cell mimics. The presented studies highlight crucial aspects for the successful applications of 
such cell mimics for diagnostics, tissue engineering, as nanoreactors, as carriers for multiple 
drug delivery with controlled release profiles, or as therapeutic artificial cells. 
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1 Theoretical Background 
1.1 Introduction 
The cell is certainly one of the most complex and exciting systems in nature that scientists are 
still trying to fully understand.1 Most notably, driven largely by the motivation to replicate 
nature’s assemblies from synthetic components, the engineering of artificial cells2-7 is 
currently an emerging area of research that involves mimicking the structure and the function 
of a cell from functional materials. Constructing simplified synthetic cells has garnered 
research interest because it contributes to an understanding of biological processes and 
provides new and unique prospects for future therapeutic applications, from self-regulating 
bioreactors to new biomedical devices.8 Biological eukaryotic cells are equipped with 
multiple highly optimized and specialized internal subcompartments known as organelles that 
have the ability to carry out specific metabolic activities and are surrounded by a selectively 
permeable biological membrane that serves as a structural scaffold and partitions the cell 
interior from the external milieu (Figure 1.1).9 Thus, compartmentalization10 is one of the key 
architectural principles of the cell.11, 12 It is one of the features of biological cells that enable 
the performance of spatially separated and multiple complex biochemical reactions with high 
accuracy and specificity within confined environments. Hence the mimicry of this feature is a 
key aspect in designing artificial cells. To design and establish such artificial cells with unique 
subcompartmentalized structure, some concerns have to be taken into account. Obviously, the 
first issue is that the artificial cells should have a structural scaffold with specific permeability 
that allows controlled interaction between the cell interior and the external milieu-resembling 
cell membranes. The artificial cells also should have specialized subcompartments that allow 
for multiple, spatially separated and successive enzymatic reactions within a confined area, 
resembling cell organelles. This compartmentalized design therefore allows control over the 
metabolic reactions in space and time required for the proper functioning of cells (Figure 1.1). 
Despite the need for a broad range of synthetic multicompartmentalized systems, few 
examples of most successful subcompartmentalized carriers have been reported to date, 
including vesosomes13-15 and capsosomes16-20. Compared to these liposomes-based 
multicompartmentalized systems, polymersomes-based multicompartmentalized systems hold 
promise to better mimic the structural properties of viral capsids21 because of their higher 
flexibility, tunable permeability, higher mechanical and colloidal stability, enhanced 
durability and potential stimulus-responsive properties22-28. In a more recent approach, Weitz 
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and coworkers presented ‘‘polymersome-in-polymersome’’ with microfluidics technique 
based on the emulsions method29-33. However, most of these structures have different 
limitations, such as nonbiofriendly processing techniques, low loading capacity, low stability 
and poor functionality in terms of release, permeability, variable surface chemistry, 
orthogonal behavior and stimuli response (e.g., pH, temperature, etc). 
 
Figure 1.1 Eukaryotic cell biomimicry: towards cellular structure and function.9  
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Herein, specifically designed to address these crucial shortcomings, this work reports a novel 
artificial cell, not only presenting organelle mimics but also incorporating various stimuli for 
regulating enzymatic cascade reactions within the cell and for controlled simultaneous and/or 
subsequent release of the encapsulated (therapeutic) molecules. This artificial cell is 
conducted by combining the advantages of both pH-responsive Ada-polymersomes as 
organelle mimics and multifunctional hollow capsule as biomimetic cellular membrane. 
1.2 Synthetic Methods to Produce Polymers 
In a typical free radical polymerization (RP) of chain growth polymerization, an initiator 
cleaves or decomposes homolytically to form radical(s) to initiate polymerization. The active 
radicals attack monomers continuously to propagate their chain length until termination, by 
which, the radical is transferred to another molecule or chain or two radicals are combined 
together. The initiation is relatively slow while the propagation process is very fast (around 1 
s or shorter). Since the lifetime of growing chains is very fast, end-group and addition of a 
second monomer to form block copolymer are impossible. In addition, control of molecular 
weight and molecular weight distribution are low, i.e. large dispersity (Ð), due to radical 
termination.34  
Controlled radical polymerization (CRP), which aims to eliminate transfer and termination 
reactions from chain growth polymerization, has been developed by Matyjaszewski et al.35, 36 
A dynamic equilibrium between propagating radicals and dormant species in the presence of 
catalyst complex is established under CRP. The initiation step is fast while the propagation 
rate is relatively slow to control the chain length and minimize the proportion of terminated 
chains. The long propagation step also endues opportunity of chain-end functionalization and 
block copolymer formation.  As a result, chain architecture, such as unbranched, well defined 
block copolymers with good control of MW and distribution as well as end-group, can be 
achieved.    
Hence, to ensure that block copolymer will assemble to the desired nanostructure, it is 
mandatory to design block copolymers with precise blocks length and with low molar mass 
distribution (Ð). Thus, a CRP technique has to be applied for copolymer synthesis. In 
particularly, atom transfer radical polymerization (ATRP) and reversible addition-
fragmentation chain transfer radical polymerization (RAFT) are wildly used to synthesis the 
amphiphilic block copolymers and they are discussed in the following section. 
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1.2.1 Atom Transfer Radical Polymerization (ATRP) 
For forming polymersomes, the polymer needs a precise structure in terms of a well-defined 
block length in both, the hydrophobic and hydrophilic segments to obtain the desired 
morphology. The choice of the polymerization technique is greatly dependent on the 
monomer to be processed. In our polymersomes studies, methacrylate derivatives are widely 
used within the hydrophobic part, making atom transfer radical polymerization (ATRP)37, 38 
the method of choice. 
The key component for ATRP is the metal catalyst and copper(I) salt37-39 is the most 
frequently used whereas iron compounds40, ruthenium,41, molybdenum42 and palladium43 can 
be also utilized. Figure 1.2 illustrates the reaction mechanism of a typical ATRP with Cu(I) 
used in the catalytic complex. In order to perform the ATRP reactions under homogeneous or 
heterogeneous conditions, the transition metal complex (Cu(I)/2L) has to be fully or at least 
partially soluble in the reaction medium. In this regard, the complexing ligand plays an 
essential role in improving the solubility, selectivity and reactivity of the metal catalyst. Those 
ligands mostly contain nitrogen atoms, which are prone for metal complexation due to their 
lone pair of electrons (e.g. the solid 2,2'-bipyridine(bpy)).44 Thus, ATRP is initiated by the 
homolytic cleavage of the carbon-halide bonding of the alkyl halide (R-X) initiator by the 
metal/ligand catalyst complex (Mt
n/L) to generate an oxidized metal halide complex (Mt
n+1X/L) 
and an active radical (R·) with rate constant Kact.
45 The radical is now the active polymerizing 
species and reacts with the methacrylic monomers present in the solution to a growing 
polymer chain. The propagation process exists in equilibrium, which is mainly in the side of 
the dormant species which produce continuously unreactive chains. Thus, the reaction can be 
simply aborted by exposing it to air, which results in copper oxidation so as to have 
unreactive dormant polymer chains.  
 
Figure 1.2 General mechanism of the transition-metal catalyzed ATRP having the following 
reaction rate constants: kact (activation), kdeact (deactivation), kp (propagation), kt 
(termination).45   
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Using ATRP, the growth of the polymer chains can be controlled in an effective manner, 
usually leading to a polymer with a low dispersity (Ð) of 1.3 or lower. A low Ð means that all 
polymer chains roughly have the same length, a necessary precondition to form 
polymersomes in a uniform and controlled fashion. And according to equation 1.1,46 Ð can be 
reduced by decreasing the ratio of kp/kdeact. That means, the polymer uniformity can be 
improved by increasing the deactivator concentration and monomer conversion. In addition, 
transition metal which contributes to high kdeact can give low Ð even it is used in low 
concentration.  
Mw
Mn
= 1 +
1
DPn
+ (
[RX]0𝑘𝑃
𝑘𝑑𝑒𝑎𝑐𝑡[Mt
n+1 X/L]
) (
2
Covn.
− 1)                                                                          (1.1)                                                   
1.2.2 Reversible Addition-fragmentation Chain-transfer Radical Polymerization 
(RAFT) 
For temperature responsive multilayers as cell membrane to form, the polymer should consist 
of N-isopropyacrylamide (NIPAM) and acid segments. Since a major advantage of the 
reversible addition-fragmentation chain transfer radical polymerization (RAFT)47, 48 process 
over other processes for living/controlled free-radical polymerization is that it is compatible 
with a very wide range of monomers including functional monomers containing acid and 
amino groups, the RAFT has to be applied to synthesize our desired polymer containing end 
or side chain functionality in a one-step process without any need for protection or 
deprotection.  
Figure 1.3 shows the reaction mechanism of RAFT with thiocarbonylthio compounds. In the 
early stages of the polymerization, addition of a propagating radical (P•n) to the 
thiocarbonylthio compound (RSC(Z)=S (1)) followed by fragmentation of the intermediate 
radical provides a polymeric thiocarbonylthio compound (PnS(Z)C=S (3)) and a new radical 
(R•). Reaction of this radical (R•) with monomer forms a new propagating radical (P•m). 
Eventually, rapid equilibrium between the active propagating radicals (P•n) and (P
•
m) and the 
dormant polymeric thiocarbonylthio compounds (3) provides equal probability for all chains 
to grow and allows for the production of narrowly disperse polymers.49 The narrow molecular 
weight distribution, an important feature of controlled RAFT polymerization, is apparently 
due to rapid establishment of the pre-equilibrium, efficient reinitiation by the R• fragment, and 
attainment of the main equilibrium in which the population of dormant chains (macro-CTAs) 
and/or intermediate radicals (4) (not reactive enough to add to monomers) is much higher than 
the total number of propagating chains P•n and P
•
m.
50 Indeed, the pseudo-first-order kinetics, 
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the linear evolution of molecular weight with time, narrow molecular weight distributions, 
and the ability to prepare block copolymers under appropriate conditions attest to significant 
elimination of chain termination events such as radical coupling and chain transfer common to 
conventional free radical polymerization also shown in Figure 1.3.49 When the polymerization 
is complete (or stopped), most of the chains retain the thiocarbonylthio end-group and can be 
isolated as stable materials. 
 
Figure 1.3 Mechanism of RAFT polymerization.49   
1.3 Self-assembled Block Copolymers for Polymersomes  
Polymersomes, which are synthetic mimics of liposomes, are formed via the self-assembly of 
amphiphilic block copolymers.51 Similar to liposomes, comprise an aqueous lumen 
sequestered from the external aqueous environment by a hydrophobic membrane and 
therefore can encapsulate and deliver both hydrophilic and hydrophobic cargo.52, 53 However, 
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in comparison to liposomes, polymersomes have several benefits.54 The higher molecular 
weight of block copolymers compared to phospholipids results in the generation of thicker 
membranes, and interdigitation (caused by entanglement) of the hydrophobic chains55, 56 
yields greater membrane mechanical strength.23 Importantly, the enhanced toughness of the 
polymer membrane compared to lipid membranes does not compromise its elastic and fluid-
like nature.55 Structures formed from block copolymers can retain encapsulated cargo for long 
time periods (i.e., at least 3 months)57 as a consequence of their very slow membrane 
dynamics and subsequent formation of kinetically stable, locally isolated structures.58 
Furthermore, the synthetic nature of the block copolymers enables the incorporation of 
components that allow polymersomes to respond to external stimuli such as pH, oxidative 
species, and enzymatic degradation.59 Because of these desirable properties, polymersomes 
have received considerable attention within the materials science community.  
1.3.1 Self-Assembly Principles of Amphiphilic Block Copolymers 
In principal, the self-assembly of amphiphilic block copolymers may result in a wide range of 
structure morphologies including spherical micelles, cylindrical micelles and vesicles 
depending on the relative size of hydrophilic to hydrophobic segments.60-63 One of the 
common approaches to predict the structure morphology of the assembled copolymer is 
developed by Israelachvili et al. using the molecular packing parameter (p) (equation 1.2),64 
where v denotes the hydrophobic volume, l is the critical length of the hydrophobic block and 
a is the interfacial area between the hydrophobic and hydrophilic blocks. This model relies on 
geometrical considerations to describe the influence of relative hydrophilic/hydrophobic ratio 
on the resulted morphology. 
p =
v
al
                                                                                                                                                     (1.2) 
By calculating the p values, the resulting shape of the self-assembled structures can be 
predicted as seen in Table 1.2,65 for instance, spherical micelle (p<1/3), cylindrical micelle 
(1/3<p<1/2), vesicle (1/2<p<1), and inverted structure (p>1). However, it should be noted that 
the packing parameter is defined by means of geometrical aspects and therefore it is not 
adequate to fully explain the self-assembly of amphiphilic block copolymers. The free energy 
of the system, which is the combination of the interfacial energy of the hydrophobic-
hydrophilic interface and the entropy loss of the polymer chains during vesicle formation, 
have a considerable effect on the resulting morphologies. In this manner, Disher and 
Eisenberg reported another critical parameter known as mass or volume fraction of the 
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hydrophilic segment of the block copolymer (ƒ) to predict the morphology of the self-
assembled structures (Table 1.1). In fact, vesicular structures are predicted from the self-
assembly of block copolymers with ƒ=10–40%. At ƒ=45–55%, cylindrical micelles are 
usually obtained, while spherical micelles are predominantly formed at ƒ=55–70%.66, 67  
Table 1.1 Packing parameter and hydrophilic fraction of different self-assemblies.65-67  
Shape of the assemblies Packing parameter [p] Hydrophilic Fraction [f]a) 
Spherical Micelle p < 1/3 f = 0.55 - 0.70 
Cylindrical Micelle 1/3 < p < 1/2 f = 0.45 - 0.55 
Vesicle 1/2 < p < 1 f = 0.10 - 0.40 
a)  Hydrophilic fraction of the block copolymers either mass or volume ratios. 
Although the hydrophilic/hydrophobic ratio is an important factor to predict the shape of 
assemblies, it should be stressed that it is not the only determinative parameter. The 
morphology of the resultant nanostructure could be also influenced by several other factors 
including the preparation method, block copolymer structure and concentration, ratio of 
organic solvent/water, the nature of the solvent, temperature and and the presence of salts, 
acids or bases.68, 69  
1.3.2 Preparation Techniques 
Numerous techniques exist for preparing polymersomes from the self-assembly of 
amphiphilic block copolymers. There are several strategies like solvent inversion, film 
rehydration, electroformation and direct dissolution method which is indeed utilized in this 
study. Indeed, choosing the suited preparation technique is mainly dictated by the copolymer 
chemistry and the desired application. It should be also noted that the technique for preparing 
polymersomes has an important influence on the resulting polymersome size from nanometer 
to micrometer scale. Thus, this is also an essential criterion for choosing the most suitable 
preparation method.  
For solvent inversion the whole block copolymer needs to be dissolved completely in an 
organic solvent such as THF, chloroform, dichloromethane or ethanol which would be 
miscible with water in any ratio without forcing phase separation between the solvents. 
Subsequently, the dissolved polymer is gradually mixed with water under vigorous stirring, 
the hydrophobic blocks become insoluble and form the membrane, while the solvated 
hydrophilic blocks create the polymersome corona.70, 71 Using dialysis against water or 
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ultrafiltration, a pure polymersome solution can be achieved through removing the residual 
organic solvent. The biggest problem is that the morphology of the resulting self-assembled 
structures may be affected during the prolonged dialysis period.60, 72  
For film rehydration the amphiphilic block copolymer also should be dissolved in an organic 
solvent such as chloroform and ethanol. Then the solvent is evaporated slowly to produce a 
thin film on a solid surface, followed by adding the water to form the polymersomes.56, 73 In 
contrast to solvent inversion, this method combines with an extrusion step to obtain 
polymersomes with a narrow size distribution.74 
Electroformation, which is similar to the film hydration method, is widely used in liposome 
production.75 The polymer is spread onto an electrode surface followed by adding the water, 
and the vesicles eventually detach from the surface to yield micrometer-sized giant 
polymersomes by applying the electric current.23, 70 
Besides exchanging the solvent at some point, the direct dissolution method is conducted by 
directly self-assembling the block copolymers in water or aqueous buffer solutions under 
vigorous stirring. The advantages of this method over the previously mentioned ones are that 
the solution does not need to be cleaned afterwards and no solvent exchange is necessary.76 
For example, the poly(ε-caprolactone)-b-poly(2-aminoethyl-methacrylate) and poly(ε-
caprolactone)-b-poly[2-(methacryloyloxy)ethyl phosphorylcholine] based polymeromes have 
been successfully prepared in pure water within this technique.77, 78 Especially for pH 
sensitive polymer, the self-assembly can be easily performed by adjusting the pH of the 
corresponding polymer solution. The pH-sensitive groups, such as 2-(diisopropylamino)ethyl 
methacrylate, 2-(diethylamino) ethyl methacrylate and dimethylaminoethyl methacrylate, 
enable the direct dissolution of the copolymer in an acidic water by means of protonation. 
And then, the self-assemble process is promoted by increasing the pH to basic value. 
Deprotonation of the amino groups at the basic pH restores the amphiphilic character of the 
block copolymers leading to polymersomes formation.79, 80 In this study the polymersomes 
established in this thesis are also prepared through the direct dissolution of pH-sensitive block 
copolymers. 
1.3.3 Applications of Polymersomes in Synthetic Biology 
Polymersomes as synthetic biomimetics of liposomes are receiving very high interest in 
recent years because of their application potential in synthetic biology and in biomedicine.9, 23, 
26, 81-87 polymersomes are able to host both hydrophilic and hydrophobic compounds either in 
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their aqueous lumen or in the membrane. Besides, the synthetic polymer chemistry provides 
flexible structure design which enables to prepare controlled membrane permeability through 
stimuli-responsive segments27, 88-90 and selective recognition by integrating functional groups 
before or after the polymersome formation. In this respect they can act as nanocontainers91, 92 
for storage, transport and release of drugs, enzymes, proteins, gold or magnetic nanoparticles 
by using the hosting ability either individually or in combination with responsiveness and 
functionality. In addition, they can have the task of nanoreactors83, 85, 93 to mimic the cell 
functions through metabolic reactions as well as to be used in various other reaction platforms 
such as enzymatic catalysis. Both of these duties widen the application areas of polymersomes, 
particularly in biomedical science including drug delivery systems52, 94-98 synthetic biology99, 
100 in combination with multicompartmentalization to form artificial organelles and 
therapeutic delivery carriers. 
As an example of applications in synthetic biology for carrying out various enzymatic 
reactions, the group of van Hest has prepared polymersomes self-assembled from 
polystyrene-b-poly(L-isocyanoalanine(2-thiophen-3-yl-ethyl) amide) (PS40-PIAT50) block 
copolymers.101 The polymersomes showed a relatively high diffusion towards small 
molecules whereas proteins as being larger molecules cannot move across the membrane. The 
enzymes used in this study were positioned at different regions of the polymersomes in which 
glucose oxidase (GOx) was in their lumen, candida antartica lipase B (CalB) was in the 
bilayer membrane and horseradish peroxidase (HRP) was conjugated to the surface by using 
click chemistry. Every enzyme is feeding the next one with substrate. Initially, CalB 
deacetylates glucose-tetracetylate to form glucose and transports it into the polymersome 
lumen. The free glucose inside the polymersome is now oxidized by GOx, yielding the 
corresponding lactone. The third step of the reaction was to oxidize 2,2’-azinobis (3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS) using the hydrogen peroxide from the previous 
reaction by HRP on the surface.101 Although this polymersome enabled efficient cascade 
reactions, the permeability and thus the activity of the enzymes were not tunable. Hence, a 
more sophisticated nanoreactor should be less substrate specific and have an implemented 
reaction control mechanism. In this context, pH-responsive polymersomes having controlled 
membrane permeability were used to perform enzymatic reactions by Voit group. This pH-
tunable working tool was used to investigate their use in sequential enzymatic reactions 
(glucose oxidase and myoglobin) where enzymes are loaded in one common polymersome or 
in two different polymersomes. The reaction was switched off (pH 8) and on (pH 6) in 
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accordance with the increased permeability of the polymersome membranes under acidic 
conditions.99 
1.4 Layer-by-Layer (LbL)-Assembled Polymer Capsules 
1.4.1 LbL Assembly Technique 
The concept of LbL assembly was first proposed by Iler in 1966, who suggested alternating 
deposition of oppositely charged particles to create a film of multiple layers.102 This concept 
was later developed by Decher in 1991 to create multilayers by the consecutive deposition of 
oppositely charged polyelectrolytes from dilute aqueous solution onto charged solid 
substrates.103 LbL is a simple, affordable, and versatile process that does not require any 
expensive or specialized equipment and allows a wide variety of components to be used as 
building blocks on a range of substrates. Thus, the LbL technique has been used to fabricate 
functional thin films with tailored properties and controlled architectures. 
Electrostatic binding is the main approach used in the formation of the multilayers.104, 105 A 
general LbL procedure to form polyelectrolyte multilayer films via electrostatic interactions is 
illustrated in Figure1.4.105 In this process, a charged substrate is first immersed into a solution 
containing an oppositely charged polyelectrolyte, which adsorbs onto the surface, thus leading 
to an overcompensation of charge and in turn to a reversal of the net surface charge. When the 
polyelectrolyte adsorption reaches equilibrium, the substrate is rinsed to remove any excess 
polymer. The reversal charge of the surface allows the adsorption of subsequent oppositely 
charged polyelectrolyte. The sequential adsorption of these oppositely charged 
polyelectrolytes can be repeated to form multilayer films with desired thickness depending on 
the number of deposited layers. The resulting films are stable and uniform, but have highly 
interpenetrated architectures. The properties of the films (i.e., thickness, roughness, 
wettability, and swelling behavior) can also be tailored by varying the conditions used to 
assemble the films such as salt and pH of the solution,106-109 solvent polarity,108, 110 and 
temperature of adsorption, 111 and polymer functionality. 
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Figure 1.4 (A) Schematic of the film deposition process using substrates and beakers. Steps 1 
and 3 represent the adsorption of a polyanion and polycation, respectively, and steps 2 and 4 
are washing steps. The four steps are the basic buildup sequence for the simplest film 
architecture, (A/B)n. The construction of more complex film architectures requires only 
additional beakers and a different deposition sequence. (B) Simplified molecular conception 
of the first two adsorption steps, depicting film deposition starting with a positively charged 
substrate. Counterions are omitted for clarity. The polyion conformation and layer 
interpenetration are an idealization of the surface charge reversal with each adsorption step.105 
Besides electrostatic force, other molecular interactions such as hydrogen bonding,112, 113 
covalent interactions,114-116 DNA hybridization,117, 118 hydrophobic interactions,119 charge-
transfer interactions,120 metal-ligand coordination,121 and stereocomplexation122 have also 
been used to drive the LbL assembly process. Due to the choice of interactions, this assembly 
technique is applicable to a wide range of materials, including a variety of charged and 
noncharged polymers18 and other components such as nucleic acids,117 proteins,123 
polypeptides,124 polysaccharides,115 viruses,125 and nanoparticles.126, 127 The versatility of the 
LbL strategy lies not only in the wide range of suitable layer components that can be used and 
the control that can be exerted over the film thickness and structure, but also in the 
applicability to a variety of templates such as planar surfaces (e.g., glass slides,128 quartz 
slides,129 gold substrates,130 and silicon wafers108) and three dimensional templates (e.g., silica 
particles,131 polystyrene particles,126 gold nanoparticles,132, 133 liquid crystal droplets,134 
nanotubes,135, 136 enzymes,137 model drugs,138, 139 liposomes,140, 141 and red blood cells142, 143). 
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Thus, LbL assembly technique has proved to be a versatile and most common approach today 
for the formation of functional thin films. 
1.4.2 LbL Capsule Engineering 
In 1998, Donath et al. extended the LbL assembly technique to the formation of polymer 
capsules by the use of charged colloidal templates.144 The sequential adsorption of interacting 
polymers onto these substrates followed by selective template removal leads to the formation 
of hollow polymer capsules (Figure 1.5). This approach affords capsules with control over 
their size, shape, composition, and physiochemical properties, including stability and 
permeability. 
 
Figure 1.5 Schematic illustration of the formation of hollow polymer capsules by LbL 
assembly technique. Interacting polymers (i and ii) are adsorbed onto a particle template; this 
step can be repeated until the desired number of layers is achieved (iii). Dissolution of the 
sacrificial template of the core-shell particle (iv) results in the formation of a hollow polymer 
capsule. 
LbL-assembled capsules have attracted particular interest in the past few years, largely 
because of the simplicity of the assembly coupled with facile control over capsule chemical 
and structural properties, and have emerged as multifunctional carrier systems for a diverse 
range of applications such as biosensing,145 controlled delivery of therapeutics,146 optical 
sensing,147 and materials encapsulation.148 The properties such as composition, 
permeability149-151 or degradation152-154 of the capsule can be tailored by designing the 
deposited polymer and the number of layers adsorbed. The shell characteristics of the 
capsules can be engineered and adapted to be suitable for a wide range of applications, for 
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example the surface of the capsules can be functionalized to include poly(ethylene glycol) 
(PEG) for low-fouling properties124, 155, 156 or antibodies for targeted therapeutic delivery.146, 
157 Polymer capsules provide a versatile platform for the encapsulation of different types of 
cargo such as drugs,158-160 oligonucleotides,161-164 molecular dyes,139 enzymes,163 and 
peptides.165, 166 There are two different strategies developed for encapsulating different types 
of substances within polymer capsules, namely pre-loading and post-loading (Figure 1.6). The 
first method involves adsorption of cargo onto a template or integration of cargo into a 
template (e.g. using the cargo-CaCO3 coprecipitation approach to fabricate the template) 
followed by subsequent deposition of polymer multilayers. As an alternative, cargo-loaded 
emulsions and crystals or aggregates of the molecule of interest, e.g., crystallized small 
molecule dyes and drugs,139 protein crystals,137 protein aggregates,167 and condensed DNA168 
can be used as the template themselves. Otherwise, cargo can be post-loaded to preformed 
capsules through diffusion driven by a concentration gradient between the external 
environment and the hollow cores of the capsules. This method usually involves changing the 
permeability of the capsule wall, which can be done by changes in pH169, 170 or temperature.171 
 
Figure 1.6 Strategies for cargo encapsulation in LbL-assembled polymer capsules. (A) Pre-
loading method: cargo is adsorbed onto or integrated into the template prior to the LbL 
assembly of the membrane of the polymer capsule and (B) post-loading method: cargo is 
infiltrated to the preformed capsule, which requires changes in the permeability of the capsule 
wall. 
Furthermore, polymer capsules that respond to specific stimuli have attracted intense research 
interest for several biological applications172-178 because they offer the enhanced therapeutic 
benefits and allow for a controlled and specific delivery of cargos to the surrounding 
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medium,179-186 which prevents unwanted release and reduces the pollution of the environment. 
Hollow capsules formed by layer-by-layer (LbL) assembly have the ability to respond to 
internal stimuli such as biomolecules152, 159, 187, 188 and ionic strength189 and external stimuli 
such as light,190, 191 pH,192-195 temperature,196, 197 redox,198-200 enzyme201-203 to control the 
transport behaviors. One appealing strategy that has emerged recently is the introduction of 
polymeric systems that can respond to multiple stimuli, such as pH/temperature,196, 204 
pH/reduction,205 temperature/reduction,206 enzyme/enzyme.207, 208 Most of these described 
hollow capsule systems have been degradable by redox potential205, 206 and in the presence of 
enzymes,207, 208 while their pH and temperature response states were far from cellular 
compartments in synthetic biology.196, 204 Moreover, for most of these systems reactive 
enzymes as well as nanoparticles were enclosed into the inner cavity of the polymeric hollow 
capsules during their formation process,19, 209-212 while there is a poor controlled-release rate 
under pathological conditions similar to cellular compartments for cargo post-
encapsulation.205, 213 However, there is still a lack of multi-responsive hollow capsules with a 
tunable membrane permeability that can control the post-encapsulation of biomolecules in the 
nanometer range of up to 10 nm, but also their sustained release triggered by pH and 
temperature similar to cellular compartments in synthetic biology. 
1.5 Current Development of Artificial Cells 
Engineering artificial cells is a relatively young field of research and includes several different 
concepts to reconstruct cellular components into synthetic compartments.2-6, 214-216 The study 
of such artificial cell models has garnered significant interest because it would contribute to a 
better understanding of biological cells. These synthetic cells are designed to mimic cellular 
functions and biological responses within small-scale domains and are expected to have an 
impact on next-generation therapeutic concepts as a powerful biomedical tool for potential 
therapeutic applications, such as enzyme therapy, gene therapy, drug delivery, and diagnostics. 
The role of these biomimetic structures in enzyme therapy predominantly focuses on 
enzymatic activities to degrade waste products or to support the synthesis of medically 
relevant biomolecules. The loss or absence of a specific enzymatic activity in humans is often 
a lifelong condition and requires regular medication, which can be cost intensive, and patient 
compliance. Artificial cells have the potential to replenish missing or deficient cellular 
enzymatic activities and therefore hold tremendous promise for treating diseases on the 
cellular and subcellular levels. The development of this biomedical platform would not only 
be beneficial for individual patients but also for the healthcare system.  
18 
 
Designing cell-like structures therefore has attracted increasing attention as it provides 
potential methodologies that will open up new and unique prospects for therapeutic 
applications in the future-from enzyme therapy to new biomedical devices and self-regulating 
bioreactors. Mimicking biological cells requires the understanding of the cells’ key features, 
some of them include: (i) cell membrane, which separates the cell interior from the external 
environment and controls the passage of nutrient molecules and waste into and out of the cells; 
(ii) cell organelles, which are specialized subunits within a cell with the ability to carry out 
specific metabolic activities; (iii) cascades of chemical reactions in cells, which are catalyzed 
by active enzymes; and (iv) self-regulating system to respond to specific stimuli.8 With the 
complexity of biological cells, the ability to mimic cellular functions currently still lags 
behind the understanding of the underlying mechanism and this has prompted many 
researchers to simplify the objectives of cellular biomimicry into smaller, readily achievable 
goals; hence, the current synthetic cell systems fulfil only typically one simple cellular 
function. 
Artificial cells can be assembled via two methods; top-down or bottom-up approaches.4 The 
former concept employs biological components and involves the encapsulation of whole cells 
or organelles into a system. For example, cells were immobilized within a semipermeable 
polymer membrane, which allows for the transport of nutrients, oxygen, and therapeutic 
agents.217-220 The latter concept on the other hand refers to an encapsulation strategy where 
(macro)molecular building blocks are assembled into functional components via directed- 
and/or self-assembly techniques to mimic a living cell.221-223 This bottom-up approach not 
only allows nanoscale control over material properties, but also provides the ability to 
construct artificial cells with specific functionality without the inherent complexities of 
biological cells. The bottom-up approach starts with the construction of a cell model in a 
suitable compartment to allow the encapsulation of biochemical reactions. 
Although the aforementioned cell-mimicking systems are already remarkably complex, they 
are still based on single-compartment structures.  Biological cells have specialized internal 
subcompartments known as organelles, which are surrounded by a selectively permeable 
biological membrane that serves to partition the cell interior into numerous subcompartments. 
The movement of reactive species across these membranes is controlled by specific 
transmembrane protein channels, allowing precise regulation over the chemical species 
present within the organelles. Due to this unique compartmentalized structure, biological cells 
are able to spatially separate and precisely regulate hundreds of enzymatic (cascade) reactions, 
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even in the presence of multiple potentially reactive species in the cell interior. Assembling 
such nature-inspired structures presents a significant challenge; nevertheless, 
multicompartmentalization is an essential key requirement for the development of next-
generation carriers because these systems combine physicochemical properties that are not 
readily achievable using single-component assemblies.215 These cell mimics are engineered 
for specific tasks related to therapeutic applications and this research direction has been on the 
ultimate agenda of synthetic biology. 
1.6 Biomimetic Compartmentalized Assemblies 
Mimicking biological cells has led to the development of several compartmentalized 
assemblies, which is a key requirement for the development of artificial cells. Designing 
hierarchical systems that mimic the compartmental organization of biological cells not only 
sequesters diverse chemical reactions within a single carrier but also allows coencapsulation 
of diverse molecules that are spatially confined. 
1.6.1 Vesosomes (liposomes-in-liposomes) 
Zasadzinski and co-workers first demonstrated the multicompartment liposome architecture, 
termed vesosomes, where small unilamellar liposomes are entrapped within a larger liposome 
(Figure 1.7).15, 224, 225 These assemblies are formed via a temperature-induced approach to 
form vesicles from lipid bilayer sheets. Below phase transition temperature (Tm), the addition 
of ethanol to aqueous dispersions of saturated phospholipids, e.g., 
dipalmitoylphosphatidylcholine, leads to the formation of interdigitated bilayer sheets. When 
these bilayers are heated at elevated temperature above the Tm, the membrane sheets become 
less rigid and spontaneously close to form unilamellar lipid vesicles. During the transition 
from bilayer sheets to closed vesicles, these interdigitated membranes can simultaneously 
encapsulate preformed cargo-loaded liposomes, thus form a multicompartment liposome 
assembly. The encapsulation process does not require specific recognition or other chemical 
or mechanical processing. In addition, the newly generated vesicles are capable of 
maintaining their structural integrity, even at temperatures below the Tm. 
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Figure 1.7 Liposomes are used as components for the design of multicompartmentalized 
vesosomes.15 
The potential of vesosomes to act as therapeutic carriers is evidenced by the successful 
encapsulation of DNA, a model drug prochlorperazine, or antibiotic ciprofloxacin within the 
compartments as well as the sustained release profile of the encapsulated cargo.15, 225 Given 
the multicompartment nature of vesosomes, this carrier system has been proven to retain the 
essential features of conventional unilamellar liposomes and also overcome the major 
limitation of unilamellar liposomes, i.e., the premature cargo release in physiological 
environments. Hence, it is envisaged that vesosomes would be a viable alternative for the 
delivery of weakly basic drugs, which leak too rapidly from liposomes. The vesosomes could 
be also used for transcutaneous immunization (TCI), where the model antigen, tetanus toxoid 
(TTx), was encapsulated within the internal liposomal compartments.226 It was observed that 
TCI with vesosomal systems significantly increased the level of anti-TTx antibodies in an in 
vivo model in comparison to topically administered cationic unilamellar liposomes or a free 
TTx formulation, suggesting a more effective stimulation of the immune response, possibly 
due to better localization of the internal vesicles along with the encapsulated antigen in a 
confined environment. These findings suggest the potential of vesosomes for effective topical 
delivery of vaccines.  
1.6.2 Capsosomes (liposomes-in-polymer capsules) 
Capsosomes, which comprise LbL capsules containing nanometer-sized liposomes,16, 19, 227-229 
have demonstrated their effectiveness in microreactor16, 19, 228 and drug-delivery 
applications.229 By combining these two assemblies, capsosomes present a promising platform 
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toward the design of therapeutic artificial cells because they retain the beneficial properties of 
both polymer capsules and liposomes, namely, the semipermeable nature and structural 
stability of the capsules as well as the ability of liposomes to entrap diverse cargo and provide 
confined environments for enzymatic catalysis. Capsosomes are fabricated via the sequential 
deposition of polymers and liposomes onto particle templates (Figure 1.8a). A polymer 
precursor layer is first adsorbed onto a silica core, followed by the deposition of liposomes to 
form the initial polymer/liposome layer. This step can be repeated until the desired number of 
liposome layers is achieved. A polymer capping layer is then adsorbed, followed by LbL 
assembly of the membrane of the polymer carrier capsule and subsequent dissolution of the 
particle template to yield colloidally stable and (bio)degradable capsosomes. 
The potential of capsosomes as drug delivery vehicles has been demonstrated.229, 230 Small, 
hydrophobic antitumor drugs (thiocoraline or paclitaxel) were encapsulated in the membrane 
of the liposomal subcompartments, and cell studies using colon cancer cells confirmed the 
functionality of these capsosomes, as evidenced by reduced proliferation when cells were 
treated with (1 μm-diameter) capsosomes encapsulating the cytotoxic drugs.229, 230 The cargo-
concentration-dependent viability of cancer cells when exposed to capsosomes containing a 
different number of drug-loaded liposomes was verified, confirming the control over the 
amount of therapeutic payload achieved by simply varying the number of deposited liposome 
layers.230 
A significant development achieved with capsosomes relates to triggered encapsulated 
catalysis en route toward enzymatic applications. An enzyme, glutathione reductase 
encapsulated in liposomes, actively reduces glutathione disulfide (GSSG) into reduced 
glutathione (GSH, an antioxidant), and disulfide-linked PMA-KP9 polymer-peptide 
conjugates into capsosomes (Figure 1.8a).212 The induced catalysis of encapsulated 
glutathione reductase employing increased membrane permeability at the Tm of the liposomes 
results in the production of GSH, which subsequently triggers the release of encapsulated 
antigenic peptide KP9 from the capsosomes by reducing the disulfide linkages of the 
conjugates (Figure 1.8b). Employing Tm of the liposomes allows successive enzymatic 
catalytic reactions without any loss of the functional activity of the enzymes.16 These results 
demonstrate the potential of capsosomes to continuously generate a potent antioxidant at 
human body temperature while simultaneously releasing small-molecule therapeutics. 
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Figure 1.8 (a) Schematic illustration of the assembly of capsosomes coencapsulating 
glutathione reductase-loaded liposomes and PMA-KP9 polymer−peptide conjugates into the 
polymer carrier capsules. (b) Release of encapsulated KP9 oligopeptides triggered by the 
catalytic activity of glutathione reductase in capsosomes via the increased membrane 
permeability at the Tm of the liposomes.
212  
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1.6.3 Other Subcompartmentalized Assemblies 
1.6.3.1 Subcompartmentalized Polymer Capsules 
Multilayer polymer capsules fabricated by the LbL assembly technique have emerged as 
versatile components for the assembly of multicompartment particles due to their desirable 
physicochemical properties. The compartmentalization facilitates segregation of multiple 
enzymes for spatial control of enzymatic cascade reactions. For example, Bäumler et al. 
presented a three compartment enzyme particle system containing β-glucosidase (βGLU), 
GOX, and POD confined to outer, middle, and inner compartments, respectively using the 
enzyme-CaCO3 coprecipitation approach (Figure 1.9a).
231 Particles with barrier compartments 
of bovine serum albumin (BSA) located between the enzyme compartments showed a 
retarded reaction rate in comparison to particles without barrier compartments (Figure 1.9b). 
This was attributed to the additional diffusion resistance for substrate molecules resulting 
from the barrier layers. By tailoring barrier thickness, these structures may allow individual 
kinetic parameters in complex enzyme cascades to be determined. 
Fabrication of Janus capsules is attracting increasing interest as they may act as large 
amphiphiles, allowing the self-assembly of supramolecular aggregate structures. Delcea et al. 
first produced small (500 nm-diameter) and large (4.8 μm-diameter) polyelectrolyte capsules 
(Figure 1.10).232 The large capsules were then embedded in a multilayer film of hyaluronic 
acid (HA) and poly(Llysine) (PLL) supported on a glass slide. Partial embedding of the large 
capsules was observed, thus allowing the anisotropic adsorption of small capsules to the 
surface of the large capsules by electrostatic interactions. Multicompartment Janus capsules 
were isolated by inversion of the glass slide followed by the addition of sodium hydroxide, 
causing disassembly of the HA/PLL film without compromising the integrity of the Janus 
capsules. 
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Figure 1.9 Fabrication scheme of multicompartment particles and coupled enzyme reaction 
(a). Time-dependent increase in resorufin fluorescence for three-compartment three-enzyme 
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particles and five-compartment three-enzyme particles, i.e., particles containing BSA barrier 
compartments between enzyme compartments. Green represents fluorescein located in the 
outer compartment, and blue represents Alexa Fluor 680-labeled BSA (not enzymatically 
active) (b).231 
 
Figure 1.10 Schematics of multicompartment Janus capsules depicting the following steps: 
(1) entrapping large silica capsules/particles (grey spheres) in biocompatible polymeric 
(PLL/HA)12/PLL films (labeled in green), followed by (2) adsorption of small silica 
containers (in red), and (3) film destruction by NaOH and anisotropic construct extraction 
onto a glass substrate.232 
De Geest et al. first produced a system not only presenting organelle mimics but also a rough 
cytoskeleton mimic in a larger compartment.233 Briefly, An external microcapsule (150 μm) 
formed by the layer-by-layer LbL technique contained a gel bead enclosing 3 μm internal LbL 
microcapsules (Figure 1.11). Both kinds of microcapsules were formed using core templates 
(calcium carbonate for the inner capsules, the microgels for the outer ones) and successive 
deposition of biopolyelectrolytes dextran sulfate and poly(L-arginine).233 Under physiological 
conditions, the dex-HEMA gel beads are degraded in a few days or weeks, depending on 
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crosslinking density. As a result of this cross-link cleavage (through hydrolysis of the 
carbonate esters connecting the polymerized methacrylate groups with the dextran backbone), 
degradation products dextran and HEMA-co-DMAEMA oligomers increased inner osmotic 
pressure, causing internal swelling until the outer LbL shell cracked at localized spots, thereby 
releasing the inner LbL microcapsules. 
 
Figure 1.11 Schematic representation of a polyelectrolyte coated gel bead (>100 mm) loaded 
with LbL microcapsules of a few micrometers in size.233  
1.6.3.2 Polymersomes in Polymersomes 
Similar to vesosomes, multicompartmentalized polymersomes based on the emulsions method, 
termed polymersome-in-polymersome, have also recently been developed.29-31, 33 Chiu et al. 
reported the first example of a polymersome-in-polymersome assembly prepared by a two-
stage double emulsion technique in a water/oil/water system.234 Weitz and coworkers also 
reported the multicompartmentalized polymersome prepared via a double emulsion technique 
using a capillary microfluidic device.29 The main advantage of this technique is the ability to 
control the number as well as the size of the compartments in the assembly simply by tuning 
the flow rates of the phases in the microfluidic channels and by changing the capillary 
diameter. Another recent development in polymersome-in-polymersome assemblies by 
emulsion centrifugation was reported by Lecommandoux and coworkers (Figure 1.12).30, 235 
The inner polymersomes were formed by nanoprecipitation of poly(trimethylene carbonate)-
b-poly(L-glutamic acid) (PTMC-b-PGA).236 This suspension was then loaded in larger 
polymersomes of polybutadiene-b-poly(ethylene oxide) (PB-b-PEO) by emulsion-
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centrifugation237 with a quantitative loading efficiency. An interesting feature of this system is 
the incorporation of highly viscous alginate or dextran solution into the cavity of the ~20 μm-
diameter compartmentalized assembly to resemble the cell cytoplasm. Using emulsion-
centrifugation approach, van Hest et al. also described the combination of both the structural 
cell mimicry of polymersomes-in-polymersomes and the functional aspects of enzymatic 
polymersome nanoreactors as organelle mimics into a single system.33 The enzymes involved 
in the cascade reaction were encapsulated in intrinsically porous, sub-micrometric PS40-b-
PIAT50 nanoreactors. The PS-b-PIAT nanoreactors, cytosolic enzymes and reaction 
components were then quantitatively encapsulated in micrometer-sized PB-b-PEO 
polymersomes by emulsion-centrifugation approach, create the functional 
multicompartmentalized structure.  
 
Figure 1.12 Schematic representation of the emulsion-centrifugation process generating giant 
polymersomes or polymer vesosomes (the smaller red vesicles represent the inner nanosize 
polymersomes of PTMC-b-PGA in an aqueous solution).30 
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Despite the need for a broad range of synthetic multicompartmentalized systems, few 
examples of most successful subcompartmentalized carriers have been reported to date. Thus, 
the approaches to realize multicompartmentalized systems are still limited and give new 
opportunities for a new development of preparative techniques, e.g. combining polymeric 
approach with material science approach, to obtain higher hierarchically organized 
multicompartmentalized systems for simultaneous actions as synthetic bionanoreactor and 
transport and delivery system.  
1.7 Characterization Methods of Polymeric Multicompartmentalized 
Systems 
In this context, the most frequent techniques such as dynamic light scattering for size 
determination, transmission electron microscopy and confocal laser scanning microscopy for 
shape visualization and ultraviolet visible spectroscopy for quantitative and qualitative 
analysis are highlighted in this section. Primary emphasis is given here to the theoretical 
principles, the general setup of the corresponding instruments, and their function in 
characterization of materials.  
1.7.1 Dynamic Light Scattering (DLS) 
Dynamic light scattering (DLS) is a frequently used technique to determine size and size 
distribution of the vesicles dispersed in a liquid. The principle of the technique is relying on 
the measurement of translational diffusion coefficient which is then related to the size by 
using relevant theoretical relations. In brief, the sample is illuminated by a monochromatic 
and coherent laser beam. When the laser light strikes the particles the light is scattered in all 
directions due to interactions of the light with the electric field of the particle. The Brownian 
motion of the particles in solution additionally generates time dependent fluctuations in the 
scatter intensity since the particles have different distances to each other. This enables either 
constructive or destructive interference of the scattered light. Hence the first step is the 
detection of fluctuations in scattered light by a detector. The correlation function is then 
analyzed using an autocorrelator which is shown in below along with the exponential fitting 
expression (equation 1.3). 
G(τ) =< I(t). I(t + τ) ≥ A[1 + Bexp(−2Dq2τ)]                                                                        (1.3) 
In the above equation, I is the scattering intensity, t is the initial time, τ represents the delay 
time, B is the baseline at infinite time, A is the intercept and q is the scattering vector. 
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Additionally, D represents the diffusion coefficient, an important parameter to define the size. 
How D is dependent on other values in a fluid is described using the Stokes-Einstein equation 
(equation 1.4) where RH is the z-average hydrodynamic radius, T is temperature, kB is the 
Boltzmann constant and η is the viscosity of the solvent.238-240 
D =
kBT
6πηRH
                                                                                                                                          (1.4) 
Since the Stokes-Einstein equation has now only two unknown values (D and RH). It is 
therefore easy to calculate the hydrodynamic radius (RH) of particles, once D is known. The 
radii discovered are usually not uniform, but have a certain dispersity. This dispersity is also 
characterized using a polydispersity index (PDI), but should not be mistaken for the dispersity 
value (D) used to characterize polymers. In contrast to the D for polymers which is always 
greater than 1, the PDI resulting from DLS is ranging between 0 and 1. Generally, if the PDI 
is above 0.5, the distribution is very broad and the value obtained should be analyzed very 
critically. Together with the hydrodynamic radius, the DLS also results in a mean diameter 
over all particles detected, the so-called z-average. For monodisperse samples, the values for 
z-average and the hydrodynamic radius almost match each other. 
In addition to the size information, the zeta potential of the particles can be determined 
through DLS by measuring the electrophoretic mobility of the particles in a capillary cell 
containing two electrodes. In brief, an electrical field is applied to the electrodes and the 
charged particles move towards the oppositely charged electrode with a velocity known as the 
electrophoretic mobility (UE) which is then related to the zeta potential (ζ) by the Henry 
equation shown in below. Herein, the parameters like viscosity (η) and dielectric constant (ε) 
is already known whereas the Henry’s function, f(ᴋa), is assumed as equation 1.5 for the 
aqueous solutions of moderate electrolyte concentration.  
UE =
2εζf(ᴋa)
3η
                                                                                                                                     (1.5) 
1.7.2 Transmission Electron Microscopy (TEM) 
Transmission electron microscopy (TEM) is widely used for imaging the nano-sized vesicles 
to observe their morphology and size.241, 242 Indeed, visualization is the most feasible way to 
understand the shape of the self-assembled structures whether they are in the form of vesicles, 
micelles or other morphologies. TEM therefore can reveal the fine detail of nanostructured 
materials as well as objects on an atomic level. TEM requires measurements to be performed 
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under vacuum as air molecules would rapidly spread and attenuate electron beams. In addition, 
samples have to be ultrathin (< 100 nm) to allow transmission of the electrons through the 
specimens. 
Typical components of TEM include: (i) an electron gun; (ii) a series of electromagnetic 
lenses; and (iii) a fluorescent screen or camera housed within a column (Figure 1.13). 
Electron gun produces a beam of electrons through thermoionic emission from a tungsten 
filament cathode. This beam, travelling in vacuum in the column of the microscope, is then 
accelerated by an anode and focused onto a sample by a condenser lens. The electrons interact 
with the sample as they pass through, carry information about the structure of the specimen, 
and form an image produced by an objective lens. Apertures are used to control the size of the 
electron beam that passes through it. The image formed is further magnified by a projector 
lens and projected onto a fluorescent screen. Level of magnification can be controlled simply 
by adjusting the amount of current that flows through the lenses. 
 
Figure 1.13 Schematic diagram of a transmission electron microscope (TEM). 
Since the specimen preparation of TEM requires the drying of the sample by dropping them 
onto a thin carbon film stretched over fine-meshed metal grid, some artifacts can occur 
especially for soft colloidal particles. To avoid such artifacts based on drying as well as the 
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interactions of sample with the film support, one can use cryo-TEM which enables to 
visualize the vesicles in their native hydrated state. This is basically sourced by the rapid 
cooling (1000 K/s) of the sample solution through vitrification but avoiding crystallization to 
form a frozen thin film. In this case, the morphological changes caused by different stimuli, 
e.g pH can be also observed as vitrifying the samples in acidic and basic aqueous solutions.243-
245 
1.7.3 Confocal Laser Scanning Microscopy (CLSM) 
Confocal laser scanning microscopy (CLSM) produces high resolution optical images from 
selected depth of field by using point illumination to focus an image onto one plane and a 
spatial pinhole to eliminate out-of-focus light. By scanning the specimen point-by-point, 
three-dimensional reconstructions of topologically complex objects can be obtained. 
In CLSM, laser light reflects off a dichroic mirror and is focused by an objective lens onto a 
specimen, where fluorophores are excited and emit light (Figure 1.14). The emitted 
fluorescence is then recollected by the same objective lens and passes through the dichroic 
mirror, which directs solely emitted light to a pinhole. The pinhole excludes out-of-focus light 
(red lines) so that only light from a selected plane is received by the detector. All CLSM 
characterizations were performed on a Leica TCS SP2 AOBS confocal microscope equipped 
with an argon laser (λ = 488 nm) using a 63x oil immersion objective. 
 
Figure 1.14 Schematic diagram of a confocal laser scanning microscope (CLSM). 
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1.7.4 Ultraviolet visible spectroscopy (UV-Vis) 
Ultraviolet visible spectroscopy (UV-Vis) allows for the quantitative determination of the 
concentration of specific compounds in solution via the measurement of the attenuation of 
light upon irradiation of a sample.246 When light is passed through a sample, photons collide 
with the molecules in the sample and raise them to an excited state; this process is known as 
absorption. This phenomenon is described by Lambert-Beer Law (equation 1.6) where A is 
the absorbance, I0 and I are the initial and outgoing intensities, c is the concentration of the 
sample in the solution, L is the optical path length and ε (M-1cm-1) is the extinction coefficient 
of the absorbing species. 
A = log
I0
I
= ε. c. L                                                                                                                               (1.6) 
A typical setup of a UV-Vis spectrophotometer consists of: (i) a light source; (ii) a diffraction 
grafting in a monochromator to separate different wavelengths of light; (iii) a sample holder; 
and (iv) a photoiodide detector. UV-Vis spectrophotometer uses two light sources, a 
deuterium arc lamp and a tungsten lamp for UV (190 – 380 nm) and visible (380 – 800 nm) 
measurements, respectively. 
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2 Motivation and Aim  
In recent years, the development of state-of-the-art strategies and techniques to exploit the 
unique properties and functions of novel materials has opened up new avenues to a wide 
range of biomedical applications, such as encapsulated catalysis, drug delivery, and 
diagnostics.8 Most notably, the field of biomimetics has seen a dramatic escalation in the 
development of advanced particulate systems, driven largely by the motivation to replicate 
nature’s assemblies from synthetic components. Constructing simplified synthetic cells4, 6, 7, 
214, 215 is an increasingly expanding area because it contributes to an understanding of 
biological processes and provides new and unique prospects for therapeutic applications in the 
future from enzyme therapy to new biomedical devices and self-regulating bioreactors. 
Mimicking biological cells requires the understanding of the cells’ key features, some of them 
include: (i) cell membrane, which separates the cell interior from the external environment 
and controls the passage of nutrient molecules and waste into and out of the cells; (ii) cell 
organelles, which are specialized subunits within a cell with the ability to carry out specific 
metabolic activities; (iii) cascades of chemical reactions in cells, which are catalyzed by 
active enzymes; and (iv) self-regulating system to respond to specific stimuli. With the 
complexity of biological cells, the ability to mimic cellular functions currently still lags 
behind the understanding of the underlying mechanism and this has prompted many 
researchers to simplify the objectives of cellular biomimicry into smaller, readily achievable 
goals. 
Despite the need for a broad range of synthetic multicompartmentalized systems, few 
examples of most successful subcompartmentalized carriers have been reported to date, 
including vesosomes13-15, capsosomes16-20 and ‘‘polymersome-in-polymersome’’29-33. Despite 
recent development in the field of multicompartmental systems, there are still important 
limitations and issues to be considered. For instance, the mechanical and colloidal stability of 
liposomes-based multicompartmentalized systems (vesosomes and capsosomes) is usually 
low and the permeability is also uncontrollable, because of the deficiency of liposomes; the 
limitations of current ‘‘polymersome-in-polymersome’’ systems, such as low loading capacity, 
poor functionality in terms of release, permeability, variable surface chemistry and stimuli 
response (e.g., pH, temperature, etc), have a detrimental effect on their applications. Second, 
the post-encapsulation and the independent and sequential release of multiple types of cargo 
molecules in the nanometer range of up to 10 nm have not been demonstrated in the literature. 
The main issue to be resolved is the maintenance of the integrity of the 
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multicompartmentalized systems when tuning the overall permeability of the microcapsule 
shells. This so-called orthogonal behavior is also critical for achieving controlled release in a 
selective way triggered by multiple stimulus-responsive properties. For instance, one stimulus 
can be used to control the release behavior of the multicompartmentalized systems, and 
another, orthogonal stimulus can be used to independently tune the overall permeability of the 
microcapsule shell without significantly affecting the multicompartmentalized systems 
properties. Such dual-responsive orthogonal behavior can be utilized for loading different 
components in different compartments followed by triggering their independent release in a 
preprogrammed, sequential, and reversible fashion. Thus, the approaches to realize 
multicompartmentalized systems are still limited and give new opportunities for a new 
development of preparative techniques, e.g. combining polymeric approach with material 
science approach, to obtain higher hierarchically organized multicompartmentalized systems 
for simultaneous actions as synthetic bionanoreactor and transport and delivery system.  
With regard to this, the overall aim of this study is to fabricate novel artificial cells, not only 
presenting organelle mimics but also incorporating various stimuli for regulating enzymatic 
cascade reactions within the cell mimics and for controlled simultaneous and/or subsequent 
release of the encapsulated (therapeutic) molecules by integrating Ada-polymersomes and 
multilamellar polymeric drug-delivery-system(s) in different compartments (Figure 2.1). By 
combining the advantages of both pH-responsive Ada-polymersomes as organelle mimics and 
multifunctional hollow capsule as biomimetic cellular membrane, these 
multicompartmentalized systems present an attractive biomedical platform for the creation of 
artificial cells. In particular, in comparison to multicompartmentalized systems reported in the 
literature, the reported multicompartmentalized systems in this study have several prominent 
advantages, such as high structural stability of multicompartmentalized systems, the ability to 
load diverse cargo within their subcompartments, responsiveness of both capsules and 
polymersomal subcompartments to specific stimuli, controlled interaction between the 
internal and external milieu and the ability to act as synthetic bionanoreactor and transport 
and delivery system for different biomedical applications (diagnostics, therapy, gene 
transfection, bioactive coatings) as well as for aspects of synthetic biology.  
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Figure 2.1 Aim of this work: Dual-responsive and photo-crosslinked hollow capsules are 
formed as biomimetic cellular membrane; pH-switchable Ada-polymersomes as organelle 
mimics are fabricated; the multicompartmentalized systems as cell mimics are constructed by 
loading pH-switchable Ada-polymersomes inside multifunctional cell membrane; the 
metabolism mimicry of multicompartmentalized systems is realized by performing the two-
enzyme cascade reactions and the competitive bienzymatic reactions. 
In the way of reaching this goal, the following objectives are addressed in this thesis: 
1) For mimicking cell membrane, dual-responsive and photo-crosslinked hollow capsules 
are formed and finally used for the subsequent and easily available post-encapsulation 
process of protein-like macromolecules and their controllable release triggered by 
external stimuli. Starting with the synthesis of a dual-responsive and photo-
crosslinkable block copolymer PNMB, the oppositely charged polyelectrolytes are 
deposited on silica template via electrostatic interaction to fabricate an ultrathin 
multilayer film with dual stimuli-responsive behaviors. Furthermore, the temperature 
and pH dual-responsive characteristics and the stability of the hollow capsules with 
different crosslinking degree are analyzed by DLS. Eventually, to evaluate the 
potential of the photo-crosslinked hollow capsules for mimicking controlled cell 
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compartment functions, the uptake and release properties of the resulting hollow 
capsules with different degree of photo-crosslinking for cargos are further investigated 
at different pH and temperature. 
2) The synthesis of Ada-polymersome forming amphiphilic, photo-crosslinkable and pH 
sensitive block copolymers comprising amine and adamantane groups is aimed at 
further anchoring to the membrane of multicompartmentalized systems as organelle 
mimics by host-guest interactions and visualizing of the polymersomal 
subcompartmens in multicompartmentalized systems by fluorescence microscopy. In 
addition, the reversible pH dependent swelling/shrinking ability of these 
multifunctional, pH responsive, photo-crosslinked and post-labelled polymersomes are 
analyzed by DLS and cryo-TEM. Lastly, the reported enzyme-loaded Ada-
polymersomes are treated with substrate to investigate the various enzymatic reactions, 
including the single enzyme reaction and enzyme cascade reaction. 
3) The multicompartmentalized systems are constructed by loading pH-sensitive Ada-
polymersomes inside multifunctional cell membrane. In brief, the pH responsive and 
photo-crosslinked Ada-polymersomes are taken as organelle mimics to incorporate to 
the multicompartmentalized systems by non-covalent host-guest interaction; 
temperature responsive and photo-crosslinkable PMA(β-CD)/[PAH/PNMD]3 multilayers 
and outer protective capping PAH/PMA(PEG)  bilayer are further assembled to mimic 
the cell membrane. Furthermore, the position of the polymersomal subcompartments 
can be controlled using non-covalent host-guest concept for fabricating two types of 
multicompartmentalized systems: “membrane-associated” MS1 and “free-floating” 
MS2. In addition, the temperature and pH dual-responsive characteristics and the 
stability of these two types of multicompartmentalized systems are analyzed by DLS. 
4) Lastly, to realize the metabolism mimicry for our multicompartmentalized systems, 
the enzymes are immobilized or confined in different locations in the 
multicompartmentalized systems. In brief, as the first approach the 
multicompartmentalized system encapsulated with Myo-filled Ada-polymersomes is 
treated with guaiacol and hydrogen peroxide as substrates for myoglobin; as the 
second approach GOx-filled Ada-polymersomes are encapsulated in 
multicompartmentalized system and an excess of free Myo is added to the solution; for 
the third approach, GOx-filled Ada-polymersomes are encapsulated in 
multicompartmentalized system and Myo-filled Ada-polymersomes are added to the 
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solution; in a final approach an equal mixture of GOx-filled Ada-polymersomes and 
Myo-filled Ada-polymersomes is employed for the multicompartmentalized system 
assembly. The multiple successive two-enzyme cascade reactions and the competitive 
bienzymatic reactions for multicompartmentalized systems are performed. 
Each of the above-mentioned sub-objectives are discussed in detail starting from the 
fabrication of multi-responsive hollow capsules for mimicking cell membrane in chapter 7 
and continued with formation of Ada-polymersomes as organelle mimics in chapter 8. The 
last two parts of results and discussion are devoted to mimicking the structure and function of 
cell in chapter 9. 
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3 Materials and Methods 
3.1 Materials 
All commercial materials were used as received without further purification, unless stated. All 
anhydrous solvents were stored over molecular sieves. Dialysis membranes were rinsed with 
distilled water prior to use. The pH of the aqueous dialysis medium was adjusted by NaOH or 
HCl solutions unless otherwise indicated. 
Table 3.1 List of chemicals 
Chemical/Specification  Supplier 
1-Aminoadamantane, 97% Sigma-Aldrich 
4-Pentynoic acid, 98% Sigma-Aldrich 
N,N’-Dicyclohexylcarbodiimide (DCC), 99% Sigma-Aldrich 
Copper(I) iodide, ≥98% Sigma-Aldrich 
N,N-Diisopropylethylamine (DIPEA), 99.5% Sigma-Aldrich 
Poly (ethylene glycol) methyl ether (PEG-OH; Mn: 2000; Ð:1.05) Sigma-Aldrich 
2-Butanone, anhydrous Sigma-Aldrich 
2-Bromoisobutyryl bromide, 98% Sigma-Aldrich 
Triethylamine (TEA), ≥99.5% Sigma-Aldrich 
N,N-Dimethylformamide (DMF, anhydrous), 99.8% Sigma-Aldrich 
Tetrahydrofuran (THF, anhydrous), 99.5% Acros Organics 
Dichloromethane (DCM, anhydrous), 99.9% Acros Organics 
Ethyl acetate, 99.5% ; Chloroform, 99.8% ; n-Hexane, 99% Acros Organics 
Ethanol, absolute, ACS reagent, 99.5% Acros Organics 
Toluene, anhydrous, 99.8% Sigma-Aldrich 
Silica gel, high purity grade, mesh: 200-400 Merck 
2-(Diethylamino) ethyl methacrylate (DEAEMA), 99% Sigma-Aldrich 
2,2′-Bipyridine (bpy), >99% Sigma-Aldrich 
Copper(I) bromide, 98% Sigma-Aldrich 
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Aluminum oxide (neutral, activated), Brockmann I grade Sigma-Aldrich 
Trifluoroacetic acid (TFA), 99%  Sigma-Aldrich 
Sodium bicarbonate, 99.5% Sigma-Aldrich 
Magnesium sulfate, ≥99.5% Sigma-Aldrich 
2,3-Dimethylmaleic anhydride, 97% Sigma-Aldrich 
4-Amino-1-butanol, 98% Sigma-Aldrich 
Methacryloyl chloride, >97% Sigma-Aldrich 
2-(Dodecylthiocarbonothioylthio)-2-methylpropionic acid, 98% Sigma-Aldrich 
2,2′-Azobis(2-methylpropionitrile) (AIBN) , 98 % Sigma-Aldrich 
1,4-Dioxane (anhydrous), 99.8% Sigma-Aldrich 
Hydrofluoric acid (HF), 48% Sigma-Aldrich 
Ammonium fluoride (NH4F), ≥98.0% Sigma-Aldrich 
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), ≥99.0% Sigma-Aldrich 
4-(Dimethylamino) pyridine (DMAP), ≥99% Sigma-Aldrich 
Fluorescein isothiocyanate (FITC),   Sigma-Aldrich 
Sodium chloride (NaCl), ≥99.5% Sigma-Aldrich 
Poly(sodium 4-styrenesulfonate) (PSS, molecular weight 70,000) Sigma-Aldrich 
Ammonia solution (NH4OH, 29 wt.-% aqueous solution) Sigma-Aldrich 
Hydrogen peroxide (H2O2, 30 wt.-% aqueous solution) Sigma-Aldrich 
Sodium hydroxide (NaOH), ≥97% Sigma-Aldrich 
Hydrochloric acid (HCl), fuming 37%  Merck 
Phosphate buffered saline (tablet), Biotech grade Sigma-Aldrich 
D-Maltose monohydrate (Mal), >99%  Sigma-Aldrich 
Rhodamine B isothiocyanate, Mixed isomers Sigma-Aldrich 
Monosodium phosphate (), ≥99% Sigma-Aldrich 
Sodium phosphate dibasic heptahydrate (Na2HPO4.7H2O), N/A Sigma-Aldrich 
Glucose oxidase from Aspergillus niger (GOx, lyophilized powder, ~200 U/mg) Sigma-Aldrich 
Myoglobin from equine skeletal muscle (Myo, essentially salt-free, lyophilized 
powder), 95-100% 
Sigma-Aldrich 
43 
 
Guaiacol (oxidation indicator) Sigma-Aldrich 
D-(+)-Glucose (BioUltra, anhydrous), ≥99.5%  Sigma-Aldrich 
Catalase from Aspergillus niger Sigma-Aldrich 
2-Hydroxy-4-(methacryloyloxy) benzophenone (BMA), 99% Alfa Aesar  
Poly(allylamine hydrochloride) (PAH, molecular weight 70,000 g mol-1) Alfa Aesar 
Azide terminated poly (ethylene glycol) (N3PEG-OH; Mn: 2700 g/mol; Đ: 1.18) Polymer Source 
Alpha-t-butyloxycarbonylamino-omega-amino terminated poly (ethylene glycol) 
(Boc-NH-PEG-NH2; Mn: 3000; Ð: 1.03)  
Iris Biotech 
Hyperbranched poly(ethylene imine) (PEI 5, Mw= 5000 g mol
-1)  BASF SE 
Hyperbranched poly(ethylene imine) (PEI 25, Mw= 25000 g mol
-1)  BASF SE  
Doxorubicin hydrochloride (Dox), 98.0-102.0% Carbosynth 
Limited 
6-Monodeoxy-6-monoamino-β-cyclodextrin.HCl, >98% Cyclodextrin 
Shop 
N-Hydroxybenzotriazole (HOBt), 98% Sigma Aldrich 
Methacrylic acid (MA, 99%) was passed through an inhibitor removing column 
(neutral aluminum oxide) prior to being stored under an argon atmosphere in the 
refrigerator 
Sigma-Aldrich 
N-Isopropylacrylamide (NIPAM, 97%) was purified by recrystallization, from a 
n-hexane/toluene mixture (90/10 vol.-%) 
Sigma-Aldrich 
High purity and resistivity (> 18 M Ω cm) deionized water (MilliQ water) was 
obtained from an inline Milli-Q Reagent Water Purification System  
Millipore 
Corporation 
 
Table 3.2 List of separation tools and materials 
Chemical/Specification  Supplier 
500 nm diameter SiO2 particles, 5 wt.-% Microparticles GmbH 
1μm diameter SiO2 particles, 5 wt.-% Microparticles GmbH 
Dialysis membrane, made of regenerated cellulose, MWCO 2000 Carl Roth 
Dialysis membrane, made of regenerated cellulose, MWCO 5000 Carl Roth 
Dialysis membrane, made of regenerated cellulose, MWCO 150000 Carl Roth 
Hollow fiber filtration membrane, polyethersulfone, MWCO 500 kDa  Spectrum Labs 
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Table 3.3 List of buffer solutions 
Buffer solution Ingredients 
Phosphate buffer, pH 5.5, 10 mM NaH2PO4 (1.15 g), Na2HPO4.7H2O (0.11g), Millipore 
water (1 L)  
Phosphate buffer, pH 6, 10 mM NaH2PO4 (1.06 g), Na2HPO4.7H2O (0.32g), Millipore 
water (1 L) 
Phosphate buffer, pH 7.4, 10 mM NaH2PO4 (0.27 g), Na2HPO4.7H2O (2.08g), Millipore 
water (1 L)  
Phosphate buffer, pH 8, 10 mM NaH2PO4 (0.082g), Na2HPO4.7H2O (2.5 g), Millipore 
water (1 L)  
Phosphate buffer, pH 8.5, 10 mM NaH2PO4 (0.027g), Na2HPO4.7H2O (2.62 g), Millipore 
water (1 L)  
 
3.2 Methods 
Gel permeation chromatography. The molecular weight distributions of the polymers were 
measured at 40 ℃ using a Polymer Laboratories PL-GPC50 Plus Integrated GPC system 
(Varian Inc., UK) equipped with a Polymer Laboratories pump, a PL ResiPore column (300 × 
7.5 mm), a PL data stream refractive index detector, and a PL-AS-RT autosampler. The 
calibration was carried out using 12 polystyrene standards with Mn values ranging from 162 
to 371,100 g mol-1 (Varian Inc., UK). The eluent was DMAc and the flow rate was 1.0 mL 
min-1. The data were processed using Cirrus GPC offline GPC/SEC software (version 2.0). 
NMR spectroscopy. 1H NMR spectra were recorded on Bruker Avance III 500 spectrometer 
operating at 500.13 MHz using CDCl3 or DMSO-d6 as solvent at room temperature. Chemical 
shifts are expressed in ppm and referenced to the corresponding solvent signals (CDCl3: 
δ=7.26, 77.0 ppm; DMSO-d6: δ= 2.50 ppm).   
Dynamic light scattering. Dynamic Light Scattering (DLS) measurements were performed at 
25 ℃ using Zetasizer Nano-series instrument (Malvern Instruments, UK) equipped with a 
multi-purpose autotitrator and a 633 nm He-Ne laser at fixed scattering angle of 173°. The 
hydrodynamic size of polymersomes (1 mg/mL) and capsules is given as intensity-average 
diameter (zaverage) values assuming refractive index of the polymer as 1.50. The data were 
analyzed using software version 6.12.  
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Zeta potential. Zeta potential of the polyelectrolytes PAH and PNMB11 was determined 
using Zetasizer Nano-series instrument (Malvern Instruments, UK) equipped with a multi-
purpose autotitrator. PAH (1 mg mL-1) without salt (pH adjusted with HCl to pH 4) was 
titrated with NaOH solution and PNMB (1 mg mL-1) without salt (pH adjusted with NaOH to 
pH 9.5) was titrated with HCl solution.  
Zeta potential values of the bare and multilayered silica particles were measured on a 
ZETASIZER Nano series instrument (Malvern Instruments, UK) with a Dispersion 
Technology Software (version 7.10). The data was collected by three repeated experiments at 
25 ℃ with a voltage of 150V.  
Lower critical solution temperature measurements. The lower critical solution temperature 
(LCST) of the polymers was measured on a Tepper TP1 photometer (Mainz, Germany). 
Transmittance of the polymer in MilliQ water at 670 nm was monitored as a function of 
temperature (cell path length: 12 mm; one heating/cooling cycle at a rate of 1 °C min-1) and 
the critical temperature was determined at 50% of relative transmittance.  
Photo-crosslinking of polymersomes. The UV irradiation of polymersomes was performed 
using UVACUBE100 (honle UV Technologies, Germany) equipped with a low intensity (0.1 
Wcm-2) iron lamp as UV source.  
Hollow fiber filtration (HFF).  Hollow fiber filtration was performed using a KrosFlo 
Research IIi (SpectrumLabs, USA), equipped with a polysulfone based separation module 
(MWCO: 500 kDa, Spectrum Labs, USA). 
Photo-crosslinking of multilayers for multicompartmentalized systems. The UV 
irradiation was carried out within an EXFO Omnicure 1000 (Lumen Dynamics Group Inc., 
Canada), equipped with a high pressure mercury lamp as a UV source. 
Transmission electron microscopy. The diameters and morphologies of the capsules were 
observed using a transmission electron microscopy (TEM) Libra 120 equipped with a charge 
coupled device (CCD) camera at an accelerating voltage of 120 kV. 2 μL of the capsules or 
particles were dispersed in water with the concentration of 1 mg/mL and allowed to adsorb for 
2 min onto a 300 mesh, carbon film coated copper grid, and the specimen was dried at room 
temperature or the grid was blotted dry using filter paper.  
Cryo-Transmission electron microscopy. The cryo-TEM measurement was conducted on 
the same instrument with TEM. Samples were prepared by dropping 1 μl of polymersome or 
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capsules solution (1 mg/mL) on each side of a copper grid coated with holey carbon foil (so-
called Lacey type). A piece of filter paper was used to remove the excess water; the sample 
was then rapidly frozen in liquid ethane at -178 °C. The blotting with the filter paper and 
plunging into liquid ethane was done in a Leica GP device (Leica Microsystems GmbH, 
Wetzlar, Germany). Frozen grids were transferred into electron microscope using a Gatan 626 
cryo-holder. All images were recorded in bright field at -172 °C. Images processing was 
carried out by Scandium software (Olympus Soft Imaging Solutions, Germany) Version 5.2.  
Scanning electron microscopy (SEM). All SEM characterizations were performed on a 
Zeiss Ultra 55 Gemini scanning electron microscope. SEM samples were prepared from 1 μL 
of the capsules solution with the concentration of 1 mg/mL on Si wafers which were sputter-
coated with gold, and the specimen was dried at room temperature.  
Confocal laser scanning microscopy (CLSM): All CLSM characterizations were performed 
on a Leica TCS SP2 AOBS confocal microscope (Leica, Germany) equipped with an argon 
laser (λ = 488 nm) using a 63x oil immersion objective. Samples were prepared by dropping 5 
μL of the fluorescently labeled multicompartmentalized capsules system (1 mg/mL) onto 
glass slide, and cover slide was required to seal the specimen.  
UV/vis spectroscopy. The UV-Vis absorption spectra were recorded on a SPECORD 210 
Plus double beam UV-vis spectrophotometer (Analytic Jena, Germany). Samples were 
analyzed at desired wavelength range in quartz cuvettes. To monitor in vitro drug release 
experiments as well as the enzymatic reaction experiments of polymersomes or 
multicompartmentalized capsules system; disposable 1.5 mL semi-micro cuvettes of PMMA 
(Brand, Germany) were used for the measurements. 
3.3 Synthetic Methods and Characterization of Block Copolymers for 
Polymersomes 
3.3.1 Syntheses of Block Copolymers 
3.3.1.1 Synthesis of Adamantane Functionalized Poly(ethylene glycol) 
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A protocol previously reported by Iyisan et. al. was adopted.247 (1) 1-Aminoadamantane (0.6 
g, 4 mmol) was charged into a round-bottom flask and dissolved in anhydrous DCM (20 mL). 
In a separate flask, 4-pentynoic acid (0.4 g, 4 mmol) and N,N’-dicyclohexylcarbodiimide 
(DCC, 1.65 g, 8 mmol) were dissolved in anhydrous DCM (80 mL) and deoxygenated by 
purging nitrogen for 30 min. The prepared 1-aminoadamantane solution was added dropwise 
to 4-pentynoic acid containing DCC solution, then the mixture was stirred at room 
temperature for 15 h. After 15 h, the reaction mixture was filtered and the solvent was 
removed under reduced pressure. Finally, the product was obtained by purification with 
column chromatography on silica gel using n-hexane/ethyl acetate=2:1. Yield: 72%. (2) N3-
PEG60-OH (0.35 g, 0.13 mmol), alkyne functionalized adamantane (0.065 g, 0.28 mmol) and 
copper (I) iodide (0.013 g, 0.007 mmol) were loaded into a flask and dissolved in anhydrous 
DMF (10 mL). After addition of DIPEA (0.091 mL, 0.52 mmol), the mixture was stirred at 
80 ℃ for 2 days. Solvent of the resulting reaction mixture was removed under reduced 
pressure, followed by dissolving the solid product in THF. Finally, Ada-PEG60-OH was 
obtained as a white solid by precipitation in n-hexane. For further purification, Ada-PEG60-
OH was dissolved in MilliQ water and dialyzed for 24 h against EDTA solution to remove the 
copper species. After freeze drying, the pure product was obtained with a yield of 53%. 
Alkyne functionalized adamantane: 
1H NMR (500.13 MHz, DMSO-d6, ): 1.61 (s, 6H), 1.91 (d, 6H), 1.99 (s, 3H), 2.21 (t, 2 H), 
2.30 (td, 2 H), 2.72 (t, 1 H), 7.29 (s, NH). 
Adamantane functionalized poly(ethylene glycol): 
1H NMR (500.13 MHz, CDCl3, ): 1.66 (s, 6H), 1.94 (6H), 2.05 (s, 3H), 2.51 (t, 2H), 2.58 
(OH), 3.01 (t, 2H), 3.65 (s, 248H), 3.86 (t, 2H), 4.50 (t, 2H), 5.39 (s, NH), 7.52 (s, 1 H). 
3.3.1.2  Syntheses of Poly(ethylene glycol) Macroinitiator 
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The previously reported method was used as follows.96, 247 Here, poly(ethylene glycol) 
terminated with methoxy (0.5 g, 0.25 mmol), adamantane (0.733 g, 0.25 mmol) or Boc-amine 
(0.75 g, 0.25 mmol) was dried under vacuum for 30 min then dissolved in anhydrous THF 
under nitrogen gas. After adding triethylamine (0.07 mL, 0.5 mmol), 2-bromoisobutyryl 
bromide (0.06 mL, 0.5 mmol), diluted in anhydrous THF, was finally added dropwise to 
reaction mixture over 15 min. The reaction mixture was stirred for 48 h at room temperature. 
After that, the mixture was filtered to remove the salt and the filtrate was concentrated by 
evaporation most of solvent. Finally, PEG macroinitiator was obtained by precipitation in n-
hexane. Yield of the reaction was 86% for methoxy terminated PEG, 82% for adamantane 
terminated PEG and 80% for Boc-amine terminated PEG macroinitiators. 
Methoxy-terminated macroinitiator:  
1H NMR (500.13 MHz, CDCl3, ): 1.94 (s, 6H), 3.38 (s, 3H), 3.64 (s, 180 H). 
Adamantane-terminated macroinitiator:  
1H NMR (500.13 MHz, CDCl3, ): 1.66 (s, 6H), 1.94 (6H), 1.95 (s, 6H), 2.05 (s, 3H), 2.51 (t, 
2H), 3.01 (t, 2H), 3.65 (s, 248H), 3.86 (t, 2H), 4.33 (t, 2H), 4.50 (t, 2H), 5.39 (s, NH), 7.52 
(s,1 H). 
Boc-amine-terminated macroinitiator:  
1H NMR (500.13 MHz, CDCl3, ): 1.44 (s, 9H), 1.94 (s, 6H), 3.64 (s, 280 H). 
3.3.1.3 Syntheses of Block Copolymers 
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Block copolymers were synthesized by using standard ATRP procedure as reported 
previously.96, 247 In details, the desired poly(ethylene glycol) macroinitiator terminated with 
methoxy (0.5372 g, 0.25 mmol), adamantane (0.770 g, 0.25 mmol) or Boc-amine (0.7872 g, 
0.25 mmol), 2,2’-bipyridine (0.0781 g, 0.5 mmol), Cu(I)Br (0.0359 g, 0.25 mmol) and the 
corresponding amount of the crosslinker monomer 2-hydroxy-4-(methacryloyloxy) 
benzophenone (BMA) (10 mol% of the hydrophobic block, 0.7058 g, 2.5 mmol) were mixed 
in a Schlenk flasks and degassed for 30 min under vacuum. DEAEMA (5.03 mL, 25 mmol) 
and 2-butanone were deoxygenated in two separated flask by purging nitrogen for 30 min, and 
then they were added to the reaction flask by a syringe. After 22 h stirring at 50 ℃, the 
polymerization was terminated by exposure of the mixture to air by adding THF. The solution 
was passed over activated neutral aluminum oxide with THF as an eluent to remove copper 
species. Final solution was concentrated by evaporating most of the solvent, followed 
precipitation in cold n-hexane. The block copolymers were then washed with water to remove 
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the unreacted macroinitiator and dried under vacuum. The yields of the obtained polymers 
were 80% for Me-BCP, 74% for Ada-BCP, 73% for Boc-BCP.  
Me-PEG45-b-P(DEAEMA80-stat-BMA10), Me-BCP:  
1H NMR (500.13 MHz, CDCl3, ): 0.80-0.96 (m, 3 H), 0.97-1.25 (m, 6 H), 1.71-2.20 (m, 2H), 
2.46-2.61 (m, 4 H), 2.64-2.79 (m, 2 H), 3.38 (s, 3H), 3.49-3.75 (m, 4H), 3.90-4.18 (m, 2 H), 
6.60-7.72 (m, 8H). 
Ada-PEG60-b-P(DEAEMA80-stat-BMA10), Ada-BCP:  
1H NMR (500.13 MHz, CDCl3, ): 0.80-0.96 (m, 3 H), 0.97-1.25 (m, 6 H), 1.65-1.70 (m,6 H), 
1.71-2.20 (m, 6 H, m, 6H, m, 3H), 2.46-2.61 (m, 4 H), 2.64-2.79 (m, 2 H), 3.01 (t, 2H), 3.49-
3.75 (m, 4H), 3.90-4.18 (m, 2 H), 4.50 (t, 2H), 5.39 (s, NH), 6.60-7.72 (m, 8H). 
Boc-PEG68-b-P(DEAEMA80-stat-BMA10), Boc-BCP:  
1H NMR (500.13 MHz, CDCl3, ): 0.80-0.96 (m, 3 H), 0.97-1.25 (m, 6 H), 1.44 (s, 9H), 1.71-
2.20 (m, 2 H), 2.46-2.61 (m, 4 H), 2.64-2.79 (m, 2 H), 3.49-3.75 (m, 4H), 3.90-4.18 (m, 2 H), 
5.39 (s, NH), 6.60-7.72 (m, 8H). 
3.3.1.4 Deprotection of Boc-amino-terminated Block Copolymer (Boc-BCP) 
Boc group was removed using the previously reported method.96 Here, Boc-BCP (0.2 g) was 
dissolved in 5 mL of dichloromethane (DCM) followed by adding 5 mL of trifluoroacetic acid 
(TFA). The solution mixture was stirred for 4 h, then the solvent was evaporated under 
reduced pressure. To neutralize the deprotected amine group, copolymer was redissolved in 
DCM (5 mL) and washed three times with aqueous bicarbonate solution. The organic layer 
was dried over magnesium sulfate, then the solvent was evaporated under vacuum to acquire 
amino-terminated copolymer (Amine-BCP).  
Amine-PEG68-b-P(DEAEMA80-stat-BMA10), Amine-BCP:  
1H NMR (500.13 MHz, CDCl3, ): 0.80-0.96 (m, 3 H), 0.97-1.25 (m, 6 H), 1.71-2.20 (m, 2 H), 
2.46-2.61 (m, 4 H), 2.64-2.79 (m, 2 H), 3.49-3.75 (m, 4H), 3.90-4.18 (m, 2 H), 6.60-7.72 (m, 
8H). 
3.4 Synthetic Methods and Characterization of Polymers for Hollow 
Capsules 
51 
 
3.4.1 Syntheses of Homopolymer Poly(methacrylic acid) (PMA) 
 
PMA homopolymer was synthesized by RAFT polymerization, as follows: RAFT agent 2-
(dodecylthiocarbonothioylthio)-2-methylpropionic acid (36.5 mg, 0.1 mmol) and AIBN (1.64 
mg, 0.01 mmol) were added to a 10 mL round-bottom flask and degassed for 30 min. Then 
1,4-dioxane (3 ml) and methacrylic acid (0.85 mL, 10 mmol) were deoxygenated in a second 
separated reaction flask by purging nitrogen for 15 min before transferred to the reaction flask 
under protection atmosphere. The reaction mixture was stirred at 60 ℃ for 12h. To quench the 
polymerization solution, a rapid cooling of the reaction flask in liquid nitrogen was carried out. 
The 1,4-dioxane-containing monomer/polymer mixture was twice poured into diethylether to 
precipitate the PMA homopolymer, followed by the removal of the homopolymer by filtration 
and, finally, dried under suction. Yield: 80 %. 
3.4.2 Synthesis of Random Copolymer Poly[N-isopropyl acrylamide-co-methacrylic 
acid-co-2-hydroxy-4-(methacryloyloxy) benzophenone] (PRNMB) 
 
PRMNB random copolymer was synthesized by RAFT polymerization, as follows: RAFT 
agent 2-(dodecylthiocarbonothioylthio)-2-methylpropionic acid (36.5 mg, 0.1 mmol), AIBN 
(1.64 mg, 0.01 mmol), N-isopropylacrylamide (0.5659 g, 5 mmol) and the corresponding 
amount of the crosslinker monomer 2-hydroxy-4-(methacryloyloxy) benzophenone (BMA) 
(846.9 mg, 2 mmol) were added to a 10 mL round-bottom flask and degassed for 30 min. 
Then 1,4-dioxane (5 ml) and methacrylic acid (0.425 mL, 5 mmol) were deoxygenated in a 
second separated reaction flask by purging nitrogen for 15 min before transferred to the 
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reaction flask under protection atmosphere. The mixture was stirred at 60 ℃ for 15h. To 
quench the polymerization solution, a rapid cooling of the polymerization solution in liquid 
nitrogen was carried out. The 1,4-dioxane-containing monomer/polymer mixture was twice 
poured in diethylether to precipitate the desired random copolymer PRMNB, followed by the 
removal of the random copolymer by filtration and dried under suction. Yield: 75 %. 
3.4.3 Synthesis of Block Copolymers Poly[N-isopropyl acrylamide]-block-
poly[methacrylic acid-co-2-hydroxy-4-(methacryloyloxy) benzophenone] (PNMB) 
 
PNMB block copolymer was synthesized by RAFT polymerization, as follows: (1. Synthetic 
step for various macro-CTA) RAFT agent 2-(dodecylthiocarbonothioylthio)-2-
methylpropionic acid (36.5 mg, 0.1 mmol), AIBN (1.64 mg, 0.01 mmol), N-
isopropylacrylamide (6.67 mmol for PNMB21, 5 mmol for PNMB11, 3.33 mmol for 
PNMB12 or 2 mmol for PNMB14, respectively) were added to a 10 mL round-bottom flask 
and degassed for 30 min. Then 1,4-dioxane (3 ml) was deoxygenated in a second separated 
flask by purging nitrogen for 15 min, then solvent was transferred to the reaction flask under 
protection atmosphere. The mixture was stirred at 60 ℃ for 12h. To quench the 
polymerization solution, a rapid cooling of the reaction flask in liquid nitrogen was carried out. 
The 1,4-dioxane-containing monomer/polymer mixture was twice poured into diethylether to 
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precipitate the PNIPAM macro-CTA (PNIPAM-CTA), followed by the removal of the 
PNIPAM-CTA by filtration and, finally, dried under suction. Thus different PNIPAM-CTAs 
were established for the synthesis of PNMB block copolymers (Table 3.4). (2. Synthetic step 
for various block copolymers) PNIPAM-CTA (0.1mmol), AIBN (1.64 mg, 0.01 mmol) and 
the corresponding amount of the crosslinker monomer 2-hydroxy-4-(methacryloyloxy) 
benzophenone (BMA) (846.9 mg, 2 mmol) were added to a 10 mL round-bottom flask and 
degassed for 30 min. Then 1,4-dioxane (6 ml) and methacrylic acid (3.33 mmol for PNMB21, 
5 mmol for PNMB11, 7.33 mmol for PNMB12 or 8.6 mmol for PNMB14, respectively) were 
deoxygenated in a second separated reaction flask by purging nitrogen for 15 min before 
transferred to the reaction flask under protection atmosphere. The mixture was stirred at 60 ℃ 
for 2h. To quench the polymerization solution, a rapid cooling of the polymerization solution 
in liquid nitrogen was carried out. The 1,4-dioxane-containing monomer/polymer mixture was 
twice poured in diethylether to precipitate the desired PNMB block copolymer, followed by 
the removal of the block copolymer by filtration and dried under suction. 
Table 3.4 Experiment parameters of block copolymers synthesized by RAFT. 
Polymer Feed ratio of 
NIPAM and MA 
[mmol] 
Feed amount of 
NIPAM [g] 
Feed amount 
of MA [mL] 
Feed amount 
of BMA [g] 
Yield 
[%] 
PNMB21 6.67: 3.33 0.7548 0.282 0.8469 75 
PNMB11 5: 5 0.5659 0.425 0.8469 74 
PNMB12 3.33: 7.33 0.3768 0.622 0.8469 72 
PNMB14 2: 8.6 0.2263 0.729 0.8469 70 
 
3.4.4 Synthesis of Block Copolymers Poly[N-isopropyl acrylamide]-block-
poly[methacrylic acid-co-3,4-dimethyl maleic imidobutyl methacrylate] (PNMD) 
3.4.4.1 Synthesis of Photo-Crosslinker (DMIBM) 
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A protocol previously reported by Gaitzsch et. al. was adopted.100 (1) 2,3-Dimethylmaleic 
anhydride (5.0444 g, 40 mmol) was dissolved in toluene (120 ml) followed by adding 4-
amino-1-butanol (3.5656 g, 40 mol). The solution mixture was kept at reflux for 4 h at a water 
trap and the solvent was removed afterwards at reduced pressure. Finally, the crude product 
was purified using flash chromatography with n-hexane/ethyl acetate=2:1. Yield: 92%. (2) 
The obtained maleic imide (2.3276 g, 11.8 mmol) was degassed with four freeze-pump-thaw 
cycles followed by adding THF (100 ml). Then methacryloyl chloride (1.8502 g, 17.7 mmol), 
diluted in 3 ml dry THF, was finally added dropwise to the reaction solution over 15 min. 
After adding triethylamine (1.8518 g, 18.3 mmol), the reaction was carried out for 2 h at 40°C 
and aborted by pouring the reaction into water. The water was extracted three times with ethyl 
acetate. All organic phases were dried over magnesium sulfate and the solvent was removed 
at reduced pressure. The crude product is purified using flash chromatography with n-
hexane/ethyl acetate=2:1. Yield: 75%. 
3,4-dimethyl maleic imidobutanol: 
1H NMR (500.13 MHz, CDCl3, ): 1.51-1.57 (m, 2 H); 1.62-1.68 (m, 2 H); 1.74 (s, 1 H); 1.94 
(s, 6 H); 3.51 (t, J = 6.9 Hz, 2 H); 3.64 (t, J = 6.6 Hz, 2 H). 
3,4-dimethyl maleic imidobutyl methacrylate: 
1H NMR (500.13 MHz, CDCl3, ): 1.60 (m, 4 H); 1.86 (s, 3 H); 1.89 (s, 6 H); 3.46 (t, J = 5.9 
Hz, 2 H); 4.08 (t, J = 5.6Hz, 2 H); 5.44 (1 H); 6.08 (1 H). 
3.4.4.2 Synthesis of Block Copolymers 
55 
 
 
PNMD block copolymer was synthesized by RAFT polymerization, as follows: (1. Synthetic 
step for various macro-CTA) RAFT agent 2-(dodecylthiocarbonothioylthio)-2-
methylpropionic acid (36.5 mg, 0.1 mmol), AIBN (1.64 mg, 0.01 mmol), N-
isopropylacrylamide (0.5659 g, 5 mmol) were added to a 10 mL round-bottom flask and 
degassed for 30 min. Then 1,4-dioxane (3 ml) was deoxygenated in a second separated flask 
by purging nitrogen for 15 min, then solvent was transferred to the reaction flask under 
protection atmosphere. The reaction mixture was stirred at 60 ℃ for 12h. To quench the 
polymerization solution, a rapid cooling of the reaction flask in liquid nitrogen was carried out. 
The 1,4-dioxane-containing monomer/polymer mixture was twice poured into diethylether to 
precipitate the PNIPAM macro-CTA (PNIPAM-CTA), followed by the removal of the 
PNIPAM-CTA by filtration and, finally, dried under suction. Yield: 75 %. (2. Synthetic step 
for block copolymer) PNIPAM-CTA (0.4610 g, 0.1mmol) and AIBN (0.01 mmol, 1.64 mg) 
were added to a 10 mL round-bottom flask and degassed for 30 min. Then 1,4-dioxane (6 ml), 
methacrylic acid (5 mmol) and the corresponding amount of the crosslinker monomer 3,4-
dimethyl maleic imidobutyl methacrylate (DMIBM, 0.5306 g, 2 mmol) were deoxygenated in 
a second separated reaction flask by purging nitrogen for 15 min before transferred to the 
reaction flask under protection atmosphere. The reaction mixture was stirred at 60 ℃ for 2h. 
To quench the polymerization solution, a rapid cooling of the polymerization solution in 
liquid nitrogen was carried out. The 1,4-dioxane-containing monomer/polymer mixture was 
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twice poured in diethylether to precipitate the desired PNMD block copolymer, followed by 
the removal of the block copolymer by filtration and dried under suction. Yield: 70 %. 
3.4.5 Synthesis of β-Cyclodextrin Functionalized Poly(methyl methacrylate) (PMA(β-CD)) 
 
PMA sample with 10 mol% of β-cyclodextrin modification was synthesized through 
functionalization of PMA homopolymer with 6-monodeoxy-6-monoamino-β-cyclodextrin. 
PMA homopolymer (Mn = 10800 g/mol, Ð = 1.06) (0.1122 g) was dissolved in DMF (15mL) 
followed by adding EDC (95.9 mg, 0.5 mmol), HOBt (7.6 mg, 0.5 mmol) and triethylamine 
(TEA, 0.09 mL, 0.625 mmol). The mixture was stirred at room temperature for 2h to activate 
the carboxylic acid of PMA homopolymer. Then 6-monodeoxy-6-monoamino-β-cyclodextrin 
(0.1464 g, 0.125 mmol), dissolved in DMF (3mL), was finally transferred to the reaction flask. 
The reaction mixture was stirred at room temperature for 24h followed by purification via 
dialysis in deionized water for 3 days and freeze-drying to obtain β-cyclodextrin modified 
PMA polymer. Yield: 82 %. 
3.4.6 Synthesis of Poly(ethylene glycol) Functionalized Poly(methyl methacrylate) 
(PMA(PEG)) 
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PMA sample with 5 mol% of poly(ethylene glycol) modification was synthesized through 
functionalization of PMA homopolymer with poly(ethylene glycol). PMA homopolymer (Mn 
= 10800 g/mol, Ð = 1.06) (0.1122 g) was dissolved in DMF (15mL) followed by adding 4-
(dimethylamino) pyridine DMAP (30.5 mg, 0.25 mmol), EDC (191.7 mg, 1 mmol) and 
triethylamine (TEA, 0.18 mL, 1.25 mmol). The reaction mixture was stirred at room 
temperature for 2h to activate the carboxylic acid of PMA homopolymer. Then PEG45-OH 
(0.25 g, 0.125 mmol), dissolved in DMF (5mL), was transferred to the reaction flask.  The 
mixture was stirred at room temperature for 24h followed by purification via dialysis in 
deionized water for 4 days and freeze-drying to obtain PEG modified polymer. Yield: 60 %. 
3.5 Synthesis of Rhodamine B-labeled Maltose-decorated Hyperbranched 
Poly(ethylene imine) Macromolecules (PEI-Mal 5 and PEI-Mal 25) 
For the encapsulation experiments with PEI-Mal 5 and PEI-Mal 25 in this study, we have 
used positively charged maltose-decorated poly(ethylene imine) with PEI core of 5000 Da 
(PEI-Mal 5) and 25000 Da (PEI-Mal 25). PEI-Mal 5 and PEI-Mal 25 possess an open maltose 
shell which is finally described as structure B by Appelhans et al.248 PEI-Mal 5 ( 5 nm) and 
PEI-Mal 25 ( 11 nm) were synthesized and characterized as previously described in 
reference.248 To detect PEI-Mal nanoparticles in the following experiments, they were labeled 
with a UV-vis active dye rhodamine B. We labeled these molecules as follows: rhodamine B 
(1.0 mg) was dissolved in DMSO (0.2 ml). Then, PEI-Mal 5 or PEI-Mal 25 (50 mg), 
respectively, was dissolved in deionized water (1 mL). Both solutions were mixed and stirred 
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overnight. Non-bound rhodamine B was removed by dialysis method. Powders of the 
materials were obtained by freeze drying process. 
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4 Hollow Capsules Formation and Encapsulation Procedures 
4.1 Preparation of Hollow Capsules by Using LbL Assembly 
Multilayers of PAH and PNMB11 (described in chapter 3.4.3; Mn = 13000 g/mol, Ð = 1.23) 
were adsorbed on silica particles with diameters of 500 nm using the LbL method. The 
corresponding polyelectrolyte solutions for PAH, PNMB11 and PSS were prepared, using a 
concentration of 1 mg mL-1 in 0.4 M NaCl. Then, the pH of the solutions was adjusted to 7.5. 
All solutions were filtered through a 0.2 µm nylon filter prior to use. The initial 100 μL 
suspension of 500 nm-diameter silica particles (5 wt%) were centrifuged (6000 g for 2 min) 
and the supernatant was removed. For the initial washing step, MilliQ water was added, the 
particles redispersed and centrifuged again. This procedure was repeated three times before 
multilayers´ formation on silica particles could be started. Subsequently, PAH (6 mL) was 
added to the freshly washed and bare silica particles and was allowed to adsorb for 30 min 
with constant shaking (to deposit the first layer of the multilayered shell). The particles were 
then worked up by three centrifugation/redispersion cycles with MilliQ water. PNMB11 (6 
mL) was then adsorbed to the particles for 30 min, which were subsequently washed. This 
procedure was then repeated to deposit the desired bilayers (2, 3 or 4 bilayers). After washing 
three times in MilliQ water, PAH and PSS were then adsorbed to the particles to form the 
protective capping bilayers. 
4.2 Photo-Crosslinking of the Multilayers on Silica Particles 
The solution of particles was sonicated for 30 min before UV light crosslinking started. Then 
the solution was placed in the UV chamber equipped with a low intensity (0.1 W cm-2) iron 
lamp (UVACUBE 100, honle UV Technologies, Germany) and irradiated for the desired 
period (5 min, 10 min, 20 min, 30 min, or 50 min). The capsules were left overnight prior to 
removing the silica core template. 
4.3 Preparation of the Hollow Capsules via Silica Core Template 
Removal 
The particle suspensions (0.1 wt%) were mixed well by vortexing and transferred to 
Eppendorf tubes. The particles were worked up by one centrifugation/redispersion cycles with 
MilliQ water (100 μL).  The template silica cores were then removed to fabricate hollow 
capsules by the addition of a hydrogen fluoride (HF) buffered to pH 7.3 with ammonium 
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fluoride (NH4F) (5 mL, 1:13 5 M HF: 13.3 M NH4F).  (Caution! Note that hydrogen fluoride 
and ammonium fluoride are highly toxic. Extreme care should be taken when handling HF 
solution and only small quantities should be prepared.) The samples were tapped gently to 
dissolve the silica cores for about 30 min. The excess NH4F, HF, and SiF4 were removed from 
hollow capsules by three centrifugation/redispersion cycles with MilliQ water, followed by 
re-suspending in a suitable volume (typically 0.5 mL) of MilliQ water. 
4.4 Reversible Swelling-shrinking Behavior of the Crosslinked Hollow 
Capsules 
The photo-crosslinked hollow capsules (1 mg/mL) prepared by different crosslinking period 
were incubated with phosphate buffer possessing pH 5.5 and 7.4, respectively. At each pH 
state, hollow capsules were allowed to stand for 20 min. Then the temperature of the capsules 
was switched between 25 ℃ and 45 ℃ and the particles diameters were determined by DLS. 
This process was repeated for several cycles. No less than 20 measurements were taken on 
each temperature. 
4.5 Encapsulation of Doxorubicin 
To a 5 mL doxorubicin (Dox) solution (c = 0.1 mg/mL) a concentrated solution (10 mg/mL) 
containing crosslinked capsules with 5 mol-% crosslinker was added. The mixture was 
shielded from light and stirred for 12h in PBS buffer pH 7.4 at room temperature. The non-
encapsulated doxorubicin was removed by dialysis against a membrane with MWCO = 5000 
for 3 days in 0.01 M phosphate buffer pH 5.5 at 45 ℃ (3 times a day, a standard procedure for 
dialysis). The same procedure was carried out with pure water instead of the capsule solution 
for a control experiment. After selected time points, the samples were taken and analyzed 
using UV-vis spectroscopy (488 nm) according to the Dox calibration curve (Figure 4.1) to 
confirm the successful removal of the free Dox. The experiments were carried out in 
triplicate. The loading efficiency was calculated from equation 5.1. 
loading efficiency of Dox =
loaded amount of Dox
initial amount of Dox
∗ 100                                                      (5.1) 
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Figure 4.1 Calibration curves of Dox in phosphate buffer at pH 5.5 and in PBS at pH 7.4. The 
measurement was carried out at 488 nm using UV-vis spectrophotometer. 
4.6 In vitro Release Studies for Dox 
As a general rule, all experiments were carried out in triplicate and the average values were 
plotted. For the release behavior of capsules, the Dox-loaded capsules were immersed in 
solutions to study the effects of pH and cross-linking density on release kinetics. Thus, 0.01 
M PBS pH 7.4 and 0.01 M phosphate buffer pH 5.5 were used as release media. Dox loaded 
capsules solution (5 ml) was transferred to dialysis tube (MWCO 5000). The dialysis tube was 
sealed and then allowed to stir (200 rpm) in beaker containing 2 liter of the corresponding 
release medium at 45 ℃. At selected interval times, samples were removed from the dialysis 
tubes and quickly analyzed by UV-vis spectroscopy (488 nm) and returned back into the 
dialysis tube. The amount of drug released was calculated from the amount of drug initially 
present in the capsules and the amount of drug retained in the capsules at each sampling point. 
4.7 Encapsulation of PEI-Mal 5 and PEI-Mal 25 
A concentrated solution containing the capsules with 5 mol-% crosslinker and photo-
crosslinked for 30 min. was added to a PEI-Mal 5 (c = 2 mg mL-1) and PEI-Mal 25 solution (c 
= 6 mg mL-1), respectively. The mixture was shielded from light and stirred for 12h in PBS 
buffer pH 7.4 at room temperature. The non-encapsulated PEI-Mal is removed by dialysis 
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against a membrane with MWCO = 150 kDa for 3 days in phosphate buffer pH 5.5 at 45 ℃ (3 
times a day, a standard procedure for dialysis). After the time points, the samples were taken 
and analyzed using UV-vis (500 nm) according to the calibration curves (Figure 4.2) of 
rhodamine B labeled PEI-Mal 5 and PEI-Mal 25 in phosphate buffer at pH 5.5 to confirm the 
successful removal of the free rhodamine B. The experiments were carried out in triplicate. 
The loading efficiency was calculated from equation 5.2. 
loading efficiency of PEI − Mal =
loaded amount of PEI − Mal
initial amount of PEI − Mal
∗ 100                               (5.2) 
 
Figure 4.2 Calibration curves of the rhodamine B labeled PEI-Mal 5 (A) and PEI-Mal 25 (B) 
in phosphate buffer pH 5.5 and PBS pH 7.4. The measurement was carried out at 500 nm 
using UV-vis spectrophotometer. 
4.8 In vitro Release Studies for PEI-Mal 5 and PEI-Mal 
As a general rule, all experiments were carried out in triplicate and the average values were 
plotted. For the release behavior of capsules, the PEI-Mal loaded capsules were immersed in 
solutions to study the effects of pH and temperature on release kinetics. Thus, 0.01 M PBS at 
pH 7.4 and 0.01 M phosphate buffer at pH 5.5 were used as release media, respectively. PEI-
Mal loaded capsules solution (5 ml) was transferred to dialysis tube (MWCO 150 kDa). The 
dialysis tube was sealed and then allowed to stir (200 rpm) in beaker containing 2 liter of the 
corresponding release medium at 45 ℃, 37 ℃ and 25 ℃, respectively. At selected interval 
times, samples were removed from the dialysis tubes and quickly analyzed by UV-vis 
spectroscopy (500 nm) and returned back into the dialysis tube. The amount of PEI-Mal 
macromolecules released was calculated from the amount of PEI-Mal macromolecules 
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initially present in the capsules and the amount of PEI-Mal macromolecules retained in the 
capsules at each sampling point. 
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5 Ada-polymersome Formation and Characterization 
5.1 Formation of Multi-functionalized Ada-polymersomes 
A mixture of block copolymers, 85 wt% for Me-BCP, 10 wt% for Ada-BCP and 5 wt% for 
Amine-BCP, was dissolved in aqueous HCl solution (pH 2). After complete dissolution, the 
solution was filtered through a (PA) 0.2 µm nylon filter to remove any impurities. To initiate 
the self-assembly process, the pH was gradually increased to pH 9 by adding 1 M NaOH 
dropwise. The total block copolymer concentration was 1 mg/mL and Ada-polymersomes 
were formed after 4 days of stirring in dark conditions. 
5.2 Photo-crosslinking of Ada-polymersomes 
After the formation of Ada-polymersomes, the solutions were further passed through the 0.8 
μm nylon filter to remove any impurities. Then they were placed in the UV chamber equipped 
with a low intensity (0.1 W cm-2) iron lamp (UVACUBE 100, honle UV Technologies, 
Germany) and irradiated for 20 min. The photo-crosslinking was performed in round shaped-
glass vials in which the path length of light is adjusted as 1.5 cm.  
5.3 FITC-labeled Ada-polymersomes 
Only Ada-polymersomes to be investigated by CLSM were stained with fluorescein (FITC). 
Here, the Ada-polymersomes formulation was doped with 5% of Amine-BCP copolymer 
during their formation. After Ada-polymersome crosslinking, an excess of fluorescein 
isothiocyanate (FITC) was allowed to react with the free amine groups distributed on the 
surface of Ada-polymersomes in pH 8.5. After 24 h, the FITC-labeled Ada-polymersomes 
were extensively dialyzed against water (pH 8.5) for 2 days to remove the unreacted FITC. 
5.4 Reversible Swelling and Shrinking of Crosslinked Ada-polymersomes 
To monitor the swelling power of the crosslinked Ada-polymersomes, they were titrated by 
addition of 1 M HCl or 1 M NaOH to reach the pH 6 or pH 8 values respectively. The 
diameter of the vesicles was determined by DLS at each pH condition and this process was 
repeated for 5 cycles. 
5.5 Preparation of Crosslinked Enzyme-filled Ada-polymersomes  
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Preparation of GOx-filled crosslinked Ada-polymersomes: 10 mg of polymer (90 wt% for 
Me-BCP and 10 wt% for Ada-BCP) were dissolved in water (6 mL pH 1.5), while 5 mg GOx 
was dissolved in phosphate buffer (4mL, 0.1 M pH 7.4). The solutions were combined and the 
pH adjusted to 8 by adding 1 M NaOH slowly. The solution was stirred for 4 days. 
Afterwards, the solution was irradiated for 20 min in the UV-chamber and purified by the 
hollow fibre filtration. 
Preparation of Myo-filled crosslinked Ada-polymersomes: 10 mg of polymer (90 wt% for 
Me-BCP and 10 wt% for Ada-BCP) were dissolved in water (6 mL pH 1.5), while 2 mg Myo 
was dissolved in phosphate buffer (4mL, 0.1 M pH 7.4). The solutions were combined and the 
pH adjusted to 8 by adding 1 M NaOH slowly. The solution was stirred for 4 days. 
Afterwards, the solution was irradiated for 20 min in the UV-chamber and purified by the 
hollow fibre filtration. 
5.6 Purification of Enzyme-filled Ada-polymersomes with the Hollow 
Fibre Filtration 
10 ml of the unpurified enzyme-filled Ada-polymersomes solution was diluted with phosphate 
buffer (0.1 M pH 8) to 20 mL. Afterwards, the solution is transferred into a cone tube, which 
attached to the hollow fiber filtration system (HFF) with a polysulfone based separation 
module (MWCO: 500 kDa). The sample was constantly refilled with phosphate buffer (0.1 M 
pH 8) until the extraction volume was reached. To take samples, the extraction is continued 
and the fluid level is lowered until 20 ml remain in the cone tube. A summary of the 
parameters during the extraction process is given in Table 5.1. 
Table 5.1 Extraction volume and transmembrane pressure for the separation of non-
encapsulated enzymes and the enzyme-filled Ada-polymersomes with the hollow fibre 
filtration. 
Enzyme Extraction volume 
[ml] 
Transmembrane pressure 
[mbar] 
Myoglobin (Myo) 100 160 
Glucose Oxidase (GOx) 190 180 
 
5.7 Pure Enzyme Activity in pH 6 and 8 at Different Temperature 
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Stock solutions of GOx (0.1 mg/mL in phosphate buffer 0.1 M pH 6 or 8, respectively), Myo 
(1 mg/mL in phosphate buffer 0.1 M pH 6 or 8, respectively), guaiacol (0.1 M in phosphate 
buffer 0.1 M pH 7.4), glucose (1 M in phosphate buffer 0.1 M pH 7.4) and H2O2 (1 M in 
phosphate buffer 0.1 M pH 7.4) were prepared. The investigations were performed at different 
pH values by dissolving the enzymes in phosphate buffer of pH 6 and 8. To investigate the 
influence of temperature, the sample was treated and measured at different temperatures (25℃, 
37℃, 45℃). 
Myoglobin (Myo): To a Myo sample (300 μL), guaiacol (8 μL) and H2O2 (8 μL) were added. 
After preparation, the UV-vis monitoring at 470 nm was started and data points were recorded 
every second. The activity was determined after 300 seconds. For normalized activity of 
enzyme activity presented in the relevant figures, the highest value was fixed as 100% to 
normalize the other determined enzyme activities within one experiment series or repeating 
experiment series. The enzymatic activity for free Myo is given in Figure 5.1.  
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Figure 5.1 Normalized enzyme activities for free Myo at different temperatures and in 
various pH media. 
Glucose Oxidase (GOx): To a GOx sample (250 μL), Myo (50 μL), guaiacol (8 μL) and 
glucose (8 μL) were added. After preparation, the UV-vis monitoring at 470 nm was started 
and data points were recorded every second. The activity was determined after 200 seconds. 
For normalized activity of enzyme activity presented in the relevant figures, the highest value 
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was fixed as 100% to normalize the other determined enzyme activities within one experiment 
series or repeating experiment series. The enzymatic activity for free GOx in the cascade 
reaction with free Myo added later on is given in Figure 5.2.   
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Figure 5.2 Normalized enzyme activities for free GOx and Myo at different temperatures and 
in various pH media. 
5.8 Determination of the Encapsulation Efficiency for Myo in Ada-
polymersomes 
The calibration curve was plotted by determination of the change in absorption of different 
mass concentrations of myoglobin (mass concentrations of 1, 2, 4, 6, 8, 10 mg/L in phosphate 
buffer 0.1 M pH 6). Stock solutions of guaiacol (0.1 M in phosphate buffer 0.1 M pH 7.4) and 
H2O2 (1 M in phosphate buffer 0.1 M pH 7.4) were prepared. The standard calibration is 
given in Figure 5.3. 
To a sample of crosslinked Myo-filled Ada-polymersomes (purified) (300 μL, pH 6), both 
substrates guaiacol (8 μL) and H2O2 (8 μL) were added. After addition, the UV-vis 
measurement started at 470 nm. After 5 minutes at pH 6, change in absorbance was calculated 
according to the Myo calibration curve (Figure 5.3). In total, three measurements were 
conducted and the statistical average was used for the discussion. The encapsulation 
efficiency was calculated from equation 5.1, and a summary of the determination of the 
encapsulation efficiency for polymersomes is given in Table 5.2. Although only low amounts 
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could be encapsulated (below 3%), the encapsulation amount of enzymes in the 
polymersomes was sufficient to perform enzymatic studies. 
encapsulation efficiency of Myo =
absorbance × 0.02
0.02235
∗ 100                                               (5.1) 
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Figure 5.3 Change in absorption as a function of mass concentrations of Myo after 5 minutes. 
Table 5.2 Determination of the encapsulation efficiency for Myo in Ada-polymersomes. 
 
system 
 
Absorbance 
calculated 
concentration       
[mg L-1] 
Encapsulated 
amount of Myo    
[mg]a) 
Encapsulation 
efficiency  
[%] 
 
Myo-filled        
Ada-polymersomes 
0.033063 1.478121 0.029562 2.96 
0.031081 1.390649 0.027813 2.78 
0.028053 1.255168 0.025103 2.51 
a) Volume of the Myo-filled Ada-polymersomes solution after cleaning process was typically 20 mL. 
5.9 Enzymatic Reactions of Crosslinked Enzyme-filled Ada-
polymersomes 
Stock solutions of Myo (1 mg/mL in phosphate buffer 0.1 M pH 6 or 8, respectively), 
guaiacol (0.1 M in phosphate buffer 0.1 M pH 7.4), glucose (1 M in phosphate buffer 0.1 M 
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pH 7.4) and H2O2 (1 M in phosphate buffer 0.1 M pH 7.4) were prepared. The investigations 
were performed at different pH values by dissolving the enzyme-filled Ada-polymersomes in 
phosphate buffer of pH 6 and 8. To investigate the influence of temperature, the sample was 
treated and measured at different temperatures (25℃, 37℃, 45℃).  
Myo-filled Ada-polymersomes: An aliquot of 300 μL Myo-filled Ada-polymersomes was 
used for the following experiments. 3 aliquots were taken at pH 8, while 3 aliquots were taken 
after a pH switch to pH 6 and three aliquots after switch back to 8. For an activity experiment, 
the sample was treated with guaiacol (8 μL) and H2O2 (8 μL). The sample was stirred for 5 
minute and the UV-vis monitoring at 470 nm started subsequently. Data points were recorded 
every second. For normalized activity of enzyme activity presented in the relevant figures, the 
highest value was fixed as 100% to normalize the other determined enzyme activities within 
one experiment series or repeating experiment series.  
Gox-filled Ada-polymersomes and free Myo: An aliquot of 250 μL GOx-filled Ada-
polymersomes was used for the following experiments. 3 aliquots were taken at pH 8, while 3 
aliquots were taken after a pH switch to pH 6 and three aliquots after switch back to 8. For an 
activity experiment, the sample was treated with Myo (50 μL), guaiacol (8 μL) and glucose (8 
μL). The sample was stirred for 5 minute, and the UV-vis monitoring at 470 nm started 
subsequently. Data points were recorded every second. For normalized activity of enzyme 
activity presented in the relevant figures, the highest value was fixed as 100% to normalize 
the other determined enzyme activities within one experiment series or repeating experiment 
series.  
Gox-filled and Myo-filled Ada-polymersomes: The prepared solutions of Myo- and GOx-
filled crosslinked Ada-polymersomes were combined in a ratio of 1:1. An aliquot of 300 μL 
enzyme-filled polymersomes was used for the following experiments. 3 aliquots were taken at 
pH 8, while 3 aliquots were taken after a pH switch to pH 6 and three aliquots after switch 
back to 8. For an activity experiment, the sample was treated with guaiacol (8 μL) and 
glucose (8 μL). The sample was stirred for 5 minute and the UV-vis monitoring at 470 nm 
started afterwards, data points were recorded every second. For normalized activity of enzyme 
activity presented in the relevant figures, one value, the highest value was fixed as 100% to 
normalize the other determined enzyme activities within one experiment series or repeating 
experiment series.  
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6 Polymeric Multicompartmentalized System (MS) Assembly 
and  Characterization 
6.1 Preparation of Multicompartmentalized System by Using LbL 
Assembly 
Multilayers were adsorbed on silica particles with diameters of 1 μm using the LbL method. 
The corresponding polyelectrolyte solutions for PAH, PNMD, PMA(β-CD) and PMA(PEG) were 
prepared, using a concentration of 1 mg mL-1 in 0.4 M NaCl, and the polymersomes were 
prepared with 85 wt% of Me-BCP, 10 wt% of Ada-BCP and 5 wt% of Amine-BCP 
copolymer. Then, the pH of the solutions was adjusted to 8.0. The initial 100 μL suspension 
of 500 nm-diameter silica particles (5 wt%) were centrifuged (6000 g for 2 min) and the 
supernatant was removed. For the initial washing step, MilliQ water was added, the particles 
redispersed and centrifuged again. This procedure was repeated three times before 
multilayers´ formation on silica particles could be started. Subsequently, PAH (6 mL) was 
added to the freshly washed and bare silica particles and allowed to adsorb for 30 min with 
constant shaking (to deposit the first layer of the multilayered shell). The particles were then 
worked up by three centrifugation/redispersion cycles with MilliQ water. PMA(β-CD) (6 mL) 
was then adsorbed to the particles for 30 min, which were subsequently washed with MilliQ 
water. Next, a layer of enzyme-filled Ada-polymersomes (6 mL, 1 mg/mL) was deposited, 
allowing 10 h for the Ada-polymersomes to adsorb. After washing in distilled water (pH 8), 
anionic PMA(β-CD) was deposited, followed by further washing in distilled water (pH 8) and 
drying. Then PAH (6 mL) was added to the freshly washed silica particles and was allowed to 
adsorb for 30 min. The particles were then worked up by three centrifugation/redispersion 
cycles with MilliQ water. PNMD (6 mL) was then adsorbed to the particles for 30 min, which 
were subsequently washed. This bilayers of PAH/PNMD procedure was repeated to deposit 
the desired 3 bilayers. After washing three times in distilled water (pH 8), PAH and PMA(PEG) 
were then adsorbed to the particles to form the protective capping bilayers. 
6.2 Photo-crosslinking of Polymer Multilayers on Silica Particles 
The solution of the above particles was sonicated for 30 min before UV light crosslinking 
started. Then the solution was placed in the UV chamber equipped with a high pressure 
mercury lamp (EXFO Omnicure 1000, Lumen Dynamics Group Inc., Canada) and irradiated 
for 30 seconds. The capsules were left overnight prior to removing the silica core templates.  
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6.3 Preparation of the Multicompartmentalized System with Membrane-
associated polymersomes subcompartments (MS1) via Silica Core Template 
Removal 
The particle suspensions (0.1 wt%) were mixed well by vortexing and transferred to 
Eppendorf tubes. The particles were worked up by one centrifugation/redispersion cycles with 
MilliQ water (100 μL, pH 8).  The template silica cores were then removed to fabricate 
“membrane-associated” multicompartmentalized system by the addition of a hydrogen 
fluoride (HF) buffered to pH 8 with ammonium fluoride (NH4F) (5 mL, 1:13 5 M HF: 13.3 M 
NH4F). (Caution! Note that hydrogen fluoride and ammonium fluoride are highly toxic. 
Extreme care should be taken when handling HF solution and only small quantities should be 
prepared.) The samples were tapped gently to dissolve the silica cores for about 30 min. The 
excess NH4F, HF, and SiF4 were removed from “membrane-associated polymersomes” 
multicompartmentalized system by three centrifugation/redispersion cycles with MilliQ water, 
followed by re-suspending in a suitable volume (typically 0.5 mL) of MilliQ water. 
6.4 Preparation of the Multicompartmentalized System “Free-floating” 
Polymersomes Subcompartments (MS2) 
The “membrane-associated” multicompartmentalized system (MS1) was processed with free 
β-CD to separate the polymersomes subcompartments from the membrane of MS1 (Figure 
6.1). Here, the β-CD (27 mg, 15 mg mL-1) was added to the solution of MS1 
multicompartmentalized system (0.5 mL). The mixture was stirred at room temperature for 
24h to allow the excess free β-CD weaken the host-guest bonding of the Ada-polymersomes 
with the membrane of the carrier capsule promoting the localization of the polymersomal 
subcompartments into the hollow interior. The multicompartmentalized system was then 
purified via three centrifugation/redispersion cycles with MilliQ water to obtain 
multicompartmentalized system with “free-floating” polymersomes subcompartments (MS2). 
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Figure 6.1 Assembly of “free-floating” multicompartmentalized system (MS2) by processing 
“membrane-associated” multicompartmentalized system with excess free β-CD. 
6.5 Reversible Swelling-shrinking Behavior of the 
Multicompartmentalized System 
The photo-crosslinked multicompartmentalized system was incubated with phosphate buffer 
possessing pH 6 and 8, respectively. At each pH state, multicompartmentalized system was 
allowed to stand for 20 min. Then the temperature of the capsules was switched between 25℃ 
and 45 ℃ and the particles diameters were determined by DLS. This process was repeated for 
several cycles. No less than 20 measurements were taken on each temperature. 
6.6 Bienzymatic Reactions of Multicompartmentalized System 
Encapsulated with Enzyme-filled Ada-polymersomes 
Stock solutions of Myo (1 mg/mL in phosphate buffer 0.1 M pH 6 or 8, respectively), 
guaiacol (0.1 M in phosphate buffer 0.1 M pH 7.4), glucose (1 M in phosphate buffer 0.1 M 
pH 7.4) and H2O2 (1 M in phosphate buffer 0.1 M pH 7.4) were prepared. The investigations 
were performed at different pH values by dissolving MS in phosphate buffer of pH 6 and 8. 
To investigate the influence of temperature, the sample was treated and measured at different 
temperatures (25℃, 37℃, 45℃). 
Myo-filled Ada-polymersomes encapsulated in multicompartmentalized system: An 
aliquot of 300 μL multicompartmentalized system encapsulated with Myo-filled Ada-
polymersomes was used for the following experiments. 3 aliquots were taken at pH 8, while 3 
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aliquots were taken after a pH switch to pH 6 and three aliquots after switch back to 8. For an 
activity experiment, the sample was treated with guaiacol (8 μL) and H2O2 (8 μL). The 
sample was stirred for 5 minute and the UV-vis monitoring at 470 nm started subsequently. 
Data points were recorded every second. For normalized activity of enzyme activity presented 
in the relevant figures, the highest value was fixed as 100% to normalize the other determined 
enzyme activities within one experiment series or repeating experiment series.  
GOx-filled Ada-polymersomes encapsulated in multicompartmentalized system and free 
Myo (Case I): An aliquot of 250 μL multicompartmentalized system encapsulated with GOx-
filled Ada-polymersomes was used for the following experiments. 3 aliquots were taken at pH 
8, while 3 aliquots were taken after a pH switch to pH 6 and three aliquots after switch back 
to 8. For an activity experiment, the sample was treated with Myo (50 μL), guaiacol (8 μL) 
and Glucose (8 μL). The sample was stirred for 5 minute, and the UV-vis monitoring at 470 
nm started subsequently. Data points were recorded every second. For normalized activity of 
enzyme activity presented in the relevant figures, the highest value was fixed as 100% to 
normalize the other determined enzyme activities within one experiment series or repeating 
experiment series. 
GOx-filled Ada-polymersomes encapsulated in multicompartmentalized system and free 
Myo-filled Ada-polymersomes (Case II): An aliquot of 150 μL multicompartmentalized 
system encapsulated with GOx-filled Ada-polymersomes was used for the following 
experiments. 3 aliquots were taken at pH 8, while 3 aliquots were taken after a pH switch to 
pH 6 and three aliquots after switch back to 8. For an activity experiment, the sample was 
treated with Myo-filled polymersomes (150 μL), guaiacol (8 μL) and Glucose (8 μL). The 
sample was stirred for 5 minute, and the UV-vis monitoring at 470 nm started subsequently. 
Data points were recorded every second. For normalized activity of enzyme activity presented 
in the relevant figures, the highest value was fixed as 100% to normalize the other determined 
enzyme activities within one experiment series or repeating experiment series. 
GOx-filled and Myo-filled Ada-polymersomes encapsulated in one 
multicompartmentalized system (Case III): The prepared solutions of Myo- and GOx-filled 
Ada-polymersomes were combined in a ratio of 1:1 for forming the enzyme-filled 
multicompartmentalized system. An aliquot of 300 μL multicompartmentalized system 
encapsulated with GOx-filled and Myo-filled Ada-polymersomes was used for the following 
experiments. 3 aliquots were taken at pH 8, while 3 aliquots were taken after a pH switch to 
pH 6 and three aliquots after switch back to 8. For an activity experiment, the sample was 
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treated with guaiacol (8 μL) and glucose (8 μL). The sample was stirred for 5 minute and the 
UV-vis monitoring at 470 nm started afterwards, data points were recorded every second. For 
normalized activity of enzyme activity presented in the relevant figures, the highest value was 
fixed as 100% to normalize the other determined enzyme activities within one experiment 
series or repeating experiment series. 
6.7 Competitive Enzymatic Reactions of Catalase and 
Multicompartmentalized System Encapsulated with Enzyme-filled Ada-
polymersomes 
Stock solutions of Catalase (0.05 mg/mL in phosphate buffer 0.1 M pH 6 or 8, respectively), 
guaiacol (0.1 M in phosphate buffer 0.1 M pH 7.4), glucose (1 M in phosphate buffer 0.1 M 
pH 7.4) and H2O2 (1 M in phosphate buffer 0.1 M pH 7.4) were prepared. The investigations 
were performed at different pH values by dissolving MS in phosphate buffer with pH 6 and 8.  
GOx-filled Ada-polymersomes encapsulated in multicompartmentalized system and free 
Myo-filled Ada-polymersomes: An aliquot of 150 μL multicompartmentalized system 
encapsulated with GOx-filled Ada-polymersomes was used for the following experiments. 3 
aliquots were taken at pH 8, while 3 aliquots were taken after a pH switch to pH 6 and three 
aliquots after switch back to 8. For an activity experiment, the sample was treated with Myo-
filled Ada-polymersomes (150 μL), guaiacol (8 μL), glucose (8 μL) and catalase (30 μL). The 
sample was stirred for 5 minute, and the UV-vis monitoring at 470 nm started subsequently. 
Data points were recorded every second. For normalized activity of enzyme activity presented 
in the relevant figures, the highest value was fixed as 100% to normalize the other determined 
enzyme activities within one experiment series or repeating experiment series. 
GOx-filled and Myo-filled Ada-polymersomes encapsulated in one 
multicompartmentalized system: The prepared solutions of Myo- and GOx-filled Ada-
polymersomes were combined in a ratio of 1:1 for forming the enzyme-filled 
multicompartmentalized system. An aliquot of 300 μL multicompartmentalized system 
encapsulated with GOx-filled and Myo-filled Ada-polymersomes was used for the following 
experiments. 3 aliquots were taken at pH 8, while 3 aliquots were taken after a pH switch to 
pH 6 and three aliquots after switch back to 8. For an activity experiment, the sample was 
treated with guaiacol (8 μL), glucose (8 μL) and catalase (30 μL). The sample was stirred for 
5 minute and the UV-vis monitoring at 470 nm started afterwards, data points were recorded 
every second. For normalized activity of enzyme activity presented in the relevant figures, the 
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highest value was fixed as 100% to normalize the other determined enzyme activities within 
one experiment series or repeating experiment series. 
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Part III Results and Discussion 
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7 Multifunctional and Dual-Responsive Polymeric Capsules as 
Cell Membrane for Engineering Artificial Cells     
7.1 Introduction 
For functional artificial cells, the design of artificial cell membrane was among the first 
subjects84, 249-251 to simulate a first key characteristic of those compartments for the selective 
uptake and release of (bio)molecules and particles for intra- and intercellular signaling 
processes. In brief, one of the first bioinspired functions of artificial cell membrane was the 
ability to respond to multiple stimuli associated with pathological conditions, at which the 
function of tunable membrane permeability can control the post-encapsulation of smaller and 
larger biomolecules in the nanometer range of up to 10 nm, but also their release from those 
permeable supramolecular entities triggered by pH and temperature. Herein, multi-responsive 
hollow capsules are fabricated and they can be taken as ideal candidates for artificial cell 
membranes for uptaking as well as releasing various biomacromolecules in a highly 
controlled and selective manner. Further to preserve the vesicular shape of hollow capsules 
under varying conditions, 2-hydroxy-4-(methacryloyloxy) benzophenone (BMA) units are 
integrated to the block copolymer structure for photo-crosslinking the membrane of hollow 
capsules by UV-irradiation to fabricate the stable hollow capsules.252     
To formulate more sophisticated compartments with improved selectivity and targeting 
efficiency, colloidal stability in the bloodstream and low-cost production for controllable bio-
inspired functions, herein an ultrathin multilayer film with dual stimuli-responsive behaviors 
is fabricated by using LbL technique which involved alternate deposition of oppositely 
charged polyelectrolytes on silica template via electrostatic interaction (Figure 7.1) 
Furthermore, the reversible temperature and pH dual-response ability of the hollow capsules 
is analyzed. Eventually, the uptake and release properties of the resulting hollow 
nanocapsules with different degree of photo-crosslinking for cargos are further investigated in 
the external stimuli temperature (25, 37 or 45°C) and pH (5.5 or 7.4) of the solution. 
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Figure 7.1 Schematic illustration of the fabrication of photo-crosslinked hollow capsules. 
7.2 Polymer Synthesis and Characterization 
Initially, in order to fabricate capsules with desired dual responsive properties for temperature 
and pH, one of the prerequisites is to design and synthesize desired polymer materials. To 
implement this idea, a dual-responsive and photo-crosslinkable block copolymer poly-(N-
isopropylacrylamide)-block-poly[methacrylic acid-co-2-hydroxy-4-(methacryloyloxy) 
benzophenone] (PNMB) was synthesized via reversible addition-fragmentation chain-transfer 
radical polymerization (RAFT) using a two steps approach (Figure 7.2). In brief, starting from 
a RAFT chain transfer agent (CTA) and NIPAM forming the thermo-sensitive block 
PNIPAM as macro-CTA, methacrylic acid (MA) and benzophenone methacrylate (BMA) 
have been statistically copolymerized in different ratios as second block. The ratio between 
NIPAM and MA was 2:1, 1:1, 1:2 and 1:4 mentioned as PNMB21, PNMB11, PNMB12 and 
PNMB14, while BMA was incorporated with 5 mol% in the polymer chain. In addition, a 1:1 
random copolymer PRMNB was prepared also by RAFT for comparison. The composition 
and ratios of each component in the copolymers were determined by 1H NMR spectra (Figure 
7.3). In detail, every characteristic hydrogen signal of the three monomers, MA, NIPAM and 
BMA, can be found in the polymer chain, indicating copolymerization took place. 
Furthermore, the ratio of MA and NIPAM in the copolymer chain was calculated by the 
integration of the ratio between the specific signals of MA at 12-12.75 ppm and NIPAM at 
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3.84 ppm, respectively, and the content of PBMA was calculated to be about 5% by the 
integration of the ratio between the specific signals of BMA (6.3-7.7 ppm) and PNIPAM 
(3.84 ppm), respectively. 
 
Figure 7.2 General procedure for the synthesis of block copolymer PNMB. 
The polymers were further characterized by gel permeation chromatography (GPC) and the 
chemical composition, molecular weights, and dispersity (Ð) of the various PNMB block 
copolymers and random copolymer PRMNB are presented in Table 7.1. In brief, there was an 
almost linear relationship between macroinitiator/monomer ratio and molecular weights for 
all four samples and the molecular weight distributions always remained narrow (Ð ≤ 1.30). 
Hence, the low dispersity and the good agreement of copolymer composition and molecular 
weights with the monomer feed ratio indicated a controlled manner of the polymerization 
process. The resulting copolymers with appropriate molecular weights (below 20000 g mol-1) 
are ideal candidates for fabricating polyelectrolyte multilayers because of their good solubility 
in buffer and having enough carboxyl groups to form polyelectrolyte multilayers using LbL 
technique. Thus, these functionalized photo-crosslinkable PNMB block copolymers enabled 
us to realize the above-mentioned aim of capsules with controllable membrane functions 
(Figure 7.1). 
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Figure 7.3 1H-NMR spectrum (DMSO-d6) of PNMB11 with all peaks labeled to the 
corresponding groups in the molecule. 1H NMR signals of NIPAM at 3.84 ppm, BMA at 6.3-
7.7 ppm and MA at 12-12.75 ppm, respectively. 
Table 7.1 Molecular parameters of block copolymers and random copolymer synthesized by 
RAFT. 
Polymer Feed ratio of 
NIPAM and MA 
[mmol] 
Ratio of NIPAM 
and MA
a)
 
BMA 
[mol%]
b)
 
Mn          
[g mol
-1
]
c)
 
Mw         
[g mol
-1
]
d)
 
Ð
e)
 
PNMB21 6.67: 3.33 2: 1 5 13400 16800 1.26 
PNMB11 5: 5 1: 1 5 13000 15900 1.23 
PNMB12 3.33: 7.33 1: 2 5 12600 14900 1.19 
PNMB14 2: 8.6 1: 4 5 12200 14200 1.17 
PRMNB 5: 5 1: 1 5 13200 16100 1.22 
a), b)
 Calculated by 
1
H NMR spectroscopy. 
c), d), e)
 Measured by GPC. 
For checking the thermo- and pH-sensitivity of the synthesized block copolymers, the lower 
critical solution temperature (LCST) behavior of PNMB in dependence of the pH values were 
investigated by turbidity measurements. The 1:1 block copolymer PNMB11 possessed a good 
thermo-sensitivity as found for PNIPAM homopolymers over a broad pH range up to pH 8.5 
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(above pH 9 the aggregated block copolymer was highly swollen owing to ionization of 
carboxyl groups). However, the cloud point of the respective 1:1 random copolymer PRMNB 
disappeared already at pH 7.5 (Figure 7.4), because the MA components (which are ionized at 
pH 7.5) convey sufficient solubility to offset the aggregation of hydrophobic temperature-
sensitive components. Furthermore, below pH 9.5 the cloud point of block copolymer rapidly 
increased as the pH rose and the block copolymer always showed the temperature sensitivity 
over a broad pH range, although the temperature sensitivity would not occur at pH 9.5 where 
the block copolymer was highly swollen owing to ionization of carboxyl groups (Figure 7.5). 
To investigate the effect of MA content on the LCST of the block copolymers, turbidity 
measurements were performed (Figure 7.6). It was observed that the LCST values of block 
copolymer rapidly rose with the molar fraction of MA in the block copolymer, with the cloud 
point increasing from 39.9 ℃ for the 2:1 ratio of NIPAM and MA in PNMB21 to 49.0 ℃ for 
the 1:4 ratio of NIPAM and MA in PNMB14. Explanation for this can be the hydrophilic 
character of the MA monomers in the polymeric block of MA and BMA. Increasing the MA 
content in PNMB, the degree of hydrogen-bond-driven interactions in PNMB solution is 
higher than in pure PNIPAM homopolymer solution. Thus, there is a need for more energy to 
destroy the hydrogen-bond interactions which causes an increase in their LCST behavior.253, 
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Figure 7.4 Heating curves of the LCST measurements of random polymer PRMNB, block 
copolymer PNMB11 and homopolymer PNIPAM at pH 7.5, followed by transmittance (UV-
vis spectroscopy). 
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Figure 7.5 Heating curves of the LCST measurements of block copolymer PNMB11 at pH 
6.5, pH 7.5, pH 8.5 and pH 9.5, respectively, followed by transmittance (UV-vis 
spectroscopy). 
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Figure 7.6 Transmittance curve upon heating for LCST measurements of block copolymer 
PNMB21, PNMB11, PNMB12, and PNMB14 at pH 7.5 (UV-vis spectroscopy). 
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From the analysis of turbidity study, PNMB11 was selected as an ideal candidate for 
fabricating polyelectrolyte multilayers because of its LCST (39.8 ℃) being higher than the 
nominal body temperature in the physiological environment (pH 7.4). In addition, its LCST is 
lower than the nominal body temperature at slightly acidic environment (Figure 7.5). 
Furthermore, with a composition of 1:1 (NIPAM: MA), it contains enough carboxyl groups to 
form effectively polyelectrolyte multilayers using LbL technique. The transmittance of block 
copolymer PNMB11 was also investigated for reversibly switching over several cycles 
between 25 ℃ and 45 ℃ (Figure 7.7) and impressively, reversible volume phase transition 
behavior over 5 heating-cooling cycles was found, and therefore all following investigations 
are focused on PNMB11. Hereby, the LCST of the block polymer could be accurately tuned 
by adjusting the fraction of NIPAM units in the block copolymer chains and pH of the 
environment. Such key features in those dual-responsive block copolymers could be used to 
feasibly design and fabricate multi-responsive capsules with tunable LCST for mimicking cell 
compartments with controllable membrane functions. 
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Figure 7.7 Reversible volume phase transition of PNMB11 upon switching between 25 ℃ 
and 45 ℃ at pH 7. (open symbol=25 ℃; solid symbol=45 ℃). 
7.3 Polymeric Capsules Preparation by LbL Assembly 
Encouraged by the above observations, the [Poly(allylamine hydrochloride) 
(PAH)/PNMB11]3/PAH/Poly(sodium 4-styrenesulfonate) (PSS) multilayers were deposited 
on spherical silica particles (500 nm) to fabricate the photo-crosslinked capsules with dual pH 
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and temperature sensitivity. PAH was selected as the cationic polyelectrolyte due to the 
stronger interaction with PNMB. The outer bilayer PAH/PSS was assembled as protective 
capping bilayer to prevent the photo-crossslinking of the capsules with each other (Figure 7.1). 
Firstly, the effective charge of the polymer under different pH conditions represents a crucial 
parameter in the LbL technique, since electrostatic interactions are the main driving force 
governing the assembly process of the polyelectrolytes used in our study. Thus, the multilayer 
formation for of the polyelectrolytes PAH and PNMB11 used to the consecutive bilayer 
assembly was further determined by zeta potential measurements (Figure 7.8). To prove the 
successful formation of multilayers on silica particles, the variation in the zeta potential of 
silica particles coated with the bilayer PAH/PNMB11 was investigated as a function of the 
number of layers (Figure 7.9). The initial zeta potential of the silica surface changed from -45 
mV to -2 mV after the adsorption of cationic PAH polymer. This value is still negative, since 
the particle surface was not completely covered by PAH polymer. This means that the 
adsorbed PAH had not enough positive charge to offset the negative charge of bare silica 
particles. However, the increase of about 40 mV as compared with the bare particles was 
sufficient to start the fabrication of the desired hollow capsules. The subsequent addition of 
the anionic PNMB11 led again to a change in the surface charge to -45 mV. This negative 
zeta potential obtained enabled us further to carry out subsequent adsorption of the positively 
charged PAH. Such alternating reversal in the sign of the zeta potential is characteristic of 
LbL assembly of polyelectrolyte multilayers on particles surface, suggesting a successful 
stepwise layer growth of PAH and PNMB11. 
 
Figure 7.8 Zeta potential data of A) PAH and B) PNMB11 as a function of pH. 
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Figure 7.9 Zeta potential as a function of layer number for the [PAH/PNMB11]4/PAH/PSS-
coated silica particles. 
Following the reported concept (Figure 7.1), to ensure the integrity of capsules after the 
removal of the template, a crosslinking step has to be employed. Thus, in this study the well-
established photo-crosslinker BMA was integrated in PNMB11 (Figure 7.2).96 The exposure 
of the [PAH/PNMB11]3/PAH/PSS multilayers deposited on the silica particles under the 
unfiltered light of a mercury lamp for 30 min gave the desired crosslinked multilayers on the 
surface of silica particles. By subsequent etching out the silica template by NH4F/HF buffer at 
pH 7.5, hollow capsules were smoothly obtained (Figure 7.1). In order to confirm the 
molecular shape of hollow capsules, TEM and SEM measurements were performed to 
observe the real morphology of the capsules using [PAH/PNMB11]3/PAH/PSS multilayer. 
From the TEM images (Figure 7.10a) the regular spherical shape of the capsules with uniform 
diameters of about 445 nm can be clearly observed. Also the magnified image (Figure 7.10a, 
inset) clearly revealed the existence of a crosslinked multilayer shell of the capsules with a 
thickness of about 33 nm. Furthermore, the collapsed structure, shown by the SEM images in 
Figure 7.10b, further indicated that the individual hollow capsules retain their diameters. 
These diameters are similar to those obtained by TEM study after the removal of the silica 
template. Due to the vacuum drying for carrying out SEM measurements, some of the hollow 
capsules with slightly flexible multilayer shell were not stable enough to sustain the hollow 
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spherical structure. This led to the partial rupture of the vesicular structure of the hollow 
capsules. Also the magnified image (Figure 7.10b, inset) clearly demonstrates the existence of 
hollow capsules with uniform diameters of about 440 nm. This is in accordance with the 
results obtained from the analysis of TEM images. Compared with the data obtained by SEM 
and TEM, the slight increase in diameter in DLS is normal, considering the contribution from 
the swollen corona of the hollow capsules in solution (Figure 7.11). All results obtained from 
all methods indicated that the individual capsules retain their diameter of about 445 nm and 
spherical shape after removal of the template. The shell thickness of 30 ± 5 nm for the hollow 
capsules was determined by TEM. 
 
Figure 7.10 TEM (a) and SEM (b) images of [PAH/PNMB11]3/PAH/PSS-coated capsules, 
photo-crosslinked for 30 min (prepared using 500nm diameter SiO2 particles). The insets 
show membrane thickness of individual capsules (a) and a single capsule at higher 
magnification (b). 
In the following, with the aim to achieve hollow capsules which are on the one hand stable 
over a longer time, but on the other hand, should be able to show a significant swelling power 
upon external stimuli, which needs a fine-tuning of the bilayer numbers and the crosslinking 
density, best conditions for forming these hollow capsules were investigated. As illustrated in 
Figure 7.11, entire rupture of the hollow nanocapsules took place for non-photo-crosslinking 
(Figure 7.11a). Otherwise, the capsules retained more and more their diameter and spherical 
shape after removal of the template with increasing the UV-irradiation periods (5, 10, 20, 30, 
and 50 min). Corresponding TEM images are shown in Figure 7.11b-f). Especially after 30 
min of UV irradiation the spherical shape of the hollow capsules is preserved when 
[PAH/PNMB11]3/PAH/PSS multilayers were used. However, the diameter of the capsules is 
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reduced upon further UV irradiation for 50 min (Figure 7.11f) due to increased crosslinking 
density. From this point of UV irradiation dependency, one can state that UV irradiation for 
30 min is enough to remain the vesicular shape of the capsules. This can provide partially 
crosslinked capsules, hopefully, with a relatively high degree of swelling. 
 
Figure 7.11 TEM images of [PAH/PNMB11]3/PAH/PSS-coated capsules, photo-crosslinked 
for 0 min (a), 5 min (b), 10 min (c), 20 min (d), 30 min (e) and 50 min (f), respectively. 
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To explore the minimum number of bilayers deposition in multilayers needed to keep the 
stability of crosslinked hollow capsules, TEM analysis was performed on capsules with 2 to 4 
PAH/PNMB11 bilayers and 1 protective PAH/PSS bilayer (Figure 7.12). From this analysis 
the hollow capsules became more stable with at least 4 bilayers deposition consisting of 
[PAH/PNMB11]3/PAH/PSS. This also implicated the desired increase in the membrane 
thickness. Moreover, additional photo-crosslinking of the hollow capsules consisting of 
[PAH/PNMB11]4/PAH/PSS further enhanced the membrane stability as presented in Figure 
7.12c. Summarizing this key issue, four or five bilayers deposition in total can be enough to 
keep the vesicular shape of the capsules including their membrane stability (presented and 
discussed below). 
 
Figure 7.12 TEM images of [PAH/PNMB11]2/PAH/PSS (a), [PAH/PNMB11]3/PAH/PSS 
(b), [PAH/PNMB11]4/PAH/PSS-coated (c) capsules, photo-crosslinked for 30 min (prepared 
using 500nm diameter SiO2 particles). 
Finally, the formation of stable hollow capsules by LbL assembly after optimization of bilayer 
number and crosslinking density was successfully proven by the use of zeta potential, TEM 
and SEM. This enabled us to investigate their permeability and durability of such photo-
crosslinked hollow capsules, while the desired controllable membrane functions can be 
further tailored by the control over the number of bilayer deposition on silica particles and the 
degree of photo-crosslinking for the final multilayers. 
7.4 Temperature and pH Dual-Responsive Polymeric Capsules 
Characterization 
To confirm the temperature and pH dual-responsive characteristics and the stability of the 
hollow capsules with different crosslinking degree, DLS study was used to investigate the 
stability of the hollow capsules with different crosslinking degrees in different aqueous 
solution when the temperature between 25℃ and 45℃ was reversibly switched for several 
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cycles (Figure 7.13). In essence, the membrane of the hollow capsules, consisting of 
[PAH/PNMB11]3/PAH/PSS photo-crosslinked for 30 min, can undergo on/off switches for at 
least four cycles. This implies the presence of hollow capsules with tunable membrane 
permeability characteristics possibly suited for the traffic diffusion of various nanometer-
sized biomolecules from or into the capsules lumen depending on the respective pH and 
temperature stimuli. Furthermore, the permeability and durability of such photo-crosslinked 
capsules can be additionally tailored by controlling the degree of cross-linking. For example 
(Figure 7.13a), partial cross-linking of the same hollow capsules (10 min irradiation) resulted 
in capsules with a high swelling power in different pH buffer compared to those irradiated for 
30 min (Figure 7.13b). Surprisingly, those capsules also showed good temperature sensitivity 
over four cycles of swelling and shrinking observing defined changes in their diameters. 
 
Figure 7.13 Reversible swelling-shrinking of [PNMB11/PAH]3/PAH/PSS capsules photo-
crosslinked 10 min (a) and 30 min (b), upon switching between 25 ℃ and 45 ℃ at pH 5.5, pH 
7.4 and pH 8.5 buffer, respectively (open symbol=25 ℃; solid symbol=45 ℃) (n=3). 
In detail, when considering thermo-sensitive behavior of PNIPAM above LCST (Figure 
7.13a-10 min as photo-crosslinking period), the PNIPAM segments became hydrophobic and 
immediately shrink as a result of the reversible coil-to-globule transition. In contrast to the 
shrinking of PNIPAM segments, the deprotonated carboxylic acid units in PNMB block 
copolymers chains at pH 8.5 lead to electrostatic repulsion and swelling of multilayer.255 
Therefore, the membrane of the hollow capsules CP1 and CP2 (Figure 7.14: CP1 for swollen 
state and CP2 for shrunken state) exhibits a simultaneous competition between shrinking and 
swelling characteristics at different pH values and 25 ℃ (below LCST) and 45 ℃ (above 
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LCST. Keeping the temperature at 45 ℃ (above LCST), this competition or equilibrium 
between the shrinkage and the swelling characteristics of shell components in the hollow 
capsules result in a  shrinkage of hollow capsule from about 526 nm at pH 8.5 to about 490 
nm at pH 5.5. Main driving forces for the shrinkage are the less deprotonated acid groups at 
pH 5.5 compared to those at pH 8.5. This results in a lower degree of anionic repulsion forces 
at pH 5.5 than at pH 8.5. Moreover, these strong anionic repulsion forces at ≥ pH 7 are 
probably the reason that the LCST of the PNIPAM segments in PNMB raise to higher values 
(Figure 7.5). Under the given experimental condition (above LCST and pH switch between 
8.5 and 5.5) the change of the capsules diameters impressively indicates that the hollow 
capsules exhibit the desired pH responsive characteristics (Figure 7.14). 
 
Figure 7.14 Dual stimuli-responsive behavior of photo-crosslinked hollow capsule CP1 
(based on [PAH/PNMB11]3/PAH/PSS multilayers) upon temperature and pH changes. 
Furthermore, below LCST, also stronger swelling characteristic at pH 8.5 is given than at pH 
5.5 (Figure 7.13a). In this case both thermo-sensitive PNIPAM segments and anionic 
deprotonated acid-containing segments contribute to the swelling power of the hollow 
capsules, while the difference in the maximal swelling power of the hollow capsules at pH 8.5 
and 5.5, respectively, is relatively small in comparison to that above LCST. This also 
smoothly implies that the thermo-sensitive PNIPAM segments and the anionic deprotonated 
acid-containing segments contribute to the swelling power of the hollow capsules. 
However, applying longer UV irradiation of the hollow capsules for 30 min (Figure 7.13b) 
demonstrates a lower swelling power of the hollow capsules compared to those UV-irradiated 
only for 10 min (Figure 7.13a) due to the higher degree of crosslinking density of the 
multilayers. This highlights the strong influence of the crosslinking period on the swelling 
power of the photo-crosslinked hollow capsules. 
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Concluding the results of the dual-responsive characteristics for the established hollow 
capsules, the diameter and stability of formed capsules are controlled by the crosslinking 
period and are further fine-tuned by external pH and temperature stimuli. Figure 7.14 
schematically summarizes the structure-activity relationships of the hollow capsules CP1 
(swollen state) and CP2 (shrunken state) simultaneously tuned by external pH and 
temperature stimuli. This provides an exciting route for the design and fabrication of artificial 
cell compartments with possibly versatile membrane functions. 
7.5 Cargo Post-Loading and Controlled Release by Polymeric Capsules 
The potential of the photo-crosslinked hollow capsules for mimicking controlled cell 
compartment functions like uptake, retention, and release of cargo was further evaluated. The 
hollow capsules CP1, based on [PAH/PNMB11]3/PAH/PSS multilayers, were used for the 
study. CP1, swollen at pH 7.4 and 25 ℃, can be loaded with cargo to result in the state of the 
hollow capsules CP3 in the deswollen state (Figure 7.15), after separation of non-
encapsulated cargo by dialysis at pH 5.5 and 45 ℃ (Figure 7.16). The resulting cargo is 
retained in the lumen of CP3 as long as CP3 are in the “shrunken” state. When CP3 are 
triggered by decreasing temperature or base addition, CP3 will switch into a (partially) 
“swollen” state of the hollow capsules CP3 (Figure 7.15) and their cargo can be released with 
a controllable rate also depending on the degree of crosslinking. 
 
Figure 7.15 Schematic overview of the dual-responsive controlled release characteristics of 
cargos with different sizes across the membrane of photo-crosslinked hollow capsules CP3.  
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Figure 7.16 Schematic overview and UV-Vis monitoring how cargo is loaded into photo-
crosslinked [PNMB11/PAH]3/PAH/PSS hollow capsules. Capsule membrane allows for 
transmembrane diffusion at pH 7.4 and 25 ℃. When cleaned afterwards at pH 5.5 and 45 ℃ 
using dialysis (dialysis tube MWCO 5000 for Dox and MWCO 150 kDa for PEI-Mal 5 and 
PEI-Mal 25, respectively), the Dox signal (bottom, left), rhodamine B labeled PEI-Mal 5 
(bottom, middle) and PEI-Mal 25 (bottom, right) were still detectable and remained at a stable 
level, indicating a successful enclosure. 
As the first step towards this goal, doxorubicin hydrochloride (Dox)256 and rhodamine B 
labeled dendritic glycopolymers of different core sizes100 (PEI-Mal 5 with  5 nm and PEI-
Mal 25 with  11 nm) were chosen as model cargos with different molecular weights and 
nanometer sizes. Generally, the solution of cargos was mixed with a concentrated dispersion 
of the swollen hollow capsules CP1 in PBS buffer pH 7.4 at room temperature to realize a 
high loading of cargo. After the penetration of CP1 by cargo reached a steady state, the non-
encapsulated cargo was removed by dialysis in phosphate buffer pH 5.5 at 45 ℃. At this 
solution state the CP1 capsules completely switched into the “shrunken” state (CP3). Of 
special importance is the stable level of the UV spectra recorded after two and three days of 
dialysis, indicating a successful separation of non-encapsulated cargo. The loading efficiency 
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of Dox, PEI-Mal 5 and PEI-Mal 25 were determined to be about 20±5%, 35±5% and 40±5%, 
respectively (Figure 7.16).  
First, Dox was used as a model of a low molecular weight drug to investigate the crosslinking 
time dependence release behavior from the hollow capsules at 45 ℃, which was above the 
LCST (Figure 7.17). For this purpose, the release studies were performed with hollow 
capsules treated with different photo-crosslinking period. For the release behavior of capsules, 
the Dox-encapsulated capsules were immersed in solutions to study the effects of photo-
crosslinking period on the release kinetics. After that, the samples were taken and analyzed 
using UV-Vis at regular intervals as indicated in Figure 7.17. For different photo-crosslinking 
density of the capsules studied, Dox showed similar release profiles at physiological pH 7.4 
and acidic pH 5.5, respectively. This can be described as slightly sustained release 
characteristic compared with free Dox. Hence, at a physiological pH 7.4, over the course of 
72 h about 72% of Dox was released from crosslinked capsules irradiated for 10 min. 
However, when the photo-crosslinking period was increased to 30min, the high crosslinking 
density can further suppress the drug diffusion from the hollow capsules. This results in a 
slower release profile with a more sustained manner, in which only 61% of the Dox were 
released over 72 h. Thus, the permeability of the capsules and consequently the rate of drug 
release can be controlled by the photo-crosslinking period. 
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Figure 7.17 Cumulative release profile of Dox from [PNMB11/PAH]3/PAH/PSS capsules, 
crosslinked with different time of UV irradiation and in various pH media (n=3) at 45 ℃. 
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Next, the temperature and pH responsive release of larger nanometer-sized cargos, rhodamine 
B-labeled PEI-Mal 5 ( 5 nm) and PEI-Mal 25 ( 11 nm), from 30 min photo-crosslinked 
capsules was studied by carrying out the experiments at different pH and temperature (Figure 
7.18). For this purpose, temperatures of 25 ℃ (below LCST), 37℃ (body temperature and 
slightly lower than the LCST), and 45℃ (above LCST) were selected for the release study. 
These temperatures were combined with physiological pH 7.4 and acidic environment (pH 5.5) 
which simulates the internal pH of cell organelles. Generally, a significantly sustained release 
profile for both dendritic glycopolymers is given tailored by the temperature- and pH-
responsive key characteristics of cargo-containing hollow capsules CP3, as presented in 
Figure 7.18. 
 
Figure 7.18 Cumulative release profile of rhodamine B labeled PEI-Mal 5 (A) and PEI-Mal 
25 (B) from [PNMB11/PAH]3/PAH/PSS capsules, photo-crosslinked for 30 min, at different 
temperature and in various pH medium (n=3). 
Using release condition at physiological pH 7.4 and 25 ℃, CP3 switches from “shrunken” 
into the “swollen” state (Figure 7.15). This results in a slow release rate,257, 258 at which only 
27% of PEI-Mal 5 and 21% PEI-Mal 25 are released when the delivery time run up to 96 h 
(Figure 7.18). In opposite to this, when the temperature is increased to 37 ℃ and 45 ℃ at pH 
7.4  (Figure 7.18), the temperature sensitive part of the shell of the hollow capsules collapses 
and the capsules become smaller, and this causes a slight rise of the release rate for both 
dendritic glycopolymers PEI-Mal 5 and PEI-Mal 25: over 96 h the amount of released PEI-
Mal 5 and PEI-Mal 25 increases to 35% and 28%, respectively, at 37 ℃ and to 38% and 31%, 
respectively, at 45 ℃. 
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Firstly, considering the release characteristics of the hollow capsules at physiological pH 7.4 
above and below LCST, the release of the cargo macromolecules from the hollow capsules is 
generally sensitive to the temperature. More precisely, in the collapsed state for the capsule 
shell (above LCST having smaller diameters) there is a higher release rate of the cargo 
macromolecules compared to those of swollen capsule shell (below LCST having larger 
diameters). One explanation can be that at the higher temperature of 45 ℃, compared to 25 ℃, 
the mobility of cargo macromolecules is increased and in addition, the ionic interactions of 
cationic cargo macromolecules with, at pH 7.4, anionic acid groups in the shell or membrane 
might be weakened. Therefore, slightly more cargo macromolecules can be released from the 
hollow capsules even in their collapsed state. 
Beside this temperature sensitivity of the hollow capsules, the pH-responsive characteristics 
of cargo-containing hollow capsules were investigated at either T < LCST or T > LCST 
(Figure 7.18). For example, while the environmental pH decreases from pH 7.4 to 5.5 above 
the LCST (45℃), over 96 h the release of the entrapped PEI-Mal 5 increases from 38% to 
45%, respectively, and of PEI-Mal 25 from 31% to 36%, respectively. This implies that the 
release behavior and the release characteristics of PEI-Mal 5 and PEI-Mal 25 from photo-
crosslinked capsules significantly correlate with the pH of release medium and accelerate with 
a pH decrease. 
Considering the results from both stimuli, we can assume that electrostatic interactions 
between charged cargo macromolecules and the membrane of the hollow capsules are actively 
responding to the pH variation, and those are significantly involved in the retention capability 
of the capsules. As the pH drops down to pH 5.5, the carboxyl groups in the capsules shell are 
mainly protonated. This consequently leads to reduced electrostatic interactions between 
cationic cargo macromolecules and carboxyl groups in the capsules shell and results in 
boosting cargo macromolecules to get off the hollow capsules. Additionally, the 
shrinkage/swelling characteristics of the hollow capsules, mainly determined by the 
temperature sensitive part of the membrane, also have a certain effect on the cargo release 
(Figure 7.15). With decreasing the pH and raising T, the capsules shrink and undoubtedly 
reduce their inner volume of the cavity and this goes along with a reduction in the anionic 
repulsion forces in the capsules shell. Thus, the cargo macromolecules are squeezed out more 
intensively and, finally, the release quantity of the cargo macromolecules increases.259  
Summarizing the uptake, retention and release of the three different cargos by the hollow 
capsules, we can state that for small molecules similar profiles of sustained release are 
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obtained at 45 ℃ (above LCST) with a notable but weak effect of crosslinking time and pH. 
For the cationic cargo macromolecules PEI-Mal 5 ( 5 nm) and 25 ( 11 nm) the following 
observations can be stated: (A) a slower release of both cargo macromolecules can be found 
in the case of pH 7.4 and temperature below LCST (being in the “swollen” state); (B) a higher 
release of both cargo macromolecules is taken place in the case of pH 5.5 and temperature 
above LCST (being in the “shrunken” state); (C) the smaller cargo PEI-Mal 5 reveals a 
slightly larger release from hollow capsules compared to the PEI-Mal 25. Overall, a general 
size-dependent permeability of the hollow capsules at each release condition is observable. 
This is attributed to a controlled trans-membrane diffusion process;260 (D) a further sustained 
release of cargo can be obtained when further increasing the photo-crosslinking period (> 30 
min). Therefore we can state that our photo-crosslinked hollow capsules exhibited the desired 
dual-responsive behaviors usable for mimicking cell compartment functions with controllable 
uptake and release.  
7.6 Summary 
In conclusion, for mimicking cell membrane dual-responsive and photo-crosslinked hollow 
capsules have been prepared and finally used for the subsequent and easily available post-
encapsulation process of protein-like macromolecules and their controllable release of 
protein-like macromolecules from hollow capsules triggered by external stimuli. To achieve 
those polymeric capsules hybrid polyelectrolyte multilayer systems were fabricated on 
colloidal particles via layer-by-layer (LbL) assembly of the cationic poly(allylamine 
hydrochloride) (PAH) and the anionic, pH- and temperature-responsive and photo-
crosslinkable block copolymer poly-(N-isopropylacrylamide)-block-poly[methacrylic acid-co-
2-hydroxy-4-(methacryloyloxy) benzophenone] (PNMB) synthesized by RAFT 
polymerization. The successful fabrication of PAH and PNMB on silica particles was 
confirmed by zeta potential measurements. After photo-crosslinking and etching the silica 
core, dual-responsive hollow polymeric capsules towards temperature and pH changes were 
obtained. Well-defined hollow capsules were smoothly visualized by TEM and SEM study, 
while their diameters (480-560 nm) related to the degree of photo-crosslinking were 
determined by DLS measurements. The uniform photo-crosslinked hollow capsules exhibit 
the stimuli-responsive behavior towards changing environmental conditions pH and 
temperature, including the robustness and stability over several swelling/deswelling process at 
pH 5.5, 7.4, and 8.5 combined with temperature switches between 25 and 45 °C (Figure 7.19). 
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For mimicking cell functions towards tunable membrane permeability of those hollow 
capsules post-encapsulation and release of biological-active molecules can be adapted 
depending on the crosslinking density, the size of cargo, and the external stimuli temperature 
and pH of post-encapsulating and releasing medium (Figure 7.19). Besides the almost 
quantitative release of drug molecule doxorubicin a similar retarding release profile of 
protein-like macromolecules such as spherical dendritic glycopolymers with average 
diameters of 5 and 11 nm, respectively, was detected over 4 days. Thus, the dual stimuli-
responsive and photo-crosslinked hollow capsules have the potential for mimicking cell 
membrane functions with controllable diffusion process for post-encapsulating and releasing 
larger proteins (≤ 11 nm) at pH 7.4 and 37°C and at pH 5.5 and 37°C, respectively.  
 
Figure 7.19 Dual stimuli-responsive behavior of photo-crosslinked hollow capsule CP1 
(based on [PAH/PNMB11]3/PAH/PSS multilayers) upon temperature and pH changes and the 
dual-responsive controlled release characteristics of cargos with different sizes across the 
membrane of photo-crosslinked hollow capsules CP3. Release of cargo carried out at pH 7.4 
in PBS environment and at pH 5.5 in phosphate buffer environment. 
Overall, these photo-crosslinked and dual stimuli-responsive hollow capsules with different 
degrees on permeable membrane functions can be considered as attractive material for 
mimicking cell membrane functions triggered by controllable uptake and release of different 
nanometer-sized biomolecules (up to 10 nm in diameter). And such potential reversible 
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Highest permeability
of membrane
at pH 5.5 + 45 C
Cargo
CP3
LCST of PNMB11
(PNIPAM-b-(PAA-r-BMA))
as component of membrane
is 39.8 C 
Immediate start of release after closing the separation process, then using the desired
state of release by depositing dialysis tube in the corresponding environment
and 25, 37 or 45 C 
time-dependent
release at pH 5.5
and 25, 37 or 45 C 
time-dependent
release at pH 7.4
increasing diameter
45 C < 37 C < 25 C
increasing diameter
45 C < 37 C < 25 C
Swelling behavior of CP1 or CP3
pH > below/above LCST 
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processes of the outer corona for, e.g., multicompartmentalized capsules are needed at which 
the release of captured biomolecules is even more slowed-down for feeding enzymatic 
subcompartments in complex biological processes. Overall this approach enables us further to 
design and fabricate advanced and stimuli responsive capsules with complex architectures 
such as multicompartmentalized cellular structures.  
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8 Multifunctional and pH-Responsive Ada-polymersomes as 
Organelle Mimics for Engineering Artificial Cells     
8.1 Introduction 
In order to successfully fabricate multifunctional polymeric artificial cells aimed for, some 
thoughts about specialized subcompartment assembly as organelle mimics have to be 
conducted, which divide the interior of the multicompartmentalized systems into 
subcompartments and allow for multiple, spatially separated and successive enzymatic 
reactions within a confined area-resembling cell organelles. To design and establish such 
polymersomal subcompartmens, some concerns have to be taken into account. Obviously, the 
first issue is that the polymersomal subcompartmens should have effective reactive groups 
which can be anchored to the membrane of multicompartmentalized systems. Herein, pH-
responsive polymersomes decorated with adamantane groups are formed by starting with the 
synthesis of suitably end-group block copolymers. Another aspect is the visualizing of the 
polymersomal subcompartmens in multicompartmentalized systems by fluorescence 
microscopy. Thus, it is important to realize Ada-polymersomes terminated with free amine 
group which is used later for the post-labelling of Ada-polymersomes with fluorescein 
isothiocyanate (FITC). In addition, Ada-polymersomes should show a stable and robust 
behavior without facing any disassembly problems under varying conditions. Thus, 2-
hydroxy-4-(methacryloyloxy) benzophenone (BMA) units are integrated to the block 
copolymer structure for photo-crosslinking the membrane by UV-irradiation which is aimed 
to have tunable membrane permeability and proper stability.247 
 
Figure 8.1 General schematic of the assembly of the enzyme-loaded, multifunctional, pH-
responsive and photo-crosslinked 100-nm-diameter Ada-polymersomes subunits with 
different end-group block copolymers.  
Thus, this chapter describes the fabrication of enzyme-loaded, multifunctional, pH-responsive 
and photo-crosslinked Ada-polymersomes as the basis of this study. Figure 8.1 outlines the 
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discussed points by starting with synthesis of suitably end-group block copolymers to realize 
the enzyme-loaded, multifunctional, pH-responsive, photo-crosslinked and post-labelled 
polymersomes decorated with adamantane groups. In addition, the reversible pH-dependent 
swelling/shrinking ability of the Ada-polymersomes is also analyzed. Eventually, the various 
enzymatic reactions of enzyme-loaded Ada-polymersomes are investigated.  
8.2 Block Copolymer Synthesis and Characterization 
To create our desired multifunctional polymersomes, a variety of required block copolymers 
were created with some key features before starting the self-assembly process. Thus, we 
synthesized three different block copolymers (Figure 8.2) having amine, adamantane, and 
methoxy end groups at their hydrophilic segment using atom transfer radical polymerization 
(ATRP). Here, amine and adamantane functionalities were chosen to favor ease of post-
labelling of polymersomes with fluorescein isothiocyanate (FITC) and host-guest interactions 
for further anchoring to the membrane of multicompartmentalized systems. This strategy has 
been successfully applied in the Voit group, which the amine-functionalized block 
copolymers (Boc-BC) and adamantane-functionalized block copolymers (Ada-BCP) were 
previously synthesized by Yassin et al.96 and Iyisan et al.,247 respectively. In this manner, the 
block copolymers are based on pH-sensitive and photo-crosslinkable block copolymer, 
poly(ethylene glycol)-block-poly[2-(diethylamino) ethyl methacrylate-stat-2-hydroxy-4-
(methacryloyloxy) benzophenone] (Me-BCP).252 Here, poly(ethylene glycol) (PEG) is the 
hydrophilic segment of the amphiphilic block copolymer, whereas pH-sensitive 2-
(diethylamino)ethyl methacrylate (DEAEM) and a photo-crosslinker benzophenone (BMA) 
groups together form the hydrophobic part. In addition, to confer a homogenous membrane 
thickness for the polymersome, the block copolymers were designed to have relatively equal 
hydrophobic block lengths. However, the hydrophilic block lengths of the Boc-amino and 
adamantane-functionalized block copolymers (Boc-BC and Ada-BCP) were designed to be 
longer than the non-functional methoxy terminated block copolymer (Me-BCP) to increase 
the accessibility for the functional moieties on the Ada-polymersome surface.  
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Figure 8.2 Schematic overview of the chemical structures of block copolymers having 
methoxy (Me-BCP), adamantane (Ada-BCP) and amine (Amine-BCP) functionalities for 
forming Ada-polymersomes. 
To establish such functional block copolymers, atom transfer radical polymerization (ATRP) 
was adopted as a polymerization approach. Based on the previous work, the Boc-amino block 
copolymers (Boc-BC) described by Iyisan et al.96 and adamantane-functionalized block 
copolymers (Ada-BCP) described by Yassin et al.247 were integrated into this study. In this 
manner, starting from PEG-Br macroinitiator terminated with methoxy, adamantane or Boc-
amino units, pH-sensitive DEAEM units and photo-crosslinker BMA monomers have been 
statistically copolymerized to realize the desired block copolymers (Figure 8.2; Me-BCP, 
Ada-BCP and Boc-BCP). The number of photo-crosslinker (BMA) repeating unites was fixed 
at 10% of the total number of the hydrophobic repeating units since it was the essential ratio 
to acquire crosslinked polymersomes within short time of UV irradiation.252 The composition 
and ratios of each component in the copolymers were determined by 1H NMR spectroscopy 
from the peak integrals of PEG (3.6 ppm), DEAEMA (4.2 ppm) and BMA (6.6-7.7 ppm) by 
taking the PEG block as an internal standard (Figure 8.3 and Table 8.1). Herein, the total 
number of protons of each monomer units has taken into account and related with the 
equation 8.1 to determine the repeating units of each block of the copolymer. Therein, the 
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analyzed signal of the PEG unit has four protons whereas the DEAEMA and BMA monomers 
have two and eight protons respectively. 
 PEG: DEAEMA: BMA =
∫ sig.a
4
: 
∫ sig.b
2
: 
∫ sig.c
8
                                                                                (8.1)                                                                          
Thus, the length of the hydrophobic block was calculated as about 90 monomer units using 
the above equation whereas the photo-crosslinker (BMA) content was found about 10 
repeating units. Apart from that, in the 1H NMR spectrum of Ada-BCP polymer, the 
characteristics 1H NMR signals of the adamantane groups (3.01 ppm and 4.50 ppm) could be 
clearly observed. In addition, the 1H NMR spectrum of the resulted Amine-BCP copolymer 
was similar to that of the precursor Boc-BCP with the exception of disappearance the Boc 
groups signal at 1.44 ppm.  
 
Figure 8.3 1H NMR spectra (CDCl3) of AdaPEG60-b-P(DEAEMA80-stat-BMA10) (Ada-BCP) 
copolymer (blue), Boc-NH-PEG68-b-P(DEAEMA80-stat-BMA10) (Boc-BCP) copolymer 
(green), H2N-PEG68-b-P(DEAEMA80-stat-BMA10) (Amine-BCP) copolymer (gray) and 
PEG45-b-P(DEAEMA80-stat-BMA10) (Me-BCP) copolymer (red) all requested 
1H NMR 
signals to determine the part structures of various polymers. 
Furthermore, GPC analyses revealed narrow molar mass distributions (Ð) of the block 
copolymers in the range of 1.1 to 1.2, indicating the controlled manner of polymerization 
process. All block copolymers used for further investigations were within the desired block 
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length ratio, containing a hydrophobic block of 90 units which include 80 units for pH 
sensitive DEAEM and 10 units for photo-crosslinker BMA (Table 8.1). Thus, the synthesized 
block copolymers with well-defined chemical composition as well as monomodal distribution 
offer the prerequisites for a narrow-dispersed polymersomes formation.  
Table 8.1 Molecular parameters of block copolymers synthesized by ATRP. 
Polymer Copolymer chemical 
compositiona) 
Mn             
[g mol-1]b) 
Mw         
[g mol-1]c) 
Ðd) 
Me-BCP Me-PEG45-b-P(DEAEMA80- 
stat-BMA10) 
23500 26200 1.11 
Ada-BCP Ada-PEG60-b-P(DEAEMA80- 
stat-BMA10) 
29600 35200 1.19 
Boc-BCP Boc-PEG68-b-P(DEAEMA80- 
stat-BMA10) 
29900 35600 1.19 
Amine-BCP Amine-PEG68-b-P(DEAEMA80-
stat-BMA10) 
29700 35000 1.18 
a) Calculated by 1H NMR; b), c), d) Measured by GPC 
8.3 Polymersomes Preparation and Characterization 
Using the similar strategy of polymersomes formation previously described by Voit group,247  
the enzyme-loaded, multifunctional and pH-responsive polymersomes subunits decorated 
with adamantane groups was formed by the aqueous co-assembly of the suitably end-group 
block copolymers mixture (Table 8.2) without the need for organic solvents,76 which is much 
more beneficial for maintaining the bioactivity and biofunction of the enzyme (Figure 8.1). 
Recently, Iyisan et al.247 have reported the multifunctional polymersomes based on 
adamantane-functionalized block copolymers (Ada-BCP) and azide-functionalized block 
copolymers, while Yassin et al.96 have used the amine-functionalized block copolymers (Boc-
BC) in combination of folate-terminated copolymers to form polymersome system which 
showed remarkable specificity towards cancer cells. Based on these previous works, the Boc-
amino block copolymers (Boc-BC) and adamantane-functionalized block copolymers (Ada-
BCP) were incorporated to form Ada-polymersomes in this study. Simply, the desired weight 
ratio of Me-BCP, Ada-BCP and Amine-BCP were dissolved in acidic water (pH 2) at total 
polymer concentration of about 1 mg mL-1. Then, to induce the self-assembly process, 
deprotonation of the tertiary amine groups was performed by gradually increasing the pH to a 
basic state (pH 9). After 4 days of stirring, the final Ada-polymersome structure is formed 
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with a membrane having a central hydrophobic part based on DEAEM and BMA segments 
and a hydrophilic inner and outer PEG corona with adamantane and amine functionalities. 
Importantly, compared to the PEG block (Mn = 2000 g mol-1) of the non-functionalized block 
copolymer (Me-BCP), Ada-BCP with longer PEG block (Mn = 3000 g mol-1) placed 
adamantane groups as protruding antennae not shielded by the dense PEG corona. Thus, Ada-
polymersomes can be incorporated to the multicompartmentalized systems by host-guest 
interactions with β-CD receptors in the membrane of multicompartmentalized systems (more 
information is available in chapter 9.3).  
To inhibit the reversible disassembly of Ada-polymersomes, the photo chemical reactivity of 
benzophenone units that had been part of the hydrophobic blocks was used for photo-
crosslinking the membrane of the Ada-polymersomes by UV irradiation with a low intensity 
UV lamp for 20 min.247 Then, the surface of the preformed Ada-polymersomes was post-
labelled with fluorescein isothiocyanate (FITC) to allow visualization by fluorescence 
microscopy (Figure 8.1).96 The prepared Ada-polymersomes were characterized by dynamic 
light scattering (DLS) to determine the size distributions. Table 8.2 shows the hydrodynamic 
diameter as well as polydispersity index of the multifunctional Ada-polymersomes at pH 9. 
Importantly, low PDI values about 0.15 demonstrate the low dispersity of the Ada-
polymersomes. Additionally, the prepared Ada-polymersomes having sufficient adamantane 
(10%) and amine (5%) groups on the outer region of the Ada-polymersomes possess the 
prerequisite for the further step to be incorporated to the multicompartmentalized systems and 
post-labelled with fluorescein isothiocyanate (FITC). 
Table 8.2 Specification of the Ada-polymersomes with different functional groups. 
Polymersome Me-BCP 
[wt%] 
Ada-BCP 
[wt%] 
Amine-BCP 
[wt%] 
Photo-  
crosslinked 
Diameter 
[nm]a) 
PDIb) 
PS 85 10 5 yes 120.6 ± 0.8 0.15 ± 0.01 
a) Diameter is measured by DLS at pH 9. b) PDI = polydispersity index that shows the size variation. 
Our group previously investigated the stability of polymersomes at various pH conditions by 
dynamic light scattering (DLS).247 In this manner, the stability of the obtained crosslinked 
Ada-polymersomes in this study was investigated upon reversible pH switch for several 
cycles. In brief, the size change of the Ada-polymersomes upon changes in pH value from 
basic to acidic state for 5 cycles was monitored by DLS. The multifunctional Ada-
polymersome had the ability for swelling and shrinking reversibly at acidic and basic 
107 
 
conditions because of the protonation/deprotonation of the PDEAEM groups in the membrane 
of Ada-polymersomes. This further indicates that the tunable membrane permeability can be 
provided by the crosslinking. Especially, their average diameter increased from about 120 to 
185 nm revealing 54% swelling, indicating the short time of UV irradiation was sufficient to 
provide shape-persistent Ada-polymersomes. In addition, cryo-TEM investigation was 
performed to confirm the vesicular structure of our crosslinked Ada-polymersomes as well as 
their ability to conserve the vesicular structure in acidic medium. As shown in Figure 8.5, the 
average diameter of crosslinked Ada-polymersomes was about 110 nm at pH 8 and Ada-
polymersomes had a homogenous membrane thickness attributed to the use of block 
copolymers with relatively equal hydrophobic block lengths. Additionally, the average 
membrane thickness of several Ada-polymersomes about 22 nm which is much thicker than 
liposome membrane formed by phospholipid.261 Thus, the permeable Ada-polymersome 
membrane can be consider as a gate which undergoes “on” and “off” switches in response to 
pH stimuli. In the “on” state, the permeability is sufficient for substrate diffusion and 
enzymatic conversion in situ. In the “off” state, the thick membrane is also useful to avoid 
undesired leakage of the encapsulated enzymes at basic state by providing impermeable Ada-
polymersomes membrane.  
0 1 2 3 4 5
100
120
140
160
180
200
pH 8 - DEAEM
pH 6 - DEAEM+
D
ia
m
et
er
 (
nm
)
Number of cycles
 
Figure 8.4 Reversible swelling-shrinking of Ada-polymersomes (prepared with 85 wt% of 
Me-BCP, 10 wt% of Ada-BCP and 5 wt% of Amine-BCP copolymer) upon changes in pH 
value. 
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Figure 8.5 Cryo-TEM images of Ada-polymersomes photo-crosslinked for 20 min at pH 8 
and pH 6. 
8.4 Enzymatic Reactions of Enzyme-filled Ada-polymersomes 
In an initial study Gräfe et al.99 have reported the pH-responsive polymersomes, in which pH 
sensitivity is provided by poly(diethylaminoethyl methacrylate) (PDEAEM, 82 mol%) and the 
photo-cross-linkable poly(3,4-dimethyl maleic imido butyl methacrylate) (PDMIBM, 18 
mol%) provides stability towards disassembly upon UV irradiation. The hydrophilic and 
permeable membrane of these polymersomes is allowing small substrates to pass it via 
diffusion in an acidic pH value (pH 6), but enzymatic conversion is stopped by changing the 
pH to basic values (pH 8).99 In order to confirm the technical relevance of our enzyme-loaded 
Ada-polymersomes various enzymatic reactions were conducted in this study. As proposed by 
Gräfe et al.,99 the encapsulation of enzyme was achieved by mixing the enzyme to the 
preliminary solution of dissolved block copolymer and afterwards purifying with the HFF-
based cleaning method to remove any free enzyme (more information is available in chapter 
5.6). The final amount of encapsulated enzymes could be determined by comparing the 
standard calibration of activity for free enzyme. Although only low amount of Myo could be 
encapsulated (below 3%), the encapsulation amount of Myo in the Ada-polymersomes was 
sufficient to perform enzymatic studies. 
Firstly, the enzymatic activity for single enzyme was investigated. In brief, the purified Myo-
filled Ada-polymersomes were treated with guaiacol and hydrogen peroxide as substrates for 
109 
 
myoglobin. At first, at pH 8 the Ada-polymersomes are at an unswollen state and the 
membrane is not permeable for substrates. Consequently, no enzymatic activity of Myo could 
be monitored (Figure 8.6a), indicating that no free enzyme was present after the purification 
process and the substrates cannot diffuse into the Ada-polymersome lumen where the enzyme 
is hosted. In contrast, large activity could be monitored at pH 6. The acidified cross-linked 
membrane is now at a swollen state and further allows for diffusion of the substrate across the 
membrane to reach the myoglobin, which catalyze the reaction. Especially in the swollen state 
for Ada-polymersomes at pH 6, due to the native highest activity of pure enzyme Myo at 37 
℃, there was a highest activity for Myo-filled Ada-polymersomes at this temperature. 
Furthermore, the enzymatic activity subjected to several pH switches between pH 8 and 6 was 
further investigated (Figure 8.6b). It was already known that the swelling/deswelling cycles of 
the Ada-polymersomes were stable over at least 5 cycles. As expected, due to the Ada-
polymersomes being swollen at pH 6, enzymatic reactions could be monitored exclusively at 
this pH for enclosed enzymes. However, when pH 8 was reached Myo encapsulated in the 
Ada-polymersomes showed no residual activity at each time.   
 
Figure 8.6 Enzymatic activities for Myo encapsulated in Ada-polymersomes at different 
temperatures and in various pH media (a). Enzymatic activities recorded for repeated pH 
changes for Myo encapsulated in Ada-polymersomes (b). 
After the investigation of single enzyme, the enzymatic activity for a cascade reaction was 
further investigated (Figure 8.7). As proof of concept, glucose oxidase (GOx) is choose as 
enzyme 1, which turns D-glucose into D-glucono-δ-lactone and H2O2.
262 Next, H2O2 acts as a 
cosubstrate for myoglobin (Myo) to oxidize guaiacol (Figure 8.7),99, 262, 263 which can be 
detected by UV-Vis spectroscopy. As the first approach, GOx is encapsulated in the Ada-
polymersomes and free Myo was added later together with D-glucose and guaiacol. Thus, the 
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reaction product H2O2 from GOx has to leave the vesicle through the acidified membrane to 
reach the myoglobin and guaiacol for initializing the reaction of Myo. The results of this type 
of cascade reaction are presented in Figure 8.8. In this experiment an enzymatic activity was 
detected at a very low level at pH 8, which is most probably due to some initial activity of 
myoglobin.99 However, once an acidic pH value (pH 6) was reached (Figure 8.8a), the activity 
was greatly enhanced due to the production of H2O2 by GOx through the swelling membrane 
of Ada-polymersomes, regardless of the temperature. Furthermore, there was a highest 
activity at 37 ℃ similar to pure enzyme GOx because of the native highest activity of pure 
enzyme at this temperature. The switching process for this cascade reaction was then repeated 
four times (Figure 8.8b). As it could be expected, the detected activity never always reached 
zero at pH 8 due to the reasons mentioned previously for one cycle. However, a significant 
difference of the enzymatic activity between pH 8 and 6 could be monitored each time, 
indicating that the Ada-polymersomes always go back to its closed state for transmembrane 
diffusion processes and open up completely upon swelling for initializing the enzyme reaction.   
 
Figure 8.7 Enzymatic cascade reaction using glucose oxidase (GOx) and myoglobin (Myo). 
Next the enzymatic activity for GOx and Myo encapsulated in different Ada-polymersomes 
was investigated, where the intermediate reaction product H2O2 from GOx has to leave GOx-
filled Ada-polymersomes and then secondly enter the extracellular Myo-filled Ada-
polymersomes to initialize the cascade reaction. As it could be expected from previous results, 
both enzymes are completely shielded in Ada-polymersomes at pH 8, causing a total loss in 
activity. In contrast, both enzymes worked after pH 6 was reached (Figure 8.9). Like in the 
previous experiments, in the swollen state for Ada-polymersomes at pH 6, due to the native 
highest activity of both pure enzyme Myo and GOx at 37 ℃, there was a highest activity at 
this temperature. 
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Figure 8.8 Enzymatic activities for GOx encapsulated in Ada-polymersomes and free Myo 
added later on at different temperatures and in various pH media (a). Enzymatic activities 
recorded for repeated pH changes for GOx encapsulated in Ada-polymersomes and free Myo 
added later on (b). 
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Figure 8.9 Enzymatic activities for GOx and Myo encapsulated in different Ada-
polymersomes at different temperatures and in various pH media. 
8.5 Summary 
In this chapter, the formation of multifunctional polymersomes as organelle mimics and the 
various enzymatic reactions of enzyme-loaded Ada-polymersomes were discussed. Based on 
the previous work, the amine--functionalized block copolymers (Boc-BC) showed by Yassin 
et al.96 and adamantane-functionalized block copolymers (Ada-BCP) showed by Iyisan et 
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al.247 were integrated into this study. In this manner, the process started with the synthesis of 
three amphiphilic block copolymers comprising adamantane, amine and methoxy end groups 
at their hydrophilic PEG chain whereas pH-sensitive DEAEM units and a photo-crosslinker 
BMA groups together form the hydrophobic part. The integrated adamantane groups were 
utilized to anchor to the membrane of multicompartmentalized systems by host-guest 
interactions with β-CD receptors in the membrane of multicompartmentalized systems, while 
the amine groups were used for the sequential post-labelling of Ada-polymersomes with 
fluorescein isothiocyanate (FITC) to allow visualization by fluorescence microscopy. After 
photo-crosslinking the membrane of Ada-polymersomes, these multifunctional polymersomal 
subcompartmens possessed a reversible swelling (pH 6) and deswelling (pH 8) behavior and 
also preserved their vesicular shape at different pH environments. 
For the enzymatic reactions of enzyme-loaded Ada-polymersomes, the enzyme substrates can 
only diffuse through the membrane of the polymersomes in the swollen state, regardless of 
whether a single enzyme or a group of enzymes. Furthermore, the control over reactivity can 
last over repeated pH changes. This was shown by once switching back to pH 8, showing no 
enzyme activity again for the enzyme-loaded Ada-polymersomes. Apart from that, there was 
a highest activity at 37 ℃ for enzyme-filled Ada-polymersomes similar to pure enzyme due to 
the native highest activity of pure enzyme at this temperature. 
Overall, these established Ada-polymersomes have unique advantages, including their small 
size (100 nm), ease of preparation, expected good biocompatibility, tunable permeability, 
proper stability, pH responsivity and potential for introducing multiple targeting groups, and 
further exhibit new opportunities for the establishment of multicompartmentalized systems in 
synthetic biology. 
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9 Multifunctional Polymeric Multicompartmentalized Systems 
as Artificial Cells     
9.1 Introduction 
Engineering of artificial cells is currently an emerging area of research that involves 
mimicking the structure and the function of a cell from functional materials. The study of 
such artificial cell models has garnered significant interest because it would contribute to a 
better understanding of biological cells. These synthetic cells are designed to mimic cellular 
functions and biological responses within small-scale domains and are expected to have an 
impact on next-generation therapeutic concepts as a powerful biomedical tool for potential 
therapeutic applications, such as enzyme therapy, gene therapy, drug delivery, and diagnostics. 
Biological eukaryotic cells are equipped with multiple highly optimized and specialized 
internal subcompartments known as organelles that have the ability to carry out specific 
metabolic activities and are surrounded by a selectively permeable biological membrane that 
serves as a structural scaffold and partitions the cell interior from the external milieu. Thus, 
compartmentalization is one of the key architectural principles of the cell, which is one of the 
features of biological cells that enable the performance of spatially separated and precisely 
controllable hundreds of enzymatic (cascade) reactions, even in the presence of multiple 
potentially reactive species in the cell interior. Assembling such nature-inspired structures 
presents a significant challenge; nevertheless, multicompartmentalization is an essential key 
requirement for the development of next-generation carriers because these systems combine 
physicochemical properties that are not readily achievable using single-component assemblies. 
Based on the above results of chapter 7 and 8, a facile but highly effective route to construct 
the structural and functional eukaryotic cell mimics is developed by loading pH-sensitive 
Ada-polymersomes inside multifunctional cell membrane. In brief, the enzyme-loaded, 
multifunctional, pH-responsive and photo-crosslinked 100-nm-diameter Ada-polymersomes 
can be taken as organelle mimics to be incorporated into the multicompartmentalized systems 
by non-covalent host-guest interaction. Temperature-responsive and photo-crosslinkable β-
cyclodextrin functionalized Poly(methyl methacrylate) (PMA(β-CD))/[Poly(allylamine 
hydrochloride) (PAH)/Poly-(N-isopropylacrylamide)-block-poly[methacrylic acid-co-3,4-
dimethyl maleic imidobutyl methacrylate] (PNMD)]3 multilayers and outer protective capping 
PAH/poly(ethylene glycol) functionalized Poly(methyl methacrylate) (PMA(PEG)) bilayer can 
be further assembled to mimic the cell membrane. Furthermore, the position of the 
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polymersomal subcompartments can be controlled using non-covalent host-guest concept for 
fabricating two types of multicompartmentalized systems (MS): “membrane-associated 
polymersomes” (MS1) and “free-floating polymersomes” (MS2). Due to the unique 
compartmentalized structure, MS are able to spatially separate and precisely regulate multiple 
complex enzymatic (cascade) reactions with high accuracy and specificity within confined 
environments. 
Thus, this chapter describes the formation of “membrane-associated” and “free-floating” 
multicompartmentalized systems, as being a promising platform toward the creation of 
artificial cells. Figure 9.1 outlines the discussed points by combining the benefits of both pH-
responsive Ada-polymersomes as organelle mimics and multifunctional carrier capsule as 
biomimetic cellular membrane to realize MS. In addition, the reversible temperature and pH 
dual-response ability of the MS is analyzed. Eventually, the metabolism mimicry of MS by 
performing multiple successive two-enzyme cascade reactions in the cells and the multiple 
parallel reactions by using a third enzyme for deactivating the reaction product and interfering 
the cascade reaction are investigated. 
 
Figure 9.1 General overview of multicompartmentalized systems as cell mimics with 
different membrane characteristics.  
9.2 Polymer Synthesis and Characterization 
To realize our desired multicompartmentalized systems, a variety of required polymers were 
created with some specific key features for fabricating biomimetic cellular systems. Thus, 
three different PMA polymers (poly(methyl methacrylate) (PMA), β-cyclodextrin 
functionalized poly(methyl methacrylate) (PMA(β-CD)) and poly(ethylene glycol) 
functionalized poly(methyl methacrylate) (PMA(PEG))) having different functional groups 
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were synthesized in this study. Here, the β-cyclodextrin (β-CD) functionalized polymer is 
based on PMA because PMA(β-CD) is allowed to interact with Ada-polymersomes through 
strong host-guest interaction between β-CD and adamantane groups as well as slight 
electrostatic interaction between anionic PMA(β-CD) and cationic Ada-polymersomes. Herein, 
β-cyclodextrin (β-CD) functionalized poly(methyl methacrylate) (PMA(β-CD)) were used to 
incorporate Ada-polymersomes to the multicompartmentalized systems by non-covalent host-
guest interaction as well as slight electrostatic interaction. In addition, PEG-functionalized 
PMA was synthesized due to low-fouling characteristics,155, 264 reduced phagocytosis265 and 
longer circulation time in the bloodstream266 for PEG corona, which can endow the 
multicompartmentalized systems with biocompatibility as well as the ability of in-vivo protein 
resistance that enables long circulation times. The dual-responsive and photo-crosslinkable 
block copolymer poly-(N-isopropylacrylamide)-block-poly[methacrylic acid-co-3,4-dimethyl 
maleic imidobutyl methacrylate] (PNMD) was further synthesized to fabricate the membrane 
of multicompartmentalized systems with desired dual responsive properties for temperature 
and pH. Here, the synthesized 3,4-dimethyl maleic imidobutyl methacrylate (DMIBM) is 
integrated to the block copolymer structure for photo-crosslinking the outer membrane of 
multicompartmentalized systems by only 30 seconds of UV-irradiation. Importantly, the used 
photo-crosslinker DMIBM is different from that Ada-polymersomes used. This is because the 
used UV sources are different as well as the photo-crosslinking time of outer membrane of 
multicompartmentalized systems is extremely shorter than Ada-polymersomes required 20 
min of UV irradiation, thereby photo-crosslinked Ada-polymersomes incorporated to 
multicompartmentalized systems are no longer further photo-crosslinked when the outer 
membrane of multicompartmentalized systems is photo-crosslinked. 
To establish the β-CD and PEG functionalized PMA, we firstly synthesized PMA 
homopolymer via reversible addition-fragmentation chain-transfer radical polymerization 
(RAFT), PMA homopolymer was further modified with 6-monodeoxy-6-monoamino-β-
cyclodextrin and poly(ethylene glycol) to obtain PMA(β-CD) by amidation reaction (Figure 9.2) 
and PMA(PEG) by esterification reaction (Figure 9.3), respectively. The composition and ratios 
of each component in the polymers were determined by 1H NMR spectra (Figure 9.4). In 
detail, the characteristics 1H NMR signals of the β-CD groups (3.5-3.9 ppm, 4.65-5.25 ppm 
and 5.6-6.1 ppm) could be clearly observed in the 1H NMR spectrum of PMA(β-CD) polymer 
and the 1H NMR signals of the PEG groups (3.64 ppm) also could be clearly observed in the 
1H NMR spectrum of PMA(PEG) polymer compared to PMA homopolymer. Furthermore, the 
content of β-CD was calculated to be about 8% by the integration of the ratio between the 
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specific signals of MA at 12-12.75 ppm and β-CD at 4.65-5.25 ppm, respectively; the content 
of PEG was calculated to be about 5% by the integration of the ratio between the specific 
signals of MA (12-12.75 ppm) and PEG (4.84 ppm), respectively (Table 9.1).  
 
Figure 9.2 General procedure for the synthesis of polymer PMA(β-CD). 
 
 
Figure 9.3 General procedure for the synthesis of polymer PMA(PEG). 
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Figure 9.4 1H NMR spectra (DMSO-d6) of PMA homopolymer (blue), PMA(β-CD) polymer 
(red) and PMA(PEG) polymer (gray) with all requested 
1H NMR signals to determine the 
important part structures of various polymers.   
Table 9.1 Molecular parameters of polymers. 
Polymer Polymer chemical compositiona) Mn             
[g mol-1]a) 
Mw         
[g mol-1]b) 
Ðc) 
PNMD PNIPAM50-b-P(MA50-co-
DMIBM20) 
19800 21800 1.10 
PMA PMA100 10800 11400 1.06 
PMA(β-CD) P(MA90-co-β-CD8) 24300 28900 1.19 
PMA(PEG) P(MA95-co-PEG5) 23500 27700 1.18 
a) Calculated by 1H NMR; b), c), d) Measured by GPC. 
In addition, starting from a RAFT chain transfer agent (CTA) and NIPAM forming the 
thermo-sensitive block PNIPAM as macro-CTA, methacrylic acid (MA) and 3,4-dimethyl 
maleic imidobutyl methacrylate (DMIBM) have been statistically copolymerized as second 
block to synthesize PNMD block copolymer via reversible addition-fragmentation chain-
transfer radical polymerization (RAFT) using a two steps approach (Figure 9.5). Here, the 
used photo-crosslinker DMIBM is different from that Ada-polymersomes used. This is 
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because the photo-crosslinked Ada-polymersomes incorporated to multicompartmentalized 
systems are no longer further photo-crosslinked when the outer membrane of 
multicompartmentalized systems is photo-crosslinked. Simply, the ratio between NIPAM and 
MA was 1:1, while DMIBM was incorporated with 20 mol% in the polymer chain. The 
composition and ratios of each component in the copolymers were determined by 1H NMR 
spectra (Figure 9.6). In detail, the characteristics 1H NMR signals of the three monomers, 
MA, NIPAM and DMIBM, can be found in the polymer chain, indicating copolymerization 
took place. Furthermore, the ratio of MA and NIPAM in the copolymer chain was calculated 
by the integration of the ratio between the specific signals of MA at 12-12.75 ppm and 
NIPAM at 3.84 ppm, respectively, and the content of DMIBM was calculated to be about 
20% by the integration of the ratio between the specific signals of DMIBM (7.3 ppm) and 
NIPAM (3.84 ppm), respectively (Table 9.1). 
 
Figure 9.5 General procedure for the synthesis of block copolymer PNMD. 
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Figure 9.6 1H NMR spectrum (DMSO-d6) of block copolymer PNMD with all requested 
1H 
NMR signals to determine the part structures of PNMD.  
Furthermore, the polymers were further characterized by gel permeation chromatography 
(GPC) and the chemical composition, molecular weights, and dispersity (Ð) of the various 
polymers are presented in Table 9.1. In brief, the narrow molar mass distributions (Ð) of 
about 1.06 to 1.2 indicated a controlled manner of the polymerization process. The resulting 
copolymers with appropriate molecular weights (below 30000 g mol-1) are ideal candidates 
for fabricating polyelectrolyte multilayers because of their good solubility in buffer and 
having enough functional groups to endow the multicompartmentalized systems with the 
desired features.  
9.3 Polymeric Multicompartmentalized Systems Formation by LbL 
Assembly 
The LbL assembly of PAH/PMA(β-CD)/Ada-polymersomes/PMA(β-
CD)/[PAH/PNMD)]3/PAH/PMA(PEG) multilayers was conducted on spherical silica 
microparticles, followed by the core dissolution to form artificial cells with multiple 
responsiveness (Figure 9.7). As outer bilayer PAH/PMA(PEG)  was assembled not only for 
acting as protective capping bilayer to prevent the photo-crosslinking of the MS to each other. 
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This final capping layer with PEG corona should also provide MS with protein-resistant 
characteristics155, 264 to avoid the cellular uptake of proteins for validating metabolism 
mimicry. In brief, after absorbing the PAH/PMA(β-CD) polymer precursor bilayer on silica 
microparticles (Figure 9.7a), which enables the deposition of Ada-polymersomes layer, 
fluorescently labeled Ada-polymersomes were allowed to interact with the PMA(β-CD)-coated 
particles through strong host-guest interactions (Figure 9.7b), slight electrostatic interactions 
are also involved as minor contributing force, confirmed by the obvious change of zeta 
potential for silica microparticles  (Figure 9.8), for the attachment of (enzyme-containing) 
Ada-polymersomes on silica surface. For this and most fabrication steps of MS (Figure 9.7c-
e), Ada-polymersomes subsequently maintain in “off” state (= non-permeable Ada-
polymersomes membrane) at pH 8 and, thus, protect encapsulated enzymes against 
mechanical damage or harsh environmental conditions, when carrying out UV crosslinking 
(Figure 9.7e). The homogeneous green fluorescence intensity in CLSM image of the silica 
microparticles coated with FITC-labelled Ada-polymersomes indicated successful 
incorporation of a homogeneous layering of the Ada-polymersomes on the surface of silica 
microparticles (Figure 9.9). Subsequently, the PMA(β-CD)/[PAH/PNMD]3 multilayers as pH- 
and temperature-responsive outer membrane for cell mimics were deposited onto Ada-
polymersomes-coated particles at pH 8 (Figure 9.7c), followed by protective capping bilayer 
of PAH/PMA(PEG) (Figure 9.7), to mimic the cell membrane with tunable permeability, good 
biocompatibility and temperature responsivity.  
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Figure 9.7 Assembly of multicompartmentalized systems as artificial cells. A 
PAH/PMA(β-CD) precursor bilayer is deposited onto silica particles (a). Ada-polymersomes 
remain attached to the PMA(β-CD)-coated particles by means of a noncovalent host-guest 
anchoring (b). Temperature-responsive and photo-crosslinkable PMA(β-CD)/[PAH/PNMD]3 
multilayers are then absorbed onto the coated particles (c). The assembly is continued with the 
PAH/PMA(PEG) bilayer to mimic the cell membrane with tunable permeability, good 
biocompatibility and temperature responsivity (d). The polymer biomimetic membrane is 
stabilized by photo-crosslinking and core removal results in a “membrane-associated” 
multicompartmentalized system (MS1) (e). The “membrane-associated” 
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multicompartmentalized system was further processed with excess β-CD to fabricate “free-
floating” multicompartmentalized system (MS2) (f). 
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Figure 9.8 Zeta potential as a function of layer number for the PAH/PMA(β-CD)/Ada-
polymersomes/PMA(β-CD)/[PAH/PNMD)]3/PAH/PMA(PEG)-coated silica particles. 
To prove the successful formation of multilayers on silica particles, the variation in the zeta 
potential of silica particles coated with the PAH/PMA(β-CD)/Ada-polymersomes/PMA(β-
CD)/[PAH/PNMD)]3/PAH/PMA(PEG) multilayers was investigated as a function of the number 
of layers (Figure 9.8). The initial zeta potential of the silica surface changed from -45 mV to -
2 mV after the adsorption of cationic PAH polymer. This value is still negative, since the 
particle surface was not completely covered by PAH polymer. This means that the adsorbed 
PAH had not enough positive charge to offset the negative charge of bare silica particles. 
However, the increase of about 40 mV as compared with the bare particles was sufficient to 
continue the subsequent adsorption. After the adsorption of the Ada-polymersomes, zeta 
potential of the silica surface changed from -45 mV to -6 mV due to the positive charge of 
Ada-polymersomes at 7.5. This further indicates that Ada-polymersomes can be absorbed to 
PMA(β-CD)-coated particles through not only strong host-guest interaction but also slight 
electrostatic interaction. The subsequent addition of the anionic PMA(β-CD) led again to a 
change in the surface charge to -43 mV. This negative zeta potential obtained enabled us 
further to carry out subsequent adsorption of the positively charged PAH. Thus, the 
alternating reversal in the sign of the zeta potential is characteristic of LbL assembly of 
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polyelectrolyte multilayers on particles surface, suggesting a successful stepwise layer growth 
of PAH/PMA(β-CD)/ Ada-polymersomes/PMA(β-CD)/ [PAH/PNMD)]3/ PAH/PMA(PEG) 
multilayers.  
 
Figure 9.9 CLSM images of the silica microparticles coated with FITC-labelled Ada-
polymersomes. 
Afterwards, to ensure the stability of MS after the removal of the template, a crosslinking step 
has to be employed. Thus, the [PAH/PNMD]3/PAH/PMA(PEG) polymer biomimetic membrane 
was stabilized by photo-crosslinking of the maleic amide group by UV irradiation with a high 
pressure mercury lamp for 30 seconds. By subsequent etching out the silica template by 
NH4F/HF buffer at pH 7.5, “membrane-associated” MS1 was smoothly obtained (Figure 9.7e). 
The “membrane-associated” MS1 was further treated with excess β-CD to separate the 
polymersomal subcompartments (= organelle mimics) from the membrane of MS to fabricate 
“free-floating” MS2 (Figure 9.7f). The excess free β-CD has the task to destroy the host-guest 
interaction of Ada-polymersomes surface with the membrane of “membrane-associated” MS1, 
preferentially promoting the localization of the polymersomal subcompartments within the 
hollow interior of MS. The good morphological integrity and colloidal stability of these two 
types of multicompartmentalized systems were confirmed by CLSM and TEM images (Figure 
9.10 and Figure 9.11). The CLSM image of MS1 assembled using FITC-labeled Ada-
polymersomes clearly corroborated the immobilization of intact Ada-polymersomes in the 
membrane of the MS1 (Figure 9.10a). From the TEM image (Figure 9.10b), the surface is 
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clearly rough, and is in striking contrast to the capsules prepared without polymersomes,267 
providing further evidence for successful Ada-polymersomes loading. In contrast, for “free-
floating” MS2, the green fluorescence signal homogeneously distributed within the interior of 
outer capsule of MS2 undoubtedly indicated the Ada-polymersomes were successfully 
detached from the capsule membrane (Figure 9.11a) and the TEM image further confirmed 
the integrity of the assembled supramolecular structure of MS2 (Figure 9.11b). 
 
Figure 9.10 CLSM (a) and TEM images (b) images of “membrane-associated” 
multicompartmentalized system (MS1) photo-crosslinked 30 seconds showing the 
polymersomal subcompartments associated with the polymer membrane. 
 
Figure 9.11 CLSM (a) and TEM images (b) images of “free-floating” 
multicompartmentalized system (MS2) showing the polymersomal subcompartments 
distributed within the interior of outer capsule of MS2. 
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Next, to confirm the temperature and pH dual-responsive characteristics and the stability of 
both MS, DLS study was used to investigate their cyclic swelling and shrinkage in aqueous 
solution at different pH values (pH 6 and 8) and temperatures between 25 and 45 ℃ (Figure 
9.12). In brief, MS1 and MS2 can undergo on/off switches for at least five cycles on pH and 
temperature stimuli as found for hollow capsules without Ada-polymersomes in chapter 7.4. 
This implies to trigger cell mimics with an orthogonal dual response under pH and 
temperature variations possibly suited for controlling the successive enzymatic cascade 
reactions. Especially for “membrane-associated” MS1, the polymersomal subcompartments 
are attached to the membrane of MS1. It smoothly endows the MS1 with a strong pH-
responsive power at pH 6 (Figure 9.12a). This is caused by the simultaneous swelling of Ada-
polymersomes within the MS1 membrane at pH 6, while at pH 8 Ada-polymersomes also 
deswell. Therefore, MS1 exhibits a stronger swelling-shrinking characteristics responding to 
the pH variation in comparison to “free-floating” MS2 (Figure 9.12b). 
 
Figure 9.12 Reversible swelling-shrinking of MS1 (a) and MS2 (b), upon switching between 
25 ℃ and 45 ℃ at pH 6 and pH 8 buffer, respectively (open symbol=25 ℃; solid symbol=45 
℃). 
9.4 Bienzymatic Reactions for Different Biomimetic Environments in 
“Free-Floating” MS2  
Apart from the multicompartmentalized structure, artificial cells also should mimic cellular 
functions and biological responses within small-scale domains and are expected to have an 
impact on next-generation therapeutic concepts as a powerful biomedical tool for potential 
therapeutic applications, such as enzyme therapy, gene therapy, drug delivery, and diagnostics. 
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The role of these biomimetic structures in enzyme therapy predominantly focuses on 
enzymatic activities to degrade waste products or to support the synthesis of medically 
relevant biomolecules.  
With the aim to realize the metabolism mimicry of artificial cells, the multiple, spatially 
separated and pH-controllable enzymatic reactions within our confined area-resembling 
multicompartmentalized systems are reported. Firstly, the enzymatic activity for single 
enzyme in “free-floating” MS2 was investigated. In brief, the purified Myo-filled Ada-
polymersomes were incorporated in MS2. The MS2 encapsulated with “free-floating” Myo-
filled Ada-polymersomes was treated with guaiacol and hydrogen peroxide as substrates for 
myoglobin. Since the enzyme substrates can only diffuse through the membrane of the Ada-
polymersomes in the swollen state, the substrates guaiacol and H2O2 has to cross the 
multifunctional MS2 membrane and the swollen subcompartments membrane at pH 6 for 
initializing the reaction of Myo. The enzymatic activity of this enzymatic reaction is presented 
in Figure 9.13a. As expected, we detected no enzymatic activity of Myo at pH 8, which is due 
to the impermeable membrane of polymersomal subcompartments for substrates. In contrast 
to this, enzymatic reactions could be monitored exclusively at pH 6 due to the 
subcompartments being swollen at this pH. Furthermore, the enzyme showed the highest 
activity at 37 ℃ because at this temperature the enzymatic activity is more prominent than 
others. In addition, the enzymatic activity subjected to several pH switches between pH 8 and 
6 was further investigated (Figure 9.13b). As it could be expected, due to the polymersomal 
subcompartments being swollen at pH 6, enzymatic reactions could be monitored exclusively 
at this pH for enclosed enzymes. However, when pH 8 was reached the enzyme showed no 
residual activity at each time.   
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Figure 9.13 Enzymatic activities for Myo-filled Ada-polymersomes encapsulated in MS2 at 
different temperatures and in various pH medium (a). Enzymatic activities recorded for 
repeated pH changes for Myo-filled Ada-polymersomes encapsulated in MS2 (b).  
After the investigation of single enzyme, the enzymatic cascade reaction for different 
biomimetic environments in “free-floating” MS2 was further investigated: (i) cell mimics (= 
MS2) with extracellular enzyme as case I; (ii) cell mimics with extracellular organelle mimics 
(= enzyme-containing Ada-polymersomes) as case II; (iii) only cell mimics as case III (Figure 
9.14). Organelle mimics are also considered as subcompartments of cell mimics. As proof of 
concept for a bienzymatic reaction, glucose oxidase (GOx) is choose as enzyme 1, which 
turns D-glucose into D-glucono-δ-lactone and H2O2. Next, H2O2 acts as a co-substrate for 
myoglobin (Myo) to oxidize guaiacol, which is detectable by UV-vis spectroscopy. 
 
Figure 9.14 Metabolism mimicry of “free-floating” MS2 by performing bienzymatic reactions 
for different biomimetic environments.  
For case I GOx-filled Ada-polymersomes were integrated in MS2 and a corresponding 
concentration of free Myo was added to the MS2 solution, including all needed substrates for 
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this bienzymatic reaction (Figure 9.15a). Thus, the reaction product from GOx has to cross the 
swollen organelle and cell mimics membrane at pH 6 for initializing the reaction of 
extracellular Myo. The temperature-dependent (25, 37 or 45°C) enzymatic activity of this 
cascade reaction at pH 6 and 8, respectively, is presented in Figure 9.15b. With increasing 
temperature at pH 6 it causes a steadily higher enzymatic activity for Myo. This demonstrates 
the expected release rate of H2O2 through both membranes of MS2, possessing a similar 
release characteristic for a recently established cell membrane mimic as mentioned in chapter 
7.5. In contrast to this, the enzymes only encapsulated in the Ada-polymersomes showed the 
highest activity at 37 ℃ because at this temperature the enzymatic activity is more prominent 
than others (more information is available in chapter 8.4). This confirms that the MS2 
membrane with temperature sensitivity can be used to control the enzymatic reaction. In 
contrast, the enzymatic reaction is very low at pH 8, most probably due to the presence of 
residually produced H2O2 at pH 6 before the membrane of organelle mimics of MS2 became 
unpermeable99  and crossed the outer cell membrane of MS2 for feeding extracellular Myo. 
To mimic the successive enzymatic reactions of biological cells, the enzymatic activity 
subjected to several pH switches between pH 8 and 6 was further investigated (Figure 9.15c). 
As expected, the detected enzymatic activity never reaches zero at pH 8 due to the reasons 
mentioned above for one cycle (Figure 9.15b). Finally, a significant difference of the 
enzymatic activity between pH 8 and 6 is always detectable, indicating that the polymersomal 
subcompartments always go back to their closed state at pH 8 for avoiding any 
transmembrane diffusion processes at each temperature and open up completely upon 
swelling at pH 6 for initializing the bienzymatic reaction.  
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Figure 9.15 Enzymatic reaction is conducted for a sequence of two enzymes where GOx-
filled Ada-polymersomes are enclosed in MS2 and free Myo is added later on (a): shows the 
enzymatic activities at different temperatures and in various pH medium (b); shows the 
enzymatic activities recorded for repeated pH changes at 37℃ (c). 
For the second approach case II, GOx-filled Ada-polymersomes were encapsulated in MS2 
and Myo-filled Ada-polymersomes were added to the solution (Figure 9.16a) to investigate 
the second possibility for carrying out a cascade reaction, at which the intermediate reaction 
product from GOx has to leave the MS2 (including the subcompartments and the outer 
membrane of MS2) and then enters the extracellular Ada-polymersomes to initialize the 
cascade reaction. As expected, enzymatic reactions could be monitored exclusively at pH 6 
due to the subcompartments being swollen at this pH, but the system stopped working after 
pH 8 was reached (Figure 9.16b). This shows that enzymes are completely shielded in the 
subcompartments and this confirms that MS2 exhibit pH dependency of enzyme cascade 
reaction. Especially in the swollen state for subcompartments, upon increasing the 
temperature the permeability of MS2 membrane is enhanced and the release rate of reaction 
product from GOx through the MS2 membrane is higher as mentioned in chapter 7.5, thus 
showing a higher activity for Myo. This confirms that temperature can be used to trigger the 
enzymatic reaction through the MS2 membrane. In addition, there was no residual activity 
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each time pH 8 was reinitialized and the activity went up to its previous level switching back 
to pH 6 (Figure 9.16c), indicating that the multicompartmentalized system of MS2 becomes 
leaky only for the substrate and not for the enzyme. The enzymes are retained inside the 
subcompartments, the enzymatic reaction could be reinitiated at least 5 times, there is no loss 
of functional activity of the enzymes, and the multicompartmentalized system of MS2 
exhibits a highly reproducible behavior.     
 
Figure 9.16 Enzymatic reaction is conducted for encapsulated GOx-filled Ada-polymersomes 
in MS2 and Myo-filled Ada-polymersomes added later on (a): shows the enzymatic activities 
at different temperatures and in various pH medium (b); shows the enzymatic activities 
recorded for repeated pH changes at 37℃ (c). 
In a final approach, case III, an equal mixture of GOx-filled Ada-polymersomes and Myo-
filled Ada-polymersomes was employed for MS2 fabrication (Figure 9.17a), at which the 
reaction product H2O2 just needs to diffuse from the subcompartment to another adjacent 
subcompartment through the acidified membrane of subcompartments within MS2 for 
initializing the enzyme reaction. As it could be expected from previous results, no activity 
was monitored at pH 8, while both enzymes worked after pH 6 was reached (Figure 9.17b). 
However, compared to the previous approach, the reaction product H2O2 no longer needs to 
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diffuse through the membrane of MS2 for initializing the reaction of Myo, causing the highest 
activity at 37 ℃ similar to pure enzyme-filled Ada-polymersomes (more information is 
available in chapter 8.4) because of the native highest activity of pure enzyme is at this 
temperature (more information is available in chapter 5.7). Like in the previous experiments, 
the multicompartmentalized system of MS2 also demonstrates excellent reproducible 
behavior. This was shown by once switching back to pH 8, showing no enzyme activity again 
for the multicompartmentalized system of MS2 (Figure 9.17c).  
 
Figure 9.17 GOx-filled polymersomes and Myo-filled Ada-polymersomes encapsulated in 
one MS2 for enzymatic reaction (a): shows the enzymatic activities at different temperatures 
and in various pH medium (b); shows the enzymatic activities recorded for repeated pH 
changes at 37℃ (c). 
Further, the only difference between case I and case II is that the extracellular free Myo for 
case I is substituted by extracellular Myo-filled organelles mimics for case II, while all other 
experiments were repeated as in case I. This subsequently means that the intermediate 
reaction product H2O2 of GOx in cell mimics has to additionally cross the extracellular 
membrane of organelle mimics to finalize the bienzymatic cascade reaction. Similar to carry 
out bienzymatic cascade reaction in case I (Figure 9.15b and Figure 9.15c), analog pH- and 
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temperature-dependent enzymatic characteristics in case II were observed (Figure 9.16b and 
Figure 9.16c). In contrast to case I, there is no observable residual enzymatic activity at pH 8. 
The simultaneous membrane closing of polymersomal subcompartments in cell mimics and 
extracellular organelle mimics prevents the residual consumption of H2O2 by Myo-filled 
organelle mimics. Concluding case II, there is no loss of functional activity of the enzymes, 
and the combination of cell mimics with extracellular organelle mimics exhibits a highly 
reproducible enzymatic behavior.  
Compared to case I and II, case III presents an intracellularly driven bienzymatic reaction for 
cell mimics at which MS2 contain an equal mixture of GOx- and Myo-filled Ada-
polymersomes (Figure 9.17a). Thus, the reaction product H2O2 of GOx just needs to diffuse 
from GOx-filled Ada-polymersome to adjacent Myo-filled Ada-polymersome through the 
acidified membrane of Ada-polymersomes within the cell mimics at pH6 for finalizing the 
bienzymatic reaction. As found for case I and II, no enzymatic activity is detectable at pH 8, 
while both enzymes smoothly work at pH 6 combined with different temperature conditions 
(Figure 9.17b). Moreover, applying cell mimics in case III, highest enzymatic activity is 
available at 37°C behaving as native enzymes with highest activity at this temperature as 
mentioned in in chapter 5.7. In line with this, highest enzymatic activity is also available 
when using enzyme-filled Ada-polymersomes to carry out bienzymatic reactions at different 
temperatures as mentioned in in chapter 8.4. Shortly summarizing cases I-III, the results 
strongly imply that the Ada-polymersomes, used as organelle mimics, remained intact after 
silica core removal. Moreover, the bienzymatic reactions, carrying out in different biomimetic 
environments, could take place in a highly controlled, selective, specific, efficient and 
continuous manner. 
9.5 Bienzymatic Reactions of “Membrane-Associated” MS1 and “Free-
Floating” MS2  
The enzymatic reaction kinetics in multicompartmentalized system containing “membrane-
associated” MS1 to multicompartmentalized system containing “free-floating” MS2 was also 
compared in this study (Figure 9.18 and Figure 9.19). As shown in previous experiments, both 
types of cell mimics (MS1 and MS2) show no residual activity when pH 8 is reached, but the 
systems start working nicely after pH 6 was reached (Figure 9.18b and Figure 9.19b). In this 
swollen state for subcompartments at pH 6, for the enzymatic reaction approach with GOx-
filled Ada-polymersomes encapsulated in cell mimics with extracellular organelle mimics (= 
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Myo-filled Ada-polymersomes) (Figure 9.18a), the “membrane-associated” MS1 cell mimics 
showed a higher activity for Myo than the “free-floating” MS2 cell mimics (Figure 9.18b). 
The difference in enzymatic activity at 37°C is explainable by the different location of the 
enzymatically active polymersomal subcompartments in cell mimics. For “membrane-
associated” MS1, the swelling subcompartments attached to the membrane of cell mimics 
endow this system with a stronger swelling characteristic (Figure 9.12a) compared to “free-
floating” MS2 (Figure 9.12b). The substrates and the intermediate reaction product from GOx 
can diffuse faster through the membrane of MS1 cell mimics, and this causes a higher 
enzymatic activity (Figure 9.18b). In opposite to this, for the enzymatic reaction approach 
with GOx-filled Ada-polymersomes and Myo-filled Ada-polymersomes encapsulated in one 
cell mimic (Figure 9.19a), the “free-floating” MS2 demonstrated a higher activity at pH 6 
compared to “membrane-associated” MS1 cell mimics (Figure 9.19b). Since most 
polymersomal subcompartments are freely distributed within the interior for “free-floating” 
MS2 cell mimics. Then, the reaction product H2O2 of GOx diffuses faster to another adjacent 
Myo-filled subcompartment within the cell mimics compared to those of “membrane-
associated” MS1 cell mimics. Consequently, the activity for Myo is slightly higher as found 
for “membrane-associated” MS1.  
 
Figure 9.18 Enzymatic reaction is conducted for a sequence of two enzymes where GOx-
filled Ada-polymersomes are enclosed in MS1 (“membrane-associated” 
multicompartmentalized system) or MS2 (“free-floating” multicompartmentalized system) 
and Myo-filled Ada-polymersomes are added later on (a): shows the enzymatic kinetics in 
various pH medium at 37℃ (b). 
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Figure 9.19 GOx-filled Ada-polymersomes and Myo-filled Ada-polymersomes encapsulated 
in one MS1 (“membrane-associated” multicompartmentalized system) or MS2 (“free-floating” 
multicompartmentalized system) for enzymatic reaction (a): shows the enzymatic kinetics in 
various pH medium at 37℃ (b). 
9.6 Competitive enzymatic reactions for biomimetic environments in 
“Free-Floating” MS2  
Biological cells are able to perform simultaneous multiple reactions spatially separated, but 
this aspect still presents a significant challenge in cell mimicry. Here, with the aim to push the 
limits of encapsulated catalysis, an additional enzymatic reaction based on the above-
described cascade reaction using “free-floating” MS2 cell mimics was further conducted. 
Thus, the validation of flux balance (= substrate-channeling effect) and imbalance as well the 
exclusion of proteins inside of cell mimics is possible to fulfil the metabolism mimicry with 
more complexity of spatially separated enzymes triggered by pH- and diffusion-controlled 
pathways. For this, catalase was selected to deactivate the reaction product H2O2 from GOx 
and to subsequently compete with the reaction of Myo. For the enzymatic reaction approach 
with GOx-filled Ada-polymersomes and Myo-filled Ada-polymersomes encapsulated in one 
MS2 cell mimics (Figure 9.20a), at pH 6 most of reaction product H2O2 diffuses within MS2 
cell mimics to another adjacent Myo-filled subcompartment for initializing the enzyme 
reaction of Myo before decomposing by the extracellular catalase and in addition, it is not 
possible for catalase to penetrate through the membrane of MS2 cell mimics, which causes a 
slight decline of enzyme activity after adding the catalase in the solution (Figure 9.20b). In 
135 
 
contrast, for the enzymatic reaction approach with GOx-filled Ada-polymersomes 
encapsulated in MS2 cell mimics and free Myo-filled Ada-polymersomes (Figure 9.21a), after 
adding the catalase at pH 6 there was a significant decrease in enzyme reaction activity 
(Figure 9.21b). To finalize the bienzymatic cascade reaction of GOx and Myo the 
intermediate reaction product H2O2 of GOx has to leave the cell mimics and then to enter 
extracellular Myo-filled organelle mimics. Thus most of H2O2 is deactivated by the catalase in 
the solution before penetrating into the Myo-filled organelle mimics. As expected, there is no 
enzymatic activity at pH 8 as found in previous experiments. 
 
Figure 9.20 Enzymatic reaction is conducted for three enzymes where GOx-filled Ada-
polymersomes are enclosed in MS2 and Myo-filled Ada-polymersomes and free catalase are 
added later on (a): shows the enzymatic activities in various pH medium for with catalase or 
without catalase system (b). 
 
Figure 9.21 GOx-filled Ada-polymersomes and Myo-filled Ada-polymersomes encapsulated 
in one MS2 for enzymatic reaction with free catalase added later on (a): shows the enzymatic 
activities in various pH medium for with catalase or without catalase system (b). 
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9.7 Summary 
In this chapter, a highly versatile and effective methodology to prepare “membrane-
associated” multicompartmentalized systems MS1 and “free-floating” 
multicompartmentalized systems MS2 has been demonstrated. One breakthrough of this study 
was the establishment of MS as promising platform for the creation of artificial cells, 
composed of pH-responsive and enzymatically active polymersomes (= organelle mimics) 
within a pH and temperature dual-responsive capsules (= biomimetic cellular membrane with 
excluding uptake of extracellular enzymes). To realize those multicompartmentalized systems, 
PAH/PMA(β-CD)/Ada-polymersomes/PMA(β-CD)/[PAH/PNMD)]3/PAH/PMA(PEG) multilayers 
were assembled on spherical silica microparticles, followed by the core dissolution to form 
artificial cells with multiple responsiveness. In brief, the enzyme-loaded, pH-responsive and 
photo-crosslinked Ada-polymersomes as organelle mimics were incorporated into the 
multicompartmentalized systems by non-covalent host-guest interaction depositing the 
PAH/PMA(β-CD)/Ada-polymersomes/PMA(β-CD) LbL layer system first on the silica template. 
For mimicking cell membrane, temperature-responsive and photo-crosslinkable 
[PAH/PNMD]3 multilayers and an outer protective capping PAH/PMA(PEG)  bilayer were 
further assembled on top of these. After removing the template, two types of artificial cells: 
“membrane-associated” MS1 and “free-floating” MS2 through non-covalent host-guest 
concept were realized, whereas the “free-floading” MS2 were achieved by breaking the host-
guest interactions of the Ada-polymersomes with the LbL layer through addition of excess of 
β-CD. The successful fabrication of PAH/PMA(β-CD)/Ada-polymersomes/PMA(β-
CD)/[PAH/PNMD)]3/PAH/PMA(PEG) multilayers was confirmed by zeta potential 
measurements. After photo-crosslinking the outer membrane of MS, these two types of MS 
had a good morphological integrity and colloidal stability. Moreover, these two types of MS 
showed different temperature and pH dual-responsive characteristics.  
The metabolism mimicry for various enzymatic reactions has been performed in a highly 
controlled and reproducible, efficient, successive and continuous manner. Due to the multiple 
key characteristics of artificial cells and organelle mimics, the enzymes are better protected in 
the subcompartments and reinitiated at pH 6 with no loss of functional activity after cyclic pH 
switches between pH 6 and 8; while biomimetic cellular membrane is constantly permeable 
for small substrate and metabolite molecules at each pH value used. Moreover, flux balance 
and imbalance of intermediate metabolites pave also the way in our metabolism mimicry 
caused by the combination of spatially separated enzymes, constantly permeable biomimetic 
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cellular membrane and substrate-channeling effect within artificial cells and/or competitive 
metabolite pathways due to multiple membrane crossing.  
Overall, by combining the benefits of both pH-responsive Ada-polymersomes as organelle 
mimics and multifunctional hollow capsule as biomimetic cellular membrane, these artificial 
cells exhibit various valuable key characteristics: High level of sub-compartmentalization, the 
ability to load diverse cargos, orthogonal pH and temperature dual responsiveness of cellular 
membrane and organelle mimics as subcompartments, structural stability at various pH values 
and temperatures, tunable membrane permeability of subcompartments and prevention of 
undesired protein interaction on the surface of the cell mimic due to a PEG outer shell. Thus, 
this study, combining artificial cells (=architectural multicompartmentalization) with(out) 
extracellular enzymes and organelle mimics and metabolism mimicry, will open an exciting 
avenue to many different research areas, particularly in biotechnology and nanomedicine.      
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10 Conclusion and Outlook 
Engineering artificial cells is currently an emerging area of research that involves constructing 
mimics of biological cells. These biomimetic cellular systems hold tremendous promise for 
the different biomedical applications (diagnostics, therapy, tissue engineering, gene 
transfection, bioactive coatings) as well as aspects of synthetic biology. Therefore, this thesis 
aimed at developing novel artificial cells, not only presenting organelle mimics but also 
incorporating various stimuli for regulating enzymatic cascade reactions within the artificial 
cell and for controlled simultaneous and/or subsequent release of the encapsulated 
(therapeutic) molecules. In this manner, the main features of the developed artificial cells are: 
  (i) Development of a pH and temperature dual-responsive and photo-crosslinked hollow 
capsules as biomimetic cellular membrane, which separates the interior of cell mimics from 
the external environment and controls the passage of nutrient molecules and waste into and 
out of the cell mimics. 
  (ii) Realization of enzyme-loaded and pH-responsive Ada-polymersomes as organelle 
mimics, which are specialized subunits within cell mimics with the ability to carry out 
specific metabolic activities. 
  (iii) Construction of multicompartimentalized cell mimics, which incorporate enzyme-
loaded and pH-responsive Ada-polymersomes in multi-responsive and multifunctional 
polymer hollow capsules. 
  (iv) Metabolism mimicry for various enzymatic reactions, which are perform by multiple 
successive two-enzyme cascade reactions in the cell mimics and competitive enzymatic 
reactions by using a third enzyme for deactivating the reaction product and interfering the 
cascade reaction. 
Each of these findings was shown at different stages of the whole research period as 
summarized in Figure 10.1. These are fulfilling the sub-objectives of the thesis to reach the 
overall goal.  
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Figure 10.1 General overview of the main research developments within this work indicating 
the sub-divisions (1: chapter 7; 2: chapter 8; 3&4: chapter 9). 
In this context, in the first step pH and temperature dual-responsive and photo-crosslinked 
hollow capsules as biomimetic cellular membrane were prepared via layer-by-layer (LbL) 
assembly of the cationic poly(allylamine hydrochloride) (PAH) and the anionic, pH- and 
thermo-responsive and photo-crosslinkable block copolymer poly-(N-isopropylacrylamide)-
block-poly[methacrylic acid-co-2-hydroxy-4-(methacryloyloxy) benzophenone] (PNMB) 
synthesized by RAFT polymerization. These well-defined hollow capsules were smoothly 
visualized by TEM and SEM study, while their changes in diameters (480-560 nm) were 
related to the degree of photo-crosslinking determined by DLS measurements. The uniform 
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photo-crosslinked hollow capsules exhibited stimuli-responsive behavior towards changing 
environmental conditions of pH and temperature. In addition, for mimicking cell membrane 
functions those hollow capsules were used for the subsequent and easily available post-
encapsulation process of protein-like macromolecules, specifically dendritic glycopolymers of 
different sizes (PEI-Mal5 and PEI-Mal25), and the controllable release of the cargo triggered 
by external stimuli was studied. The important finding here was that post-encapsulation and 
release of biological-active molecules were adapted depending on the crosslinking density, 
the size of cargo, and the external stimuli temperature and pH of post-encapsulating and 
releasing medium. Importantly, the state of charge and hydrogen bonding controlled within 
the LbL membrane by the external trigger have a major influence on the cargo release. Thus, 
these photo-crosslinked and dual stimuli-responsive hollow capsules with different degrees of 
membrane permeability can be considered as attractive materials for mimicking cell 
membrane functions where uptake and release of different nanometer-sized biomolecules (up 
to 10 nm in diameter) can be controlled (Figure 10.1-1).  
Besides, following previous expertise of our group,96, 247 the starting point of forming 
polymersomal subcompartmens as organelle mimics was the synthesis of three amphiphilic 
block copolymers comprising adamantane, amine and methoxy end groups at their 
hydrophilic PEG chain whereas pH-sensitive DEAEM units and a photo-crosslinker BMA 
groups together form the hydrophobic part (Figure 10.2). The integrated adamantane groups 
were utilized to anchor the polymersomes to the membrane of the LbL capsules by host-guest 
interactions with β-CD receptors, while the amine groups were used for the sequential post-
labelling of Ada-polymersomes with fluorescein isothiocyanate (FITC) to allow visualization 
by fluorescence microscopy. After photo-crosslinking the membrane of Ada-polymersomes, 
these multifunctional polymersomal subcompartmens possessed reversible swelling (pH 6) 
and deswelling (pH 8) abilities up to 5 cycles and also demonstrated a remarkable pH-stability 
at different pH environments. In addition, using the similar strategy for enzymatic reactions of 
polymersomes previously described by Voit group, various enzymatic reactions of our 
enzyme-loaded Ada-polymersomes were conducted. The important finding here was that the 
enzyme substrates only diffused through the membrane of the Ada-polymersomes in the 
swollen state, regardless of whether a single enzyme or a group of enzymes is presented, and 
the control over reactivity lasted over repeated pH changes. Thus, these established Ada-
polymersomes have unique advantages, including their small size (100 nm), ease of 
preparation, expected good biocompatibility, tunable permeability, proper stability, pH 
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responsivity and potential for introducing multiple targeting groups, and further exhibit new 
opportunities for integrating in MS for synthetic biology (Figure 10.1-2). 
 
Figure 10.2 Schematic overview of the chemical structures of block copolymers having 
methoxy (Me-BCP), adamantane (Ada-BCP) and amine (Amine-BCP) functionalities for 
forming Ada-polymersomes. 
Based on the above concepts, a bottom-up approach was developed to assemble a structural 
and functional eukaryotic cell mimics by loading pH-responsive and enzymatically active 
Ada-polymersomes as organelle mimics within a pH and temperature dual-responsive 
capsules biomimetic cellular membrane (Figure 10.1-3). In brief, the enzyme-loaded, pH-
responsive and photo-crosslinked Ada-polymersomes are taken as organelle mimics to 
incorporate to the MS by non-covalent host-guest interaction; temperature responsive and 
photo-crosslinkable PMA(β-CD)/[PAH/PNMD]3 multilayers and outer protective capping 
PAH/PMA(PEG)  bilayer are further assembled to mimic the cell membrane. Upon photo-
crosslinking the polymer biomimetic membrane and dissolution of the particle templates, two 
types of artificial cells: “membrane-associated” MS1 and “free-floating” MS2 through non-
covalent host-guest concept were realized, whereas the “free-floading” MS2 were achieved by 
breaking the host-guest interactions of the Ada-polymersomes with the LbL layer through 
addition of excess β-CD. The successful fabrication of PAH/PMA(β-CD)/Ada-
polymersomes/PMA(β-CD)/[PAH/PNMD)]3/PAH/PMA(PEG) multilayers was confirmed by zeta 
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potential measurements. Moreover, these two types of artificial cells showed different 
temperature and pH dual-responsive characteristics and also had a good morphological 
integrity and colloidal stability.  
In the final part of this work, a metabolism mimicry for various enzymatic reactions in 
enzyme-loaded MS was performed in a highly controlled and reproducible, selective, specific, 
efficient and continuous manner (Figure 10.1-4). Due to the multiple key characteristics of 
artificial cells and organelle mimics the enzymes were better protected in the 
subcompartments and reinitiated with no loss of functional activity in enzymatic cascade 
reactions at pH 6 after cyclic pH switches between pH 6 and 8, while biomimetic cellular 
membrane was constantly permeable for small substrate and metabolite molecules at each pH 
value used. Moreover, flux balance and imbalance of intermediate metabolites pave also the 
way in our metabolism mimicry caused by the combination of spatially separated enzymes, 
constantly permeable biomimetic cellular membrane and substrate-channeling effect within 
artificial cells and/or competitive metabolite pathways due to multiple membrane crossing. 
Thus, the bienzymatic reactions and competitive enzymatic reactions performed in multiple 
ways could be switched off and on completely in a highly reproducible enzymatic behavior 
and were controlled in the biomimetic multicompartmentalized systems.  
Thus, by combining the advantages of pH-responsive Ada-polymersomes as organelle mimics 
and multifunctional hollow capsule as biomimetic cellular membrane, these artificial cells 
retain the key advantages of Ada-polymersomes and polymer capsules while overcoming the 
inherent limitations of each individual component, i.e., (i) Ada-polymersomes provide 
specialized subcompartments, allowing encapsulation of fragile cargo and successive 
triggered enzymatic catalysis within confined environments and (ii) polymer capsules provide 
structural scaffold with controlled permeability. Furthermore, compared to the already 
described multicompartment systems in the literature, our artificial cells exhibit various 
valuable key characteristics. For instance, structural stability at various pH values and 
temperatures is higher because of both photo-crosslinked subcompartments and biomimetic 
cellular membrane. The permeability of membrane is also controllable due to the pH-
responsive organelle mimics as well as temperature and pH dual-responsive cellular 
membrane. The orthogonal behavior of our artificial cells for achieving controlled release in a 
selective manner is realized, which pH can be used to control the release behavior of the 
organelle mimics while orthogonal stimulus (temperature) can be used to independently tune 
the overall permeability of the cellular membrane without affecting the organelle mimics 
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properties. The high level of sub-compartmentalization can be utilized for loading different 
and diverse components in different compartments. The variable surface functionality can 
prevent undesired protein interaction on the surface of the cell mimic due to a PEG outer shell. 
Based on the achieved goals, this work can go further in diverse directions, demonstrating the 
potential of the multicompartmentlized carrier system for miniaturized devices to be used in 
the application of such cell mimics for diagnostics, gene transfection, tissue engineering, as 
nanoreactors, as carriers for multiple drug delivery with controlled release profiles. Especially, 
our multicompartmentalized systems can be utilized to load different and diverse components 
in different compartments followed by triggering their independent release of the 
encapsulated (therapeutic) molecules in a preprogrammed, sequential and reversible fashion. 
Moreover, cargo encapsulation in the subcompartments and triggered multiple encapsulated 
catalysis in MS described in this thesis highlight crucial aspects for future therapeutic 
applications from self-regulating bioreactors to new biomedical devices, which focus on 
enzymatic activities to degrade waste products or to support the synthesis of medically 
relevant biomolecules. Especially, our multicompartmentalized systems have the potential to 
replenish missing or deficient cellular enzymatic activities and therefore hold tremendous 
promise for treating diseases on the cellular and subcellular levels.  
Furthermore, these MS can simultaneously be used as drug carriers and applied in complex 
biological environments with changing stimuli-responsive conditions and has potential in 
biomedical applications and sensory devices because of their high biocompatibility and 
protection against biological attacks. Besides, future research is also likely to direct the MS as 
tools in theranostics, which combines therapeutic delivery and diagnostic imaging. 
Therapeutic molecules and imaging agents can be spatially coencapsulated in different 
compartments, and this system will enable the simultaneous imaging and monitoring of drug 
delivery kinetics and their efficacy in diseased tissue. 
In addition, these engineered MS with tailored properties present new opportunities en route 
to the development of biomimetic structures toward next-generation therapeutic concepts, 
including the investigation into the performance of MS in chemically diverse biological 
environments and studies of their interactions with cellular structures, which are critical to 
ensure long-term performance of these assemblies in biological systems. It is envisaged that 
future research based upon the findings presented in this thesis will lead to fabrication of 
robust, subcompartmentalized assembly approaching the long-term catalytic performance of 
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living cells. The ultimate goal will be to develop valuable artificial organelles, simulate the 
proliferation and differentiation of cells and used successfully to produce tissue-like structures 
with interesting and important applications in regenerative medicine, for instance, the 
regeneration of cornea, skin, liver, heart and blood vessels. Therefore, one can expect the 
growing interest in such biomimetic approaches to soon offer many new opportunities in drug 
delivery, cell-like reactor systems, synthetic biology, biosensors and biomaterials, allowing 
better communication and interaction with living systems. 
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11 Abbreviations and Symbols 
Ada Adamantane 
ATRP  Atom transfer radical polymerization  
AIBN 2,2′-Azobis(2-methylpropionitrile)  
ACS American Chemical Society 
β-CD β-Cyclodextrin 
bpy 2,2'-Bipyridine 
βGLU β-glucosidase 
BMA 2-Hydroxy-4-(methacryloyloxy) benzophenone  
BSA Bovine serum albumin 
Boc-NH-PEG-NH2 Alpha-t-butyloxycarbonylamino-omega-amino terminated poly 
(ethylene glycol)  
BC Block polymer 
Cu(I)Br Copper (I) bromide 
CaCO3 Calcium carbonate 
cryo-TEM Cryogenic transmission electron microscopy  
CLSM Confocal laser scanning microscopy  
CTA chain transfer agent  
DCC N,N’-Dicyclohexylcarbodiimide 
DLS Dynamic Light Scattering 
DIPEA N,N-Diisopropylethylamine  
DMF N,N-Dimethylformamide  
DCM Dichloromethane  
DEAEMA 2-(Diethylamino) ethyl methacrylate  
DMAP 4-(Dimethylamino) pyridine  
DMIBM 3,4-Dimethyl maleic imidobutyl methacrylate 
DMSO Dimethyl sulfoxide  
DMAC  Dimethylacetamide  
Dox  Doxorubicin  
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EDC N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride  
FITC Fluorescein isothiocyanate  
GSSG glutathione disulfide 
GSH glutathione 
GOx Glucose oxidase  
GPC Gel permeation chromatography 
g Gram 
H2O Water 
H2O2 Hydrogen peroxide  
HA Hyaluronic acid 
HF Hydrofluoric acid  
HFF Hollow fiber filtration 
HOBt N-Hydroxybenzotriazole  
HCl Hydrochloric acid 
LbL Layer-by Layer 
LCST lower critical solution temperature  
MA Methacrylic acid  
Mal D-Maltose monohydrate  
Myo Myoglobin 
MWCO Molecular weight cut-off  
MS multicompartmentalized system 
MS1 “membrane-associated” multicompartmentalized system 
MS2 “free-floating” multicompartmentalized system  
NMR Nuclear magnetic resonance  
NH4F Ammonium fluoride  
nm Nanometer 
NaCl Sodium chloride  
NH4OH Ammonia solution  
N3PEG-OH Azide terminated poly (ethylene glycol)  
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NIPAM N-isopropyacrylamide 
NaOH Sodium hydroxide 
NaH2PO4 Monosodium phosphate 
Na2HPO4.7H2O   Sodium Phosphate dibasic heptahydrate 
PSS Poly(sodium 4-styrenesulfonate) 
ppm part per million 
PDI Polydispersity index  
PLL poly(Llysine) 
PAH Poly(allylamine hydrochloride) 
PMA Poly(methyl methacrylate) 
PMA(β-CD) β-Cyclodextrin Functionalized Poly(methyl methacrylate)  
PMA(PEG) Poly(ethylene glycol) Functionalized Poly(methyl methacrylate)  
PEI  Hyperbranched poly(ethylene imine)  
PEG Poly(ethylene glycol) 
PEG-OH Poly (ethylene glycol) methyl ether 
PNMB Poly-(N-isopropylacrylamide)-block-poly[methacrylic acid-co-2-
hydroxy-4-(methacryloyloxy) benzophenone] 
PRNMB Poly-(N-isopropylacrylamide)-co-poly(methacrylic acid)-co-
poly(2-hydroxy-4-(methacryloyloxy) benzophenone) random 
copolymer 
PNMD Poly-(N-isopropylacrylamide)-block-poly[methacrylic acid-co-
3,4-dimethyl maleic imidobutyl methacrylate] 
PNIPAM Poly (N-isopropyacrylamide) 
PBS Phosphate buffered saline  
RAFT reversible addition-fragmentation chain transfer radical 
polymerization 
Ref. Reference 
RSC   Royal Chemical Socitey 
SiO2 Silicon dioxide 
SEM Scanning electron microscopy  
THF Tetrahydrofuran  
150 
 
TCI transcutaneous immunization 
TTx tetanus toxoid 
TEM Transmission electron microscopy  
TEA Triethylamine  
TFA Trifluoroacetic acid  
µm Micrometer 
UV-vis  Ultraviolet-visible  
A  Absorbance  
Ð Dispersity of polymers  
1H Proton 
kB Boltzmann constant  
Mw Mass average molecular weight  
Mn Number average molecular weight  
pKa  Acid dissociation constant  
RH  z-average hydrodynamic radius  
Tm phase transition temperature 
ζ zeta potential  
η Viscosity 
ε dielectric constant 
%   Percentage / percent 
λ  Wavelength  
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